Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,40411,0.141385579803279,0.00271005872008091,0.13607386471192,0.146697294894637,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFGE8,Lactadherin,40332,-0.149042034159505,0.00372366308284469,-0.156340413801881,-0.14174365451713,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,40332,0.15518851764339,0.00263524819393163,0.150023431183284,0.160353604103496,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCG,Pro-glucagon,39980,-0.418075375995761,0.0110511341187118,-0.439735598868436,-0.396415153123086,1.1582184411474e-299
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRAP1,Proline-rich acidic protein 1,37998,-0.133508260486882,0.00373975242724499,-0.140838175244282,-0.126178345729482,7.5182320752276e-267
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS15,Enteropeptidase,40305,-0.266405407867337,0.00826390547795417,-0.282602662604127,-0.250208153130547,6.7255007435937e-221
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PYY,Peptide YY,37562,-0.272008388333878,0.00845901975463527,-0.288588067052963,-0.255428709614793,1.9651246167162e-218
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGSF9,Protein turtle homolog A,37990,-0.224833448015873,0.00710304771353495,-0.238755421534401,-0.210911474497344,3.36575474649494e-212
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS8,Prostasin,40293,-0.113491954021665,0.00362602003312493,-0.12059895328659,-0.10638495475674,1.02300910818043e-208
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PON3,Serum paraoxonase/lactonase 3,40422,0.0749666679269489,0.00246709277388132,0.0701311660901415,0.0798021697637563,3.24064977824677e-197
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37900,-0.144519028364744,0.00489059317770892,-0.154104590993054,-0.134933465736435,5.34468270147748e-186
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPY,Pro-neuropeptide Y,40489,-0.165885479618727,0.00602820630130826,-0.177700763969291,-0.154070195268162,6.32030052264788e-163
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,40228,-0.0715175741326746,0.00265763822970375,-0.076726545062894,-0.0663086032024553,5.42458594979257e-156
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFPI,Tissue factor pathway inhibitor,40309,0.0746735175166866,0.00282612511601792,0.0691343122892915,0.0802127227440817,1.34675041590148e-150
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGRP,Agouti-related protein,40516,-0.126565153977945,0.00484406501110619,-0.136059521399714,-0.117070786556177,2.07731967739501e-147
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOF,Apolipoprotein F,37987,0.0569480037320834,0.00218683986195422,0.0526617976026532,0.0612342098615137,6.44213557613984e-146
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OXT,Oxytocin-neurophysin 1,40471,-0.311013253343248,0.0119911725079192,-0.334515951458769,-0.287510555227726,2.5177740903125e-145
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40500,0.265457844628372,0.0106719640963391,0.244540794999547,0.286374894257197,4.82109805105754e-134
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPR37,Prosaposin receptor GPR37,40042,-0.144456774433872,0.0061216109721564,-0.156455131939298,-0.132458416928445,5.31171933598053e-121
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,-0.068742078491851,0.00291661645047506,-0.0744586467347822,-0.0630255102489199,9.6710106955763e-121
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C9,Complement component C9,37987,0.102321939858551,0.00443054295854349,0.0936380756598054,0.111005804057296,8.9383350074702e-116
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC39A5,Zinc transporter ZIP5,40341,-0.110993135797289,0.00487687269593546,-0.120551806281323,-0.101434465313256,7.38535214538068e-113
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17RB,Interleukin-17 receptor B,40126,0.109856118449306,0.00486922225952574,0.100312442820636,0.119399794077977,6.03384647863217e-111
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA14,Carbonic anhydrase 14,40489,0.0701872407708864,0.00314926176857139,0.0640146877044864,0.0763597938372863,2.17798868366358e-108
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS4,Galectin-4,40357,-0.105181985410953,0.00482509559847836,-0.114639172783971,-0.0957247980379357,7.82276698254581e-104
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIP,Gastric inhibitory polypeptide,37628,-0.102786044664336,0.00470970393497461,-0.112017064376886,-0.093555024951786,9.28925897913769e-104
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOM,Apolipoprotein M,40372,0.0523634477968157,0.00244786768990978,0.0475656271245925,0.0571612684690388,4.10039560984318e-100
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADIPOQ,Adiponectin,38013,0.128055933555725,0.0060623644781845,0.116173699178484,0.139938167932967,1.79928799571448e-97
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPY,Pancreatic prohormone,40337,-0.193709986947677,0.00921573836797038,-0.211772834148899,-0.175647139746455,9.00807437749023e-97
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACY1,Aminoacylase-1,40359,-0.11304034229375,0.00544137964868161,-0.123705446405166,-0.102375238182334,1.3311343491323e-94
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MUC13,Mucin-13,39961,-0.0927827316632372,0.00460025250750045,-0.101799226577938,-0.0837662367485363,2.55233275586447e-89
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LDLR,Low-density lipoprotein receptor,40356,-0.0966076436521716,0.0047915647904174,-0.10599911064139,-0.0872161766629534,2.74887762215562e-89
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NHLRC3,NHL repeat-containing protein 3,37370,-0.0583519626346116,0.00292105694594325,-0.0640772342486604,-0.0526266910205628,1.84118099549987e-87
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MET,Hepatocyte growth factor receptor,40375,0.03672001895681,0.00184228702613099,0.0331091363855932,0.0403309015280267,2.50085866096533e-87
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFF3,Trefoil factor 3,40309,-0.0966241354130978,0.00489921127240775,-0.106226589507017,-0.0870216813191786,1.46602072863052e-85
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTRK3,NT-3 growth factor receptor,40471,0.0391275044494833,0.00199749511534793,0.0352124140234014,0.0430425948755653,1.89048310020632e-84
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,40372,0.0532509751656044,0.00272100538210682,0.047917804616675,0.0585841457145338,2.70449044054934e-84
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,-0.120636603255371,0.00618260143680441,-0.132754502071507,-0.108518704439234,8.29065641467262e-84
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37942,0.0651182486637255,0.00335772597509062,0.0585371057525479,0.0716993915749031,1.16315408552256e-82
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN1,CCN family member 1,40280,-0.137637693089424,0.00713979437209287,-0.151631690058726,-0.123643696120122,7.18576344804408e-82
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40453,-0.0736347113426525,0.00384013068309333,-0.0811613674815154,-0.0661080552037896,4.84382898170859e-81
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37790,-0.0455074839835384,0.00237275857548622,-0.0501580907914914,-0.0408568771755854,6.76153582851231e-81
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMOT,Angiomotin,37671,-0.0731695756102093,0.00381867657911633,-0.0806541817052773,-0.0656849695151413,9.7102265011799e-81
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCG2,Secretogranin-2,40392,-0.0563792685362572,0.00295246008762321,-0.0621660903079987,-0.0505924467645157,2.16310998887737e-80
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INHBC,Inhibin beta C chain,40332,-0.0744635296513009,0.00389953367493661,-0.0821066156541767,-0.0668204436484251,2.18781462017019e-80
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,-0.05990701810536,0.00316137617303023,-0.0661033154044992,-0.0537107208062207,3.28789220660002e-79
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACE2,Angiotensin-converting enzyme 2,40042,-0.0849614857718879,0.0044856090070564,-0.0937532794257184,-0.0761696921180574,4.05359343979978e-79
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40489,-0.0638188719078481,0.00338922845485837,-0.0704617596793705,-0.0571759841363257,2.9954966777984e-78
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CES1,Liver carboxylesterase 1,40352,-0.131195878591763,0.0069796083204372,-0.14487591089982,-0.117515846283706,5.58743889310336e-78
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL16,C-C motif chemokine 16,40536,-0.0907102169712305,0.0048528384511001,-0.100221780335387,-0.0811986536070743,3.75991021249524e-77
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPL,Lipoprotein lipase,40359,0.0780463768105857,0.00420762232235029,0.0697994370587792,0.0862933165623923,5.27499924734954e-76
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MVK,Mevalonate kinase,40044,-0.129995354457018,0.00702857553009253,-0.143771362496,-0.116219346418037,1.44822017000863e-75
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GDF15,Growth/differentiation factor 15,40536,-0.0729694607815949,0.0039506901020359,-0.0807128133815852,-0.0652261081816045,2.16364504450484e-75
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMBP,Protein AMBP,40470,-0.0338292098729433,0.00183244612916206,-0.0374208042861009,-0.0302376154597856,2.55766691849689e-75
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHI3L1,Chitinase-3-like protein 1,40054,-0.125668986962648,0.00683132688424142,-0.139058387655761,-0.112279586269535,8.72822382878274e-75
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM3B,Protein FAM3B,40305,-0.0606324472203795,0.00331463414108904,-0.067129130136914,-0.054135764303845,5.4884881060463e-74
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FURIN,Furin,40411,-0.0561360234366501,0.00308487043201747,-0.0621823694834044,-0.0500896773898959,2.98642449459746e-73
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37671,-0.0626384308563889,0.00344713382260019,-0.0693948131486853,-0.0558820485640925,6.71960413851323e-73
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,40359,0.0447912767404165,0.00246870066115471,0.0399526234445533,0.0496299300362798,7.81101611080093e-73
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCAM,Cell surface glycoprotein MUC18,40403,0.0562331603877804,0.0031249289925551,0.0501082995623724,0.0623580212131884,1.0895961793119e-71
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPA2,Carboxypeptidase A2,40398,-0.105639598955424,0.00588188782542068,-0.117168099093248,-0.094111098817599,2.01898763861938e-71
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTH,Parathyroid hormone,37572,-0.129697687476944,0.00721712959773176,-0.143843261488498,-0.115552113465389,2.35925512532575e-71
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHA1,Ephrin type-A receptor 1,40400,-0.0558536040751018,0.00313004915643956,-0.0619885004217233,-0.0497187077284803,1.55097383489216e-70
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RTN4R,Reticulon-4 receptor,40489,-0.0548028067248309,0.00310430782175476,-0.0608872500554702,-0.0487183633941916,4.28307503727283e-69
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UMOD,Uromodulin,40502,0.0876089402572997,0.00497699468518636,0.0778540306743344,0.0973638498402649,1.03654904871321e-68
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF21,Fibroblast growth factor 21,40453,-0.188748821448134,0.0107315791852542,-0.209782716651232,-0.167714926245036,1.34099288542715e-68
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,40063,-0.0675237321251693,0.00389107506394154,-0.0751502392504947,-0.0598972249998439,7.8612310870449e-67
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,0.0411046318268914,0.00237743297132955,0.0364448632030855,0.0457644004506973,2.2497153976769e-66
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,-0.0549018965384236,0.00318923054048192,-0.0611527883977681,-0.048651004679079,8.08130676952409e-66
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPM,Carboxypeptidase M,40415,-0.0539948351866354,0.00314039637009897,-0.0601500120720293,-0.0478396583012414,1.15595345507436e-65
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEP1A,Meprin A subunit alpha,37901,-0.106532789476688,0.00626187218572474,-0.118806058960709,-0.0942595199926677,3.09036933828218e-64
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F9,Coagulation factor IX,40372,-0.0278780729406929,0.00165258616317239,-0.0311171418205107,-0.024639004060875,2.68054883021691e-63
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRP1,Neuropilin-1,40424,0.0434827385942113,0.00259016436303633,0.0384060164426601,0.0485594607457625,1.03607636267269e-62
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,-0.0521136347661389,0.00311447417915481,-0.0582180041572824,-0.0460092653749955,2.58060635815732e-62
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL15,C-C motif chemokine 15,40536,-0.0682983747936716,0.00409299398644682,-0.0763206430071074,-0.0602761065802358,5.44141744585693e-62
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,-0.0635044761298369,0.00381440832628183,-0.0709807164493493,-0.0560282358103245,1.03527533218103e-61
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OMD,Osteomodulin,40422,0.0676154486264538,0.00407332585866762,0.0596317299434653,0.0755991673094424,2.29264215708005e-61
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLA,Alpha-galactosidase A,37642,-0.0550490266020364,0.00332058971387955,-0.0615573824412403,-0.0485406707628325,4.16230348679454e-61
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F7,Coagulation factor VII,40376,-0.0452609786995637,0.00275272524700229,-0.0506563201836881,-0.0398656372154392,2.98958305339123e-60
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AREG,Amphiregulin,40305,-0.074543766777136,0.00455726148264443,-0.0834759992831191,-0.0656115342711529,1.19131013642239e-59
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,40313,-0.0820055725690366,0.00505657354180035,-0.0919164567109653,-0.0720946884271079,1.12227922690734e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,40379,0.0473033941706653,0.00291730128991167,0.0415854836424385,0.0530213046988922,1.16924630686773e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,40305,-0.0815951859816063,0.00503487325135395,-0.09146353755426,-0.0717268344089525,1.35224706921891e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSD,Cathepsin D,39243,-0.0594574592497358,0.00367261435839463,-0.0666557833921893,-0.0522591351072823,1.90376172402504e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCAM2,Neural cell adhesion molecule 2,40332,0.040060770697185,0.00248308166591616,0.0351939306319894,0.0449276107623807,4.29697240367812e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,40341,-0.0784670899564566,0.00487881193237501,-0.0880295613439116,-0.0689046185690015,9.55272584465726e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,-0.056114430924444,0.00350649306582665,-0.0629871573334643,-0.0492417045154238,3.36917726774331e-57
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN1,Contactin-1,40536,0.0405237141735572,0.00254286315163182,0.0355397023963588,0.0455077259507555,9.6490918761515e-57
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UPB1,Beta-ureidopropionase,37990,-0.133366722110532,0.00837028889602068,-0.149772488346733,-0.116960955874332,1.21611044051171e-56
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGR3,Anterior gradient protein 3,39963,-0.0866525873813691,0.00547020276564071,-0.0973741848020249,-0.0759309899607133,4.47477448265766e-56
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,40424,-0.0671185648866792,0.00424291021719201,-0.0754346689123755,-0.0588024608609828,6.11864385261704e-56
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSO,Cathepsin O,40516,-0.043710247105458,0.00276450750174073,-0.0491286818088698,-0.0382918124020462,6.87062520811716e-56
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NECTIN2,Nectin-2,40330,-0.0419287869835401,0.00266176690710264,-0.0471458501214612,-0.0367117238456189,1.74383435339378e-55
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCAM1,Neural cell adhesion molecule 1,40403,0.0400929306358887,0.00254643116664581,0.035101925549263,0.0450839357225145,1.95080795314502e-55
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GUSB,Beta-glucuronidase,40419,-0.0843490919983997,0.00537410158202401,-0.0948823310991667,-0.0738158528976326,4.19194078003058e-55
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,40359,-0.0430399477513989,0.00274956532657417,-0.0484290957914843,-0.0376507997113136,8.08000337317339e-55
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,-0.113291118174016,0.00727459020576755,-0.12754931497732,-0.0990329213707116,2.77997228899428e-54
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39839,-0.145273155659446,0.00933652696268131,-0.163572748506302,-0.126973562812591,3.53890424174967e-54
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FETUB,Fetuin-B,40372,-0.0479598919260095,0.00311241629612642,-0.0540602278664173,-0.0418595559856017,3.43552735169941e-53
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,40141,-0.209317240522836,0.0136247753556187,-0.236021800219849,-0.182612680825823,7.03357602005199e-53
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MME,Neprilysin,40305,-0.114421225275117,0.00748470504673596,-0.12909124716672,-0.0997512033835146,2.19511977539527e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,0.0340075391145856,0.00223119347103352,0.0296343999113599,0.0383806783178113,4.31120174163541e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,40332,-0.0606119130033141,0.00399022280330212,-0.0684327496977863,-0.052791076308842,9.50061825446794e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSB,Cathepsin B,40353,0.0754654493885698,0.00497582956470773,0.0657128234417426,0.0852180753353969,1.35502095461842e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GHR,Growth hormone receptor,37671,-0.0401628838221585,0.00265131525955908,-0.0453594617308943,-0.0349663059134227,2.09932823454952e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACAN,Aggrecan core protein,40224,0.0395972558419668,0.00261669530163646,0.0344685330507593,0.0447259786331742,2.26679402861545e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTSS1,Protein MTSS 1,37901,-0.153122052329475,0.0101478052879698,-0.173011750693896,-0.133232353965055,4.98948411478571e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,-0.0810244039472575,0.00539095088600381,-0.091590667683825,-0.0704581402106901,1.06597776319645e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HJV,Hemojuvelin,37959,-0.0630659396449148,0.00423189721711883,-0.0713604581904677,-0.0547714210993619,7.89358104731119e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSZ,Cathepsin Z,40345,-0.0425999341411916,0.0028624815546517,-0.048210397988309,-0.0369894702940743,9.30712245865529e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGF,Placenta growth factor,40516,-0.0356932732020961,0.00241599794637018,-0.0404286291769816,-0.0309579172272105,4.54302951886976e-49
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,-0.0571591895714181,0.00387554582640459,-0.0647552593911711,-0.0495631197516651,6.6001328979469e-49
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,0.033320156544332,0.00226207434668091,0.0288864908248374,0.0377538222638266,8.69802927679089e-49
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTBS,Di-N-acetylchitobiase,37819,-0.0367197067047076,0.00249407857664934,-0.0416081007149403,-0.0318313126944749,1.1073501542144e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRP,Gastrin-releasing peptide,37628,-0.0733703245303532,0.00500502253074063,-0.0831801686906049,-0.0635604803701016,2.8161701686623e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,-0.0465167521836608,0.00319061495559376,-0.0527703574966245,-0.040263146870697,7.70276247092026e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLUL1,Clusterin-like protein 1,40338,0.0611048884133831,0.00419378978620267,0.0528850604324259,0.0693247163943404,8.82031430286587e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTA1,Glutathione S-transferase A1,40333,-0.110986065253344,0.00761741458022048,-0.125916197830576,-0.0960559326761118,8.8584082193726e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGFR,Epidermal growth factor receptor,40536,0.0219132379469715,0.00150922565167447,0.0189551556696896,0.0248713202242535,1.81949921142432e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCAN,Neurocan core protein,40471,0.0497689782115597,0.00343133094832176,0.043043569552849,0.0564943868702703,2.2721914913955e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFASC,Neurofascin,40516,-0.0363089290585495,0.00250657527971895,-0.0412218166067987,-0.0313960415103004,2.97174340516416e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPB1,Carboxypeptidase B,40536,-0.0749370874153719,0.00519161586957743,-0.0851126545197437,-0.0647615203110001,6.18994356915238e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPP4,Dipeptidyl peptidase 4,40068,0.0396623035227833,0.0027558414565526,0.0342608542679402,0.0450637527776264,1.15377301237971e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37920,-0.109864249241525,0.00763633147423888,-0.124831458931033,-0.0948970395520168,1.38170510971437e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,-0.111282391055153,0.00775293022476081,-0.126478134295685,-0.0960866478146223,1.99933893268819e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AFM,Afamin,38013,-0.0246071402498088,0.00171566995315271,-0.0279698533579881,-0.0212444271416295,2.58584682660645e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40536,0.0454092473480522,0.00318848035937352,0.0391598258436801,0.0516586688524243,9.58323625076473e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSG2,Desmoglein-2,40332,0.0350406035174404,0.00247975751089988,0.0301802787960766,0.0399009282388041,4.60990745085617e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCAN,Brevican core protein,40228,0.0436680683456674,0.00309121096167858,0.0376092948607774,0.0497268418305575,4.90502508293685e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOMO1,Nodal modulator 1,40332,-0.030715051941735,0.00217878695461897,-0.0349854743727881,-0.0264446295106818,7.35398221770073e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF23,Fibroblast growth factor 23,40469,-0.0797792982902149,0.00567875083826901,-0.0909096499332221,-0.0686489466472076,1.44198974548041e-44
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD4,T-cell surface glycoprotein CD4,40309,-0.0388513622957397,0.00280943151397109,-0.044357848063123,-0.0333448765283564,3.04077452823112e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,-0.0783366594053531,0.00567629923818383,-0.0894622059121934,-0.0672111128985128,4.53471522321638e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSF,Cathepsin F,40411,-0.050699670421678,0.00368575138652186,-0.0579237431392609,-0.0434755977040952,8.27278404265388e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASPN,Asporin,37990,0.0344865262995721,0.00250996799134427,0.0295669890365373,0.0394060635626069,1.13293336289145e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,-0.0581087745087137,0.00423277016359644,-0.0664050040293627,-0.0498125449880647,1.21122921585e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REN,Renin,40359,-0.090225739918712,0.00658094681893616,-0.103124395683827,-0.0773270841535971,1.54058186759348e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPO,Erythropoietin,40341,-0.0982784143423587,0.0072149056899667,-0.112419629494693,-0.084137199190024,5.13146714078942e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,-0.0935174521980151,0.00692141095182115,-0.107083417663585,-0.0799514867324456,2.48949619481073e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POSTN,Periostin,37998,0.0469747060802848,0.00347964152026282,0.0401546087005697,0.0537948034599999,2.89524393474247e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,-0.129625198205471,0.00965931558923768,-0.148557456760377,-0.110692939650565,7.74423328232427e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTA3,Glutathione S-transferase A3,39980,-0.0932385902828603,0.00697185241803247,-0.106903421022204,-0.0795737595435166,1.44681235370865e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INSL5,Insulin-like peptide INSL5,37901,-0.115368516945295,0.00863454220016814,-0.132292219657625,-0.0984448142329658,1.84351777674644e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37598,-0.149180852831123,0.0111805826724017,-0.17109479486903,-0.127266910793216,2.38530189617007e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,0.0460451875558688,0.00346486542136013,0.039254051330003,0.0528363237817347,4.37006297393385e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HGF,Hepatocyte growth factor,40516,-0.0418270546281922,0.00315435410554336,-0.0480095886750572,-0.0356445205813272,6.3929167105154e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F11R,Junctional adhesion molecule A,40332,-0.0687801326538023,0.00520489293171258,-0.0789817227999589,-0.0585785425076456,1.17162350704237e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C4BPB,C4b-binding protein beta chain,40411,0.0502045607640548,0.00380138371217531,0.0427538486881912,0.0576552728399184,1.29157188233314e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN5,Contactin-5,40367,0.0448089282762772,0.00341410098262419,0.0381172903503338,0.0515005662022206,3.79827535335311e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADM,Pro-adrenomedullin,40489,-0.0324484630936987,0.00248088719754887,-0.0373110020008945,-0.0275859241865029,6.83076844519878e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM3C,Protein FAM3C,40330,-0.035756806756627,0.00273930247433979,-0.041125839606333,-0.030387773906921,9.63778197637401e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",40305,-0.0925401056307593,0.0071007578734288,-0.10645759106268,-0.0786226201988388,1.26381030238572e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37959,-0.0686423417418402,0.0052742714824459,-0.0789799138474341,-0.0583047696362462,1.7227855859679e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCLY,Selenocysteine lyase,40434,-0.0570486763806883,0.00438613356067809,-0.0656454981596174,-0.0484518546017593,1.75971832306533e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,-0.0447335920388599,0.00344013781804282,-0.0514762621622238,-0.037990921915496,1.82920410357288e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40489,-0.039313276180134,0.00303634808966007,-0.0452645184358677,-0.0333620339244002,3.76726376624099e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40471,-0.041352130169488,0.00320225988437545,-0.0476285595428639,-0.0350757007961121,5.8485802066913e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37628,0.0756214386692564,0.00585950764696944,0.0641368036811963,0.0871060736573165,7.08290208981953e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,40422,-0.0338321112754896,0.0026247407950142,-0.0389766032337174,-0.0286876193172617,7.94273269990475e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASET2,Ribonuclease T2,40465,-0.0311280870525823,0.00243809890795033,-0.0359067609121649,-0.0263494131929996,3.78582885877396e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL23,C-C motif chemokine 23,40422,-0.0481973726868609,0.0037754712580602,-0.0555972963526589,-0.0407974490210629,3.85998298920646e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL27,C-C motif chemokine 27,40359,-0.0698539446265399,0.00548678430172997,-0.0806080418579306,-0.0590998473951491,6.00009225588132e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNGR2,Interferon gamma receptor 2,40228,-0.0605798996029552,0.00476255963137594,-0.069914516480452,-0.0512452827254584,6.9458253597425e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSN,Gelsolin,37928,0.0223399646996961,0.00175786163071813,0.0188945559034886,0.0257853734959037,8.61249522326671e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALCA,Calcitonin,40192,-0.0642580061898295,0.00507391410116892,-0.0742028778281206,-0.0543131345515385,1.40477482584986e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",40310,-0.0793194894589902,0.00627030571892231,-0.0916092886680779,-0.0670296902499024,1.6786167507089e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,40228,-0.0697693840313252,0.00552069387392374,-0.0805899440242157,-0.0589488240384347,1.96218139949502e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40497,0.074062568909339,0.00586155902889665,0.0625739132127016,0.0855512246059764,2.01101529630665e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37969,0.0563033974124054,0.00445667853022093,0.0475683074931724,0.0650384873316384,2.21566395462022e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRP2,Neuropilin-2,40332,0.0337299099731715,0.00268040849202541,0.0284763093288017,0.0389835106175413,3.85306420779002e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOD,Apolipoprotein D,37345,0.0515205890115979,0.00411112260477583,0.0434627887062373,0.0595783893169585,8.0659736733041e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,-0.0505247430733879,0.00404840612061261,-0.0584596190697886,-0.0425898670769872,1.41683498521741e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,40422,-0.0311101187007846,0.00249670057329623,-0.0360036518244452,-0.026216585577124,1.79251442878234e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37998,-0.0353996617622201,0.0028417552140336,-0.0409695019817259,-0.0298298215427142,2.0031468559714e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,-0.063067350226027,0.00506917425358451,-0.0730029317630527,-0.0531317686890014,2.28378826257145e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,40359,-0.0405439753784621,0.00325983095428044,-0.0469332440488518,-0.0341547067080725,2.38940817518638e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,-0.0643333777075958,0.00517094266451932,-0.0744684253300537,-0.054198330085138,2.46745978567786e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39961,-0.0627980992161851,0.00505276131160489,-0.0727015113869306,-0.0528946870454395,2.69634034525871e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,40411,0.0486375204221337,0.00391855907155108,0.0409571446418936,0.0563178962023738,3.26681448524705e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,-0.105041701804904,0.00847354444890274,-0.121649848924754,-0.0884335546850549,3.99978027384952e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PVR,Poliovirus receptor,40471,-0.0418857779446019,0.00338731298478124,-0.0485249113947731,-0.0352466444944307,5.80084891607218e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,-0.0444920271502997,0.00359859953235188,-0.0515452822337094,-0.03743877206689,5.95180755155423e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL15,Interleukin-15,40341,-0.0372204235456763,0.00302480584794192,-0.0431490430076425,-0.0312918040837101,1.2232308126907e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OCLN,Occludin,37959,-0.0494013363096521,0.00401482692975651,-0.0572703970919749,-0.0415322755273294,1.30893442847911e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS2,Trypsin-2,40403,-0.0569439944504381,0.00463471889097872,-0.0660280434767563,-0.0478599454241198,1.53560906989486e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A14,Protein S100-A14,37959,-0.0608018082276881,0.004957828877498,-0.0705191528275842,-0.0510844636277921,2.15903715169123e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSE,Cathepsin E,37671,-0.0582183435132494,0.00475733238571235,-0.0675427149892456,-0.0488939720372532,2.99862764156086e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,40391,-0.0261324124453896,0.00213726768420139,-0.0303214571064243,-0.0219433677843548,3.17374529689536e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPA1,Carboxypeptidase A1,40536,-0.0645045293934148,0.00528223171621843,-0.0748577035572029,-0.0541513552296267,3.81748950541555e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,-0.0346368015805285,0.00283842970358209,-0.0402001237995494,-0.0290734793615076,4.27070200871972e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEPH,Hephaestin,37990,-0.0278927674233725,0.00230883542012398,-0.0324180848468155,-0.0233674499999295,1.98019272409256e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPE,Carboxypeptidase E,40360,0.0425354315178969,0.00352519755138241,0.0356260443171874,0.0494448187186064,2.23101824185492e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39980,-0.0892104965982354,0.0074134757860473,-0.103740909138888,-0.0746800840575827,3.32642763710239e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELE,E-selectin,40536,-0.055461776074558,0.00461430110367765,-0.0645058062377662,-0.0464177459113498,3.89014621267503e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,0.0428812799462375,0.00357377008376473,0.0358766905820587,0.0498858693104164,5.002083613225e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBP5,Retinol-binding protein 5,40305,-0.0610203921606654,0.00510475045870669,-0.0710257030597305,-0.0510150812616003,8.59582053287837e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFHR4,Complement factor H-related protein 4,37973,0.0807753723287107,0.00678391534972944,0.067478898243241,0.0940718464141804,1.58417098296256e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHAD,Chondroadherin,37671,0.0589424951772949,0.00496657754619537,0.0492080031867519,0.0686769871678378,2.53765555546582e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEZ6L2,Seizure 6-like protein 2,40305,0.0259229196399085,0.00219495335671384,0.0216208110607493,0.0302250282190676,4.70888797378574e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,40341,-0.0409810633964629,0.00347955655976894,-0.04780099425361,-0.0341611325393158,6.90492184952299e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK14,Kallikrein-14,40489,0.0499092301998329,0.00423949747089279,0.041599815156883,0.0582186452427828,7.32213779614474e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,-0.0932261003011539,0.00793983836548101,-0.108788183497497,-0.0776640171048111,1.11279101793347e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100P,Protein S100-P,40042,-0.0580702990445517,0.00495673617144707,-0.0677855019405879,-0.0483550961485154,1.4409656183141e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,-0.040539287672111,0.00346226044218298,-0.0473253181387896,-0.0337532572054323,1.54964635654982e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA3F,Semaphorin-3F,40359,-0.0279362417807226,0.00238799911920426,-0.032616720054363,-0.0232557635070823,1.7437852541968e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,0.0478811296323599,0.00409668000749712,0.0398516368176655,0.0559106224470543,1.97678220254788e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CKB,Creatine kinase B-type,37998,0.0648319084363403,0.00556948020500984,0.053915727234521,0.0757480896381596,3.60665309346681e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOC1,Apolipoprotein C-I,37981,0.0389405941267709,0.00334574600031118,0.032382931966161,0.0454982562873808,3.68136817319914e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,40341,-0.0296684947040456,0.00255021858103385,-0.034666923122872,-0.0246700662852193,3.71520148931271e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAST,Gastrin,37942,-0.13946142500631,0.0119879825568487,-0.162957870817733,-0.115964979194886,3.92336702716518e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,0.0261142447811321,0.00224686521829015,0.0217103889532834,0.0305181006089808,4.22510896307133e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,0.0366989304652912,0.00316930201508542,0.0304870985157238,0.0429107624148586,6.96009261861926e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37671,0.0325634850214456,0.00281397216877322,0.0270480995706501,0.0380788704722411,8.03576509007194e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHBG,Sex hormone-binding globulin,37987,0.0570525022398165,0.00497869506116435,0.0472942599199344,0.0668107445596986,2.9114422717066e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HAO1,Hydroxyacid oxidase 1,40489,-0.137532991602086,0.0120190725620108,-0.161090373823627,-0.113975609380545,3.34293271448193e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH1,Cadherin-1,39806,-0.0423533522503867,0.00370365925223913,-0.0496125243847754,-0.035094180115998,3.67965062611464e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM20A,Pseudokinase FAM20A,37990,-0.0296574114401186,0.00260420031915526,-0.0347616440656629,-0.0245531788145743,6.54254860464806e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPOCK1,Testican-1,40228,0.026368195841789,0.00232458204558756,0.0218120150324374,0.0309243766511407,1.04481037915143e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,40312,-0.0212442156489116,0.00187895897458371,-0.0249269752390956,-0.0175614560587275,1.58294235856375e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,-0.0595916751224204,0.00527748614559683,-0.0699355479677902,-0.0492478022770507,1.96932962351511e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ROBO2,Roundabout homolog 2,40471,0.0242442108409531,0.00214868690816827,0.0200327845009433,0.028455637180963,2.04959938551699e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VASN,Vasorin,40116,0.0286225087831203,0.00253931142704918,0.0236454583861039,0.0335995591801367,2.34701070929054e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TTR,Transthyretin,37871,-0.026570100692923,0.00235760670932798,-0.0311910098432058,-0.0219491915426402,2.50132996013732e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,-0.0300747631565628,0.00267048736807891,-0.0353089183979975,-0.0248406079151282,2.61346981494446e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD209,CD209 antigen,40382,0.0403799608095812,0.00359137139506026,0.0333408728752631,0.0474190487438993,3.20823752779124e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,-0.0577846898130907,0.0051439738683383,-0.0678668785950337,-0.0477025010311476,3.61474973616394e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGAV,Integrin alpha-V,40489,0.0169426718589459,0.00151095045523123,0.0139812089666927,0.0199041347511991,4.50329647903887e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KHK,Ketohexokinase,37628,-0.066626518319053,0.0059450425579946,-0.0782788017327224,-0.0549742349053836,5.09237127918644e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VEGFA,Vascular endothelial growth factor A,40456,-0.0605217329194027,0.00541659542836387,-0.0711382599589959,-0.0499052058798095,7.0395855205149e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,40305,-0.0902580039433668,0.00810372461141254,-0.106141304181735,-0.0743747037049983,1.04904420928211e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,-0.03918504919746,0.00356358499178448,-0.0461696757813576,-0.0322004226135624,5.25469977158315e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTGR1,Prostaglandin reductase 1,37990,-0.0803094247898782,0.00732295020049936,-0.094662407182857,-0.0659564423968995,7.22849173203348e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLAU,Urokinase-type plasminogen activator,40332,0.029623615568581,0.00271302545662351,0.024306085673599,0.0349411454635631,1.17237194460916e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,-0.0210477186134009,0.00193647415310234,-0.0248432079534815,-0.0172522292733203,2.01644893707104e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IDUA,Alpha-L-iduronidase,40489,-0.0453185362249691,0.00416977155412309,-0.0534912884710504,-0.0371457839788879,2.03285526676771e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,40443,-0.0309289855413898,0.00285004635505304,-0.0365150763972938,-0.0253428946854859,2.42717323307672e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFNA4,Ephrin-A4,40203,-0.0294957517440093,0.00272184053977181,-0.034830559201962,-0.0241609442860565,2.87849451858624e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLB1,Beta-galactosidase,40228,-0.040483579680679,0.00376853782911254,-0.0478699138257396,-0.0330972455356184,7.95760878818445e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGA11,Integrin alpha-11,40341,0.0337526297227164,0.00314559783259076,0.0275872579708385,0.0399180014745943,9.07860003090923e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,-0.0294523686913271,0.00274678482509772,-0.0348360669485186,-0.0240686704341356,9.84871667008565e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40502,-0.0372757594980579,0.00349601194182463,-0.0441279429040341,-0.0304235760920816,1.87189114976941e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,40044,0.0379480373779546,0.00356526830156554,0.0309601115068861,0.044935963249023,2.29530206191612e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THBS2,Thrombospondin-2,40332,-0.0350909184321747,0.00330783939810789,-0.0415742836524662,-0.0286075532118833,3.33293510827331e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,40411,-0.0209108387567196,0.00197260266332736,-0.0247771399768413,-0.017044537536598,3.61634645280876e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,40341,-0.063910864761153,0.00603415754163829,-0.0757378135427641,-0.052083915979542,3.98739954173223e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37598,0.0312833960809932,0.0029764313233006,0.025449590687324,0.0371172014746624,9.78844067157562e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POF1B,Protein POF1B,37598,-0.0449917232673701,0.00428611523932807,-0.0533925091364531,-0.036590937398287,1.12548925091227e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40471,-0.0630559021375626,0.00604869693269877,-0.0749113481256522,-0.0512004561494731,2.30535854899503e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37835,-0.0314681475402427,0.00304182050298707,-0.0374301157260973,-0.025506179354388,5.46690499729713e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPIND1,Heparin cofactor 2,37981,-0.0261384523004677,0.00252747784207157,-0.0310923088709279,-0.0211845957300074,5.65291300514551e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,0.0277668206002391,0.0026863739123412,0.0225015277320503,0.0330321134684278,5.78905096549877e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIGR,Polymeric immunoglobulin receptor,40154,-0.0334689664396109,0.0032492837332534,-0.0398375625567876,-0.0271003703224342,8.41448682618234e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,40305,-0.0328421933223366,0.00319146253913593,-0.039097459899043,-0.0265869267456301,9.29158519079637e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCS1,Neuronal calcium sensor 1,40489,-0.0270907166282436,0.00263578566448382,-0.0322568565306319,-0.0219245767258553,1.05588965828723e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300LG,CMRF35-like molecule 9,40332,0.035738200054279,0.00347957411217313,0.0289182347944197,0.0425581653141383,1.13901570099248e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CES2,Cocaine esterase,40305,-0.0507154234880764,0.00494609723101874,-0.0604097740608731,-0.0410210729152797,1.36037057588523e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,-0.0414803752764074,0.00405137598369562,-0.0494210722044508,-0.033539678348364,1.58760285430974e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SBSN,Suprabasin,37977,0.0316784493691507,0.00309657802916936,0.0256091564319788,0.0377477423063227,1.78402565359366e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,0.0187955365158617,0.00184001492014167,0.015189107272384,0.0224019657593394,2.02453395692619e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,0.0273003542005258,0.00267993203004492,0.0220476874216378,0.0325530209794139,2.6873274642898e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37815,-0.02911080220198,0.00285923512519533,-0.0347149030473628,-0.0235067013565971,2.94591743598905e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37990,-0.0612227747967785,0.00601437389351086,-0.0730109476280598,-0.0494346019654972,2.99616960522033e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEL1L,Protein sel-1 homolog 1,37628,-0.0305374541644906,0.00300118536707463,-0.0364197774839569,-0.0246551308450243,3.1469817874221e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG4,Regenerating islet-derived protein 4,40379,-0.0456840238929234,0.00449649113843683,-0.0544971465242596,-0.0368709012615873,3.546708834113e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,0.0296513465674911,0.00292216112394886,0.0239239107645513,0.0353787823704309,4.03665213331877e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G15,Phospholipase A2 group XV,40411,-0.0240730595805203,0.00237575752236904,-0.0287295443243636,-0.0194165748366769,4.67317488247013e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,-0.0678207770946964,0.00669262304419816,-0.0809383182613248,-0.054703235928068,4.77239472156734e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARF6,ADP-ribosylation factor 6,37901,-0.0979300047374129,0.00967522856102603,-0.116893452717024,-0.0789665567578018,5.39390504124514e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,0.0307660336876491,0.00304633011393629,0.0247952266643339,0.0367368407109642,6.75576068742209e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F10,Coagulation factor X,37987,-0.0240915990606331,0.0023976914628951,-0.0287910743279075,-0.0193921237933587,1.13679793418712e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPCAM,Epithelial cell adhesion molecule,40358,-0.0923763596547755,0.00922735896867311,-0.110461983233375,-0.0742907360761762,1.59860390753518e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NME3,Nucleoside diphosphate kinase 3,40379,0.0221483093447558,0.00221546138454789,0.017806005031042,0.0264906136584697,1.83914182767666e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APLP1,Amyloid-like protein 1,40359,0.0480921898534396,0.00481208383093116,0.0386605055448145,0.0575238741620647,1.89775480812274e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC3B,Tetranectin,37681,0.0194283749298746,0.00195335742265756,0.0155997943814658,0.0232569554782835,3.162785480459e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL13,C-X-C motif chemokine 13,40471,-0.05804947330849,0.00584956451425034,-0.0695146197564206,-0.0465843268605593,3.82842492371325e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IDS,Iduronate 2-sulfatase,40516,0.00792596013831289,0.000799195289194323,0.00635953737149202,0.00949238290513376,4.07454342820088e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB1,Integrin beta-1,40333,0.0199719142423619,0.00202642753069554,0.0160001162821986,0.0239437122025252,7.52978712045769e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37628,-0.027569938774674,0.00280114248453947,-0.0330601780443714,-0.0220796995049767,8.85874120413846e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,-0.0243606091969814,0.00248329455672506,-0.0292278665281625,-0.0194933518658002,1.21702002075668e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL18R1,Interleukin-18 receptor 1,40516,-0.0293925962013431,0.0030058964190434,-0.0352841531826682,-0.023501039220018,1.61233360926511e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFA,Protransforming growth factor alpha,40341,-0.0432647052225809,0.00442650650034337,-0.051940657963254,-0.0345887524819079,1.68462730291178e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WIF1,Wnt inhibitory factor 1,40489,0.030899787974761,0.00316242782518089,0.0247014294374065,0.0370981465121155,1.73433924028071e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FSTL3,Follistatin-related protein 3,40293,-0.0282424485188844,0.00289069193337179,-0.0339082047082931,-0.0225766923294757,1.75065066882365e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39980,-0.0324782763771682,0.00332552146850426,-0.0389962984554365,-0.0259602542988998,1.82181806959345e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,-0.046935514901416,0.00481427816120653,-0.0563715000973808,-0.0374995297054512,2.1452357166242e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD2AP,CD2-associated protein,40359,-0.0575167209088688,0.00591049603805978,-0.069101293143466,-0.0459321486742717,2.55952819809748e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPAN8,Tetraspanin-8,37901,-0.0927390230543146,0.00958626694056257,-0.111528106257817,-0.073949939850812,4.58182686201335e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP1,Interstitial collagenase,39757,-0.0832486159053323,0.00861728713662675,-0.100138498693121,-0.0663587331175439,5.12023345911053e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KYNU,Kynureninase,40516,-0.0397648204063043,0.00411696704205121,-0.0478340758087246,-0.0316955650038839,5.17944335115744e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG1B,Lithostathine-1-beta,40536,-0.0498939398627087,0.00517283528796525,-0.0600326970271206,-0.0397551826982968,5.89659754858213e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERMAP,Erythroid membrane-associated protein,37598,-0.0398795895875438,0.00414206006014879,-0.0479980273054355,-0.0317611518696522,7.19389227205969e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,40341,-0.0544187297607931,0.00565559528453037,-0.0655036965184726,-0.0433337630031135,7.39856755118861e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL25,C-C motif chemokine 25,40516,-0.0434396157102183,0.00451500174146065,-0.0522890191234812,-0.0345902122969555,7.45435126139647e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37900,-0.0452707354698559,0.00470711066157985,-0.0544966723665524,-0.0360447985731593,7.92752570685253e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,-0.0510559827454846,0.00530873977097315,-0.0614611126965919,-0.0406508527943772,7.94099022922943e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELL,L-selectin,38013,0.0206013010865176,0.00214396659934975,0.0163991265517921,0.0248034756212431,8.59821017294818e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPPC,C-type natriuretic peptide,40341,-0.0381773149229905,0.00398021173173398,-0.0459785299171891,-0.0303760999287919,9.91457086236773e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,40305,-0.0525918420100523,0.00548539532878967,-0.06334321685448,-0.0418404671656245,1.03240262104496e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PXN,Paxillin,39961,-0.0459046959560509,0.00478846954060519,-0.055290096255637,-0.0365192956564647,1.04658238602389e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LSP1,Lymphocyte-specific protein 1,40341,-0.0353544815447158,0.00368904004141029,-0.0425850000258799,-0.0281239630635516,1.0721982950823e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37671,-0.0322835919790129,0.0033759555655064,-0.0389004648874055,-0.0256667190706204,1.34613659022498e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIAE,Sialate O-acetylesterase,40374,-0.0412383111337625,0.0043233968867597,-0.0497121690318115,-0.0327644532357135,1.6556449709671e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCN1,Ficolin-1,37967,-0.0497845113360794,0.00521890027803253,-0.0600135558810232,-0.0395554667911357,1.68092638275846e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLTP,Phospholipid transfer protein,40461,0.0301169600298669,0.00316216532951445,0.0239191159840186,0.0363148040757153,1.89641150593461e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHMP6,Charged multivesicular body protein 6,37990,-0.0489289772049572,0.00513883046035485,-0.0590010849072527,-0.0388568695026617,1.99348125411864e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUCB2,Nucleobindin-2,40447,-0.0325759862090153,0.0034279557780666,-0.0392947795340258,-0.0258571928840047,2.3211208872343e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPA33,Cell surface A33 antigen,40305,-0.11962484895525,0.012610969199633,-0.14434234858653,-0.0949073493239689,2.73986026363332e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOA4,Apolipoprotein A-IV,38013,-0.0322916512062913,0.0034060927290887,-0.0389675929553051,-0.0256157094572774,2.94325417843456e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGT,Angiotensinogen,37987,-0.0212206345621869,0.00224205586870368,-0.0256150640648461,-0.0168262050595277,3.41980774713894e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE6,Ribonuclease K6,37917,-0.0257836210139372,0.00272928873351664,-0.0311330269316298,-0.0204342150962446,4.05275514408157e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPB6,Heat shock protein beta-6,40489,-0.0317716037864345,0.00336882611193202,-0.0383745029658213,-0.0251687046070478,4.60302884395987e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,-0.0771701268925888,0.00819845339152126,-0.0932390955399705,-0.0611011582452071,5.50221888957006e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPP1,Tripeptidyl-peptidase 1,40255,-0.038906910994321,0.00413681671702391,-0.0470150717596878,-0.0307987502289541,5.90021719145173e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST3,Cystatin-C,40372,-0.0244262118742009,0.00259752179651001,-0.0295173545953605,-0.0193350691530412,5.97198191122045e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37990,-0.0517304811431045,0.00550193208596953,-0.0625142680316048,-0.0409466942546043,6.18678640533536e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,-0.0240667923754214,0.00256081697484629,-0.0290859936461201,-0.0190475911047227,6.29805119750772e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CREG1,Protein CREG1,40145,-0.0311967269137974,0.00332176219637064,-0.0377073808186839,-0.024686073008911,6.70361319032681e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37942,-0.0402512789533357,0.00429691514303664,-0.0486732326336875,-0.0318293252729839,8.59003662733288e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,A1BG,Alpha-1B-glycoprotein,38013,-0.0151356128461005,0.00161969028444291,-0.0183102058036086,-0.0119610198885924,1.06277051989633e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MBL2,Mannose-binding protein C,37810,0.0923108494966582,0.00988377917940124,0.0729386423050318,0.111683056688285,1.1175749260302e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,40341,-0.0533933407883657,0.00572556510502093,-0.0646154483942068,-0.0421712331825247,1.24789456275054e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,-0.0584679934723538,0.00627056266594631,-0.0707582962976086,-0.046177690647099,1.29502409907818e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPY30,Protein dpy-30 homolog,40414,-0.0511163112726784,0.00548560015456896,-0.0618680875756336,-0.0403645349697233,1.33375192079392e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,40303,-0.0416339850495849,0.00447458961186168,-0.0504041806888337,-0.032863789410336,1.51810193641694e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,-0.0369861635425769,0.00399057609602214,-0.0448076926907803,-0.0291646343943735,2.18047019022055e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGLN1,Egl nine homolog 1,40341,-0.0454038526751365,0.00490047681990334,-0.055008787242147,-0.0357989181081259,2.19163797961328e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FSHB,Follitropin subunit beta,37628,0.0598720025369052,0.00646319402597016,0.0472041422460037,0.0725398628278067,2.28035244999377e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37900,-0.0578839014615221,0.00625308489640212,-0.0701399478584702,-0.0456278550645739,2.41958771007834e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37901,0.0249724865573553,0.00269785500264226,0.0196846907521764,0.0302602823625341,2.42931545040329e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TF,Serotransferrin,38013,-0.0186733980478442,0.00201788182019576,-0.0226284464154279,-0.0147183496802605,2.48276592899681e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSM,Oncostatin-M,40268,-0.0619635735415748,0.00669983547873345,-0.0750952510798923,-0.0488318960032572,2.56104742931863e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARSA,Arylsulfatase A,40332,-0.0380261688493351,0.00411781674322486,-0.0460970896660558,-0.0299552480326144,2.91502233174822e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,-0.0328517504838754,0.00356788740338583,-0.0398448097945116,-0.0258586911732391,3.83291782499206e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,40280,-0.0217236763315233,0.00236671070880961,-0.0263624293207901,-0.0170849233422564,4.88521264278724e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,40167,-0.0238652460464305,0.0026003834036965,-0.0289619975176757,-0.0187684945751854,4.94643871424371e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BOC,Brother of CDO,40042,0.0200663336363331,0.00218758978143347,0.0157786576647235,0.0243540096079427,5.1744961550069e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMN,Protein amnionless,40044,-0.0403998645340833,0.00440595118583438,-0.0490355288583187,-0.0317642002098479,5.34028577271293e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,-0.0645439904763675,0.00703773140486803,-0.0783379440299089,-0.0507500369228262,5.34992349654025e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,-0.0326108729254982,0.00355713829838671,-0.0395828639903362,-0.0256388818606603,5.52300103816514e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,-0.0231446768900034,0.00252684883487716,-0.0280973006063626,-0.0181920531736441,5.83770623097441e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,-0.0384997838821043,0.00420510587772757,-0.0467417914024503,-0.0302577763617582,6.19696094164271e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPARCL1,SPARC-like protein 1,40346,0.0233681818871419,0.00255592558041545,0.0183585677495276,0.0283777960247562,6.81099707005111e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,-0.0694949017382072,0.00761108640619388,-0.0844126310943472,-0.0545771723820672,7.62559197291713e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,-0.023117665974836,0.00253362448399762,-0.0280835699634714,-0.0181517619862007,8.06201413222759e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARB2,Lysosome membrane protein 2,40011,-0.0260294466861047,0.00285296254948754,-0.0316212532831003,-0.0204376400891091,8.13697616845629e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXLNA,Alpha-taxilin,40228,-0.0749138826623723,0.00823696249986694,-0.0910583291621115,-0.0587694361626331,1.05805603773516e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNXB,Tenascin-X,40332,0.0214008492444616,0.00235630734540925,0.0167824868474594,0.0260192116414637,1.18512192014273e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENO3,Beta-enolase,37628,-0.04758612595615,0.00524641754178539,-0.0578691043380493,-0.0373031475742506,1.35407700246923e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,-0.0460215623536666,0.00508078282158379,-0.0559798966839708,-0.0360632280233624,1.48550175148897e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NXPH3,Neurexophilin-3,37598,0.025361620381139,0.00280200711533541,0.0198696864350816,0.0308535543271964,1.61019498818721e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFBR2,TGF-beta receptor type-2,40411,-0.0263641369221482,0.00291739218500599,-0.03208222560476,-0.0206460482395365,1.7934370233977e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,40341,-0.0302613356678992,0.00335594922738451,-0.0368389961535728,-0.0236836751822255,2.14538573643354e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37998,-0.0192234440330178,0.00213274389877498,-0.0234036220746167,-0.0150432659914188,2.26041097932194e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFAP,Glial fibrillary acidic protein,39959,0.0388395069954815,0.00433818603061412,0.0303366623754779,0.0473423516154852,3.84771793351819e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39961,-0.0404751028702721,0.00452493736090765,-0.0493439800976511,-0.0316062256428931,4.13675691366171e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,-0.0364680355204444,0.00407813514565182,-0.0444611804059219,-0.0284748906349668,4.30938433427236e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,-0.0577310402187818,0.00646818370431918,-0.0704086802792474,-0.0450534001583162,4.93005072401281e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPT2,Angiopoietin-2,40489,-0.031936544214906,0.00357946700904178,-0.0389522995526279,-0.0249207888771841,5.05882031111648e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,0.021973913531241,0.00246462316170264,0.0171432521343039,0.0268045749281782,5.46081024907131e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,40305,0.0338440394871657,0.00380836637274027,0.0263796413965948,0.0413084375777367,6.95683320807595e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,-0.024706200341718,0.00278197830306423,-0.0301588778157239,-0.0192535228677121,7.46995135107767e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MLN,Promotilin,40341,-0.0726212657823393,0.0081953072828657,-0.0886840680567561,-0.0565584635079225,8.73117195089134e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN4,Contactin-4,40332,0.0198925137475856,0.00224845612006086,0.0154855397522663,0.0242994877429049,9.90508095723509e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE4,Ribonuclease 4,37575,-0.0223797420872439,0.00252982104688033,-0.0273381913391293,-0.0174212928353584,1.01851170721764e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37998,0.017279931180898,0.00195433398078384,0.0134494365785617,0.0211104257832344,1.05642881477276e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,-0.0499673352842689,0.00566032226542927,-0.0610615669245103,-0.0388731036440275,1.17872840680485e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YES1,Tyrosine-protein kinase Yes,40305,-0.0925821091471177,0.0104918658910963,-0.113146166293667,-0.072018052000569,1.21586544810383e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFF2,Trefoil factor 2,40396,-0.0464485965700521,0.00527309202595174,-0.0567838569409176,-0.0361133361991867,1.3954838894437e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,-0.0465729896884434,0.00529621420411261,-0.0569535695285042,-0.0361924098483827,1.62211034153238e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39980,-0.0511640872816821,0.00582215759600709,-0.062575516169856,-0.0397526583935082,1.68215086641952e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,-0.0789089192368244,0.0089861511013349,-0.0965217753954408,-0.061296063078208,1.78061538638718e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SARG,Specifically androgen-regulated gene protein,37931,-0.0876923015387405,0.0100221381054794,-0.10733569222548,-0.0680489108520008,2.38724547715061e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,0.0208847157986101,0.0023894272900487,0.0162014383101146,0.0255679932871055,2.59164581707925e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TREH,Trehalase,37998,-0.0598732228034336,0.00686322790229453,-0.0733251494919309,-0.0464212961149363,3.00161361356706e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS5,Transmembrane protease serine 5,40159,0.0304646937856965,0.00350000280767297,0.0236046882826574,0.0373246992887355,3.5118161818791e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,40332,0.0345683194329061,0.00398516317087599,0.0267573996179892,0.0423792392478231,4.56016124087574e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUSD2,Sushi domain-containing protein 2,40332,0.0229764052103598,0.00264886234660101,0.0177846350110218,0.0281681754096977,4.56770756660298e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,-0.038940366655005,0.00449034883673916,-0.0477414503750138,-0.0301392829349963,4.73613852611451e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGN,Secretagogin,40044,-0.0352552412035932,0.00406698860058128,-0.0432265388607325,-0.0272839435464539,4.79780115081519e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,-0.0539624966671236,0.00622746086038926,-0.0661683199534866,-0.0417566733807607,4.94377285220499e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BECN1,Beclin-1,37628,-0.0487042011982877,0.00563622251520927,-0.0597511973280979,-0.0376572050684775,6.19366944860489e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL6,C-X-C motif chemokine 6,40516,-0.0620142989238228,0.00717859361312711,-0.076084342405552,-0.0479442554420937,6.20864503009817e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP1,"Fatty acid-binding protein, liver",40357,-0.0742444065929016,0.00859762073404327,-0.0910957432316264,-0.0573930699541767,6.39652035395579e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,-0.0458888791850487,0.00532571661344091,-0.0563272837473929,-0.0354504746227046,7.66806691513142e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CGA,Glycoprotein hormones alpha chain,40332,0.0713885715858054,0.00828767086798402,0.0551447366845567,0.0876324064870541,7.72160746031799e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CES3,Carboxylesterase 3,40305,-0.0546033119090555,0.00634635387046318,-0.0670421654951633,-0.0421644583229477,8.41886898250494e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL21,C-C motif chemokine 21,40422,-0.0337999303130095,0.00393078079045541,-0.0415042606623021,-0.0260955999637169,8.79431780769501e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,0.0333715969709094,0.00388193832797437,0.0257629978480796,0.0409801960937392,8.96560428042445e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,-0.0305151000714932,0.00355190663504923,-0.0374768370761897,-0.0235533630667967,9.39605132681652e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BACH1,Transcription regulator protein BACH1,40341,-0.0574862636455959,0.00670596721561586,-0.070629959388203,-0.0443425679029888,1.10558382617343e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37562,-0.0291404504234431,0.00341694385884372,-0.0358376603867768,-0.0224432404601094,1.64780848931666e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,40305,-0.0535502058322616,0.00628261968581306,-0.0658641404164552,-0.0412362712480681,1.68510486375021e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC51B,Organic solute transporter subunit beta,37562,-0.0626456615471735,0.00736176741450368,-0.0770747256796007,-0.0482165974147463,1.93354700564255e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39961,-0.0210226116049215,0.00247632999369733,-0.0258762183925683,-0.0161690048172747,2.2626475521476e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTN2,Dynactin subunit 2,40305,-0.0737071166877144,0.00870347895758119,-0.0907659354445735,-0.0566482979308553,2.69661793444991e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BPIFB1,BPI fold-containing family B member 1,40261,0.0481705001884777,0.00570114158402305,0.0369962626837925,0.0593447376931629,3.18360663130386e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,-0.0206595564350483,0.00244828284489547,-0.0254581908110435,-0.0158609220590532,3.49176913061591e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MENT,Protein MENT,37671,0.0169182318386117,0.0020064092380868,0.0129856697319615,0.0208507939452618,3.74466085935222e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUMB,Protein numb homolog,37598,-0.0647453228862141,0.00769566791233969,-0.0798288319943999,-0.0496618137780283,4.39816620205993e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD27,CD27 antigen,40411,-0.0316323194988876,0.00376271600974236,-0.0390072428779826,-0.0242573961197926,4.56621362851654e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYH9,Myosin-9,37998,-0.0869444303478445,0.0103485465428205,-0.107227581571773,-0.0666612791239162,4.83918842686777e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM3D,Protein FAM3D,37901,-0.0637806410314367,0.00759713059763176,-0.0786710170027949,-0.0488902650600785,5.10565906352988e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,-0.0572898724966688,0.00683502961046794,-0.070686530533186,-0.0438932144601516,5.72260133927992e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,-0.0464833127155807,0.00555083834202223,-0.0573629558659443,-0.0356036695652172,6.024953089993e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNAP29,Synaptosomal-associated protein 29,40411,-0.0705036391234306,0.00842038536714773,-0.0870075944430402,-0.0539996838038211,6.07988852348508e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM5,Tripartite motif-containing protein 5,40341,-0.0657849137166785,0.00786560669304241,-0.0812015028350417,-0.0503683245983154,6.58210814363198e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,-0.0408632543385771,0.00488622354620814,-0.050440252489145,-0.0312862561880091,6.63121169539854e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40536,-0.0265508330982762,0.00317652144151596,-0.0327768151236475,-0.0203248510729049,6.86822543662312e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ULBP2,UL16-binding protein 2,40228,-0.0288002456722934,0.00345074570901018,-0.0355637072619533,-0.0220367840826334,7.63471113281803e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HYAL1,Hyaluronidase-1,40214,-0.0177520049100064,0.00212890904890262,-0.0219246666458555,-0.0135793431741573,8.13634523208675e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FYB1,FYN-binding protein 1,40311,-0.0703312996490389,0.00844140618288278,-0.0868764557674892,-0.0537861435305887,8.61435865740853e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTN1,Dynactin subunit 1,40489,-0.0504921228817771,0.00607106586123315,-0.0623914119697941,-0.0385928337937601,9.75173211915979e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37598,-0.0645879994230405,0.00777958603289531,-0.0798359880475153,-0.0493400107985657,1.12081650821509e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,-0.0537857071544026,0.00647894868440939,-0.066484446575845,-0.0410869677329602,1.12651739274807e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AOC3,Membrane primary amine oxidase,40403,0.0233559841359686,0.00281747975778324,0.0178337238107135,0.0288782444612238,1.22519964786872e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,40350,-0.0378366218320401,0.00456442853197879,-0.0467829017547185,-0.0288903419093617,1.22774793089864e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,40359,0.0197648012246822,0.00238734036659885,0.0150856141061485,0.024443988343216,1.33985115152004e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPL,N-acetylneuraminate lyase,37990,-0.032950588180534,0.00398012303570815,-0.040751629330522,-0.0251495470305461,1.36014666577128e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,-0.0728173592142973,0.0087976818799621,-0.090060815699023,-0.0555739027295716,1.36397095101924e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPTX1,Neuronal pentraxin-1,40332,0.0301968157577385,0.00365021726429986,0.0230423899197108,0.0373512415957663,1.41360715566667e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH17,Cadherin-17,40359,-0.0517585228556658,0.00627278318478863,-0.0640531778978515,-0.0394638678134801,1.68865006939433e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAT2,Linker for activation of T-cells family member 2,40305,-0.0929179538787535,0.011306498464263,-0.115078690868709,-0.0707572168887981,2.22593516239578e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,-0.0371769586578717,0.00452743590028256,-0.0460507330224255,-0.0283031842933179,2.35453586376289e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SULT2A1,Bile salt sulfotransferase,40341,-0.0403531645451195,0.00492219099443547,-0.050000658894213,-0.030705670196026,2.62459218571752e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IMMT,MICOS complex subunit MIC60,37900,-0.0335625748116643,0.00409957709366036,-0.0415977459152386,-0.02552740370809,2.92175786483311e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,0.0289374686129779,0.00353698451290734,0.0220049789676795,0.0358699582582763,3.01616306095576e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,40044,-0.052744715449498,0.00644728049426428,-0.065381385218256,-0.04010804568074,3.03230678987018e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40536,-0.0370979973854877,0.00454119413308178,-0.045998737886328,-0.0281972568846474,3.33269022973362e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37671,-0.0300175861393227,0.00368263033552255,-0.0372355415969469,-0.0227996306816985,3.92809912199989e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40536,-0.0162980182666105,0.00200351674372887,-0.0202249110843191,-0.0123711254489019,4.42846203836972e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40536,-0.0234742971357629,0.00289814442141796,-0.0291546602017421,-0.0177939340697836,5.89824784466359e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40536,0.0193934374183697,0.00240664152635798,0.0146764200267081,0.0241104548100313,8.27545716882525e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39980,-0.0369357878629521,0.00458658655934583,-0.04592549751927,-0.0279460782066343,8.66104443244805e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39980,-0.0453090714462939,0.00562990788913255,-0.0563436909089937,-0.0342744519835941,9.02636454762127e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,40192,-0.0545290131868993,0.0067799325459553,-0.0678176809769717,-0.0412403453968269,9.40877830874348e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESM1,Endothelial cell-specific molecule 1,40357,0.0251285451680526,0.00313373882150875,0.0189864170778955,0.0312706732582098,1.14244695052914e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VEGFD,Vascular endothelial growth factor D,40483,0.0246753250120189,0.00308041050219153,0.0186377204277235,0.0307129295963143,1.2213785094373e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,-0.0196141418611552,0.00245198280556576,-0.0244200281600641,-0.0148082555622463,1.33661841846155e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40471,-0.0710401794402554,0.00889385770779763,-0.0884721405475388,-0.0536082183329721,1.46933735023474e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40536,-0.0302744822478604,0.00379691601064618,-0.0377164376287269,-0.0228325268669939,1.64618393788301e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,0.017794974276597,0.00223197662712244,0.013420300087437,0.022169648465757,1.65684340591679e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,-0.0515842633345511,0.00647695052279523,-0.0642790863592298,-0.0388894403098725,1.79784790053378e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFI,Complement factor I,38013,-0.0147986966030358,0.00185861260519289,-0.0184415773092139,-0.0111558158968578,1.82344382817915e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDA,Cytidine deaminase,37970,-0.0336920889822713,0.00423604839206793,-0.0419947438307245,-0.0253894341338182,1.95398431997588e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OPTC,Opticin,40305,0.0330796762474099,0.00417555849299431,0.0248955816011411,0.0412637708936788,2.4871394978383e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,L1CAM,Neural cell adhesion molecule L1,40411,0.0207338191594638,0.00261832755252553,0.0156018971565137,0.0258657411624138,2.55657295606798e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GDF2,Growth/differentiation factor 2,40359,0.0261460851633059,0.00330843845165935,0.0196615457980536,0.0326306245285582,2.90354944912094e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,-0.0398139216718366,0.00504418367517016,-0.0497005216751701,-0.0299273216685031,3.14099555046547e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNAP23,Synaptosomal-associated protein 23,40359,-0.0633954435347667,0.00804407497835649,-0.0791618304923454,-0.047629056577188,3.45654307160407e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,-0.0538600397095074,0.00684028464799631,-0.0672669976195801,-0.0404530817994346,3.70539837363721e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IKBKG,NF-kappa-B essential modulator,40341,-0.066857644794967,0.00849531894644473,-0.0835084699299987,-0.0502068196599353,3.77557801091337e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHISA5,Protein shisa-5,37998,-0.0180641451905245,0.00229574664535566,-0.0225638086154216,-0.0135644817656274,3.85936277217148e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40470,-0.0443919345246527,0.00564818639341288,-0.055462379855742,-0.0333214891935635,4.10048151797363e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASAH2,Neutral ceramidase,40228,-0.0381923523948429,0.0048607512610096,-0.0477194248664217,-0.0286652799232641,4.17702683306704e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,40332,0.0294286446320263,0.00375808293107972,0.02206280208711,0.0367944871769425,5.1541088658231e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37598,-0.0570590054807055,0.00729631234809304,-0.0713597776829678,-0.0427582332784431,5.67216932650075e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPEP2,Dipeptidase 2,40305,0.0207687974118232,0.00265765433239635,0.0155597949203263,0.02597779990332,5.85298137629715e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1R2,Interleukin-1 receptor type 2,40330,-0.0140954072758335,0.00180549268642233,-0.0176341729412213,-0.0105566416104458,6.22219981642734e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGXT,Serine--pyruvate aminotransferase,40359,-0.0555342413856098,0.00711413706935683,-0.0694779500415492,-0.0415905327296704,6.25987590950686e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM4,Intercellular adhesion molecule 4,40341,0.0380134378861317,0.00488225198283843,0.0284442239997684,0.0475826517724951,7.33824522800793e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,-0.0164887417952598,0.00212001681736289,-0.0206439747572911,-0.0123335088332285,7.84038870161239e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAXX,Protein PAXX,37671,-0.032593254905506,0.0041932168761807,-0.0408119599828202,-0.0243745498281918,8.23920035404216e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,40355,0.02612699392261,0.00336283357099286,0.019535840123464,0.032718147721756,8.36930032454516e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,-0.0531520244169654,0.00684180209178684,-0.0665619565168676,-0.0397420923170632,8.41431946246968e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL3,C-C motif chemokine 3,40341,-0.0441484777025655,0.00568863848720297,-0.0552982091374833,-0.0329987462676477,8.94962572726386e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,40305,0.0452429471861715,0.00583083636316581,0.0338145079143665,0.0566713864579765,9.06124872225314e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39535,-0.0273278332471186,0.00352228706799774,-0.0342315159003942,-0.0204241505938431,9.13907323661253e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE1,Ribonuclease pancreatic,37987,-0.0173512436088421,0.00223849806878103,-0.0217386998236529,-0.0129637873940312,9.74318854169304e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANPEP,Aminopeptidase N,40370,0.0203126583525259,0.0026218893211828,0.0151737552830076,0.0254515614220442,9.94742664360437e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,-0.0353921863172964,0.00457007084205998,-0.0443495251677339,-0.0264348474668588,1.03111820007161e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHA2,Ephrin type-A receptor 2,39759,-0.0221176136539334,0.00285828253336562,-0.02771984741933,-0.0165153798885368,1.07208762458826e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXNB2,Plexin-B2,40472,-0.0166745764124594,0.00215767156600568,-0.0209036126818305,-0.0124455401430882,1.15662173825334e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39980,-0.0776442210700157,0.0100516306096346,-0.0973454170648995,-0.0579430250751319,1.19089955923685e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEZ6L,Seizure 6-like protein,40411,0.0196190885702415,0.0025400091722721,0.0146406705925882,0.0245975065478948,1.19382380282664e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS9,Galectin-9,40350,-0.0229358970343306,0.00297216010406869,-0.0287613308383053,-0.017110463230356,1.26233847888751e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNCG,Gamma-synuclein,40228,-0.0477891658898774,0.00619280040083613,-0.0599270546755162,-0.0356512771042386,1.26310212384223e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,-0.0414823374596714,0.00538133741497064,-0.0520297587930138,-0.0309349161263289,1.34715159835683e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEG1,Protein HEG homolog 1,37671,-0.0188423498524455,0.00244453532981084,-0.0236336390988748,-0.0140510606060163,1.3696131463816e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,-0.0131377827184848,0.00170756269903441,-0.0164846056085923,-0.00979095982837739,1.51339809974665e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40536,-0.0480600375091947,0.00624935775506607,-0.0603087787091242,-0.0358112963092652,1.55137176330037e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,-0.0258313412432043,0.00335926506506351,-0.0324155007707287,-0.0192471817156798,1.56237219433166e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,-0.0412344254375977,0.00537141411046038,-0.0517623970941,-0.0307064537810953,1.72963506363699e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AXIN1,Axin-1,40341,-0.0666374434300406,0.00868311336574817,-0.083656345626907,-0.0496185412331742,1.7585442801421e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGL1,Fibrinogen-like protein 1,37987,-0.044593005632272,0.00581574025687151,-0.0559918565357402,-0.0331941547288038,1.87106432102315e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39980,-0.0454265207036909,0.00593467752257728,-0.0570584886479423,-0.0337945527594394,2.05574754548081e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD207,C-type lectin domain family 4 member K,40029,-0.0271328399931506,0.00355595047287218,-0.0341025029199801,-0.0201631770663211,2.47796784305355e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUS,RNA-binding protein FUS,39960,-0.0278219084706323,0.00365053506608354,-0.034976957200156,-0.0206668597411085,2.65578665670021e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,-0.0405103502443249,0.00531701254939542,-0.0509316948411399,-0.0300890056475099,2.70292353320651e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BMP10,Bone morphogenetic protein 10,37671,0.0202638786831874,0.00265970712426515,0.0150508527196278,0.0254769046467471,2.73353705648404e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,-0.059441520153817,0.00780668309870898,-0.0747426190272866,-0.0441404212803475,2.83401716520229e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,-0.0353137445495316,0.00465512285668824,-0.0444377853486406,-0.0261897037504227,3.48628272991033e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SORD,Sorbitol dehydrogenase,40417,-0.0468206655606217,0.00617318882984485,-0.0589201156671176,-0.0347212154541258,3.52056754876674e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,-0.0274402590284264,0.00362082750009554,-0.0345370809286137,-0.0203434371282391,3.68712502925827e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,-0.0757500182161234,0.00999722384511046,-0.0953445769525399,-0.0561554594797069,3.76479427661084e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,-0.0212672391584787,0.00280822917623511,-0.0267713683438995,-0.0157631099730579,3.84026902115546e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,-0.0584596176511492,0.00773545731240558,-0.0736211139834641,-0.0432981213188343,4.37855759119132e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTRB1,Chymotrypsinogen B,40332,-0.0371700639216202,0.0049233554975817,-0.0468198406968803,-0.0275202871463601,4.59768252517986e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C8B,Complement component C8 beta chain,38013,0.0213559230498343,0.00282974433731764,0.0158096241486917,0.0269022219509768,4.73955561191111e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B2M,Beta-2-microglobulin,38013,-0.0221621405534637,0.00293888083261389,-0.0279223469853869,-0.0164019341215404,4.95925087486988e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,40341,-0.073795685549061,0.00979444472636313,-0.0929927972127328,-0.0545985738853893,5.16783110357812e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TJAP1,Tight junction-associated protein 1,40411,-0.057408267074392,0.00762490804426539,-0.0723530868411522,-0.0424634473076319,5.38402352440722e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTNB,Dystrobrevin beta,37878,-0.0289881413590582,0.00385047793467616,-0.0365350781110234,-0.0214412046070929,5.46149161743422e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,-0.0618462124099432,0.00822228690544161,-0.0779618947446088,-0.0457305300752777,5.69471220006771e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFF1,Trefoil factor 1,40261,-0.0541263673728642,0.00719621168110064,-0.0682309422678214,-0.0400217924779069,5.70530446118111e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLSTN2,Calsyntenin-2,40516,0.0271593565641181,0.00361265188703103,0.0200785588655372,0.0342401542626989,5.86199948338075e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHRDL2,Chordin-like protein 2,40359,-0.0394202242227799,0.00527567502330702,-0.0497605472684617,-0.0290799011770982,8.30401855950693e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD5,T-cell surface glycoprotein CD5,40470,-0.022999618013106,0.003087238584951,-0.0290506056396099,-0.016948630386602,9.8169207253839e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37959,-0.0424625798895742,0.00570022840063574,-0.0536350275548202,-0.0312901322243281,9.9544522644808e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,0.0182006142897292,0.00244735601982058,0.0134037964908809,0.0229974320885775,1.08387177887602e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAYN,Layilin,40192,-0.0236216286804151,0.00318190643484816,-0.0298581652927175,-0.0173850920681127,1.19684814955858e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,-0.0312140557114886,0.00420656909315189,-0.0394589311340663,-0.0229691802889109,1.22764068638137e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPA,Apolipoprotein(a),37735,0.120901356665978,0.0163291514807702,0.088896219763668,0.152906493568287,1.4007547656504e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37987,-0.0413060771563613,0.00558949914621303,-0.0522614954829388,-0.0303506588297837,1.55498505918633e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37572,-0.081175467179827,0.010990811846769,-0.102717458399494,-0.0596334759601598,1.6073703180025e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL16,Pro-interleukin-16,40516,-0.0274849530905394,0.00373131618759275,-0.0347983328182212,-0.0201715733628576,1.84326982192442e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,40341,-0.0292078142150704,0.0039679970193654,-0.0369850883730266,-0.0214305400571143,1.91691172886915e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAX1BP1,Tax1-binding protein 1,37942,-0.0435744745285906,0.0059195826167225,-0.0551768564573667,-0.0319720925998145,1.92996166974817e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA4,Kallistatin,37781,-0.0163183525173579,0.00222049231186889,-0.0206705174486209,-0.0119661875860949,2.1134915361985e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,40136,-0.0201489542673028,0.00274318143610097,-0.0255255898820607,-0.0147723186525449,2.15706194985e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELOA,Elongin-A,40305,-0.0346298947074272,0.00472172047057083,-0.043884466829746,-0.0253753225851084,2.33885913150834e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,40042,-0.025675856449382,0.00350485581289447,-0.0325453738426551,-0.0188063390561088,2.49109698062897e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,40341,-0.0370865316704212,0.00506688407450167,-0.0470176244564445,-0.0271554388843979,2.61004742915861e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EEF1D,Elongation factor 1-delta,37990,-0.0619129710762442,0.00845757402889727,-0.0784898161728829,-0.0453361259796056,2.61138929944791e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37628,-0.0488119388441313,0.00669137954875073,-0.0619270427596827,-0.0356968349285799,3.16316755522738e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTSS2,Protein MTSS 2,37900,-0.0661121881500629,0.00906801396026188,-0.0838854955121762,-0.0483388807879496,3.25563776007426e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN3,Contactin-3,40332,-0.023521513606379,0.00323263496596807,-0.0298574781396764,-0.0171855490730816,3.5922612502179e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNR,Tenascin-R,40228,0.0284899692645968,0.00393178080663623,0.0207836788835898,0.0361962596456038,4.48884316573692e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGA,Fibrinogen alpha chain,37698,0.020671574442283,0.00285861045965388,0.0150686979413614,0.0262744509432046,5.04510736982145e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HGFAC,Hepatocyte growth factor activator,37849,0.019376799155778,0.00268615595059196,0.0141119334926177,0.0246416648189382,5.74272857567343e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YTHDF3,YTH domain-containing family protein 3,40044,-0.0565049801664975,0.00784304389756485,-0.0718773462057247,-0.0411326141272704,6.09364415821573e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GUCA2A,Guanylin,40276,-0.0223145936660797,0.00309979744266816,-0.0283901966537093,-0.0162389906784501,6.35086968466328e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,40305,-0.0568147056415794,0.00789419465030965,-0.0722873271561863,-0.0413420841269724,6.42987521701836e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAT,Linker for activation of T-cells family member 1,40516,-0.0501737332424212,0.00698361560910643,-0.0638616198362698,-0.0364858466485726,7.04188681302446e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELN,Elastin,37990,-0.0233213865312085,0.00324633406732019,-0.0296842013031561,-0.016958571759261,7.12839243618488e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HLA_E,,40341,-0.0191380002824851,0.00266633857333075,-0.0243640238862134,-0.0139119766787568,7.40654071192551e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGBL1,Integrin beta-like protein 1,37998,-0.0231298766205657,0.00322437353393123,-0.0294496487470709,-0.0168101044940605,7.69296307470148e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,40422,-0.0278162756207775,0.00388023280219142,-0.0354215319130727,-0.0202110193284823,7.90203210193869e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS3BP,Galectin-3-binding protein,38013,-0.0196388875364795,0.00274275367125883,-0.0250146847321468,-0.0142630903408122,8.4657220363513e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSME1,Proteasome activator complex subunit 1,40216,-0.0249470959185737,0.003487880146905,-0.0317833410065074,-0.0181108508306399,8.89513736756678e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,-0.0190277471466046,0.00266389507301741,-0.0242489814897187,-0.0138065128034904,9.62143575511512e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPPK1,Epiplakin,37628,-0.0485924691091392,0.00681013140585971,-0.0619403266646242,-0.0352446115536542,1.01611169479396e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JAM3,Junctional adhesion molecule C,37671,-0.0334208960628374,0.00468812021546357,-0.042609611685146,-0.0242321804405288,1.06467987898733e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,-0.021818935780568,0.00306443933226631,-0.02782523687181,-0.015812634689326,1.12503380122162e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUOM,Fucose mutarotase,37671,-0.0410676175056163,0.00577497586278758,-0.05238657019668,-0.0297486648145526,1.20860418427189e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,0.0137668849508471,0.00193862962273885,0.009967170890279,0.0175665990114153,1.2888252687724e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XCL1,Lymphotactin,40489,-0.0369414839984662,0.00521252348749956,-0.0471580300339653,-0.0267249379629671,1.42691597664914e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39961,-0.0558001046916371,0.00788077716469087,-0.0712464279344312,-0.040353781448843,1.49764698373237e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,40357,-0.0183691943396948,0.00259617048801956,-0.0234576884962132,-0.0132807001831765,1.55127161914271e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,40408,0.0158123550837457,0.00224272544937916,0.0114166132029625,0.0202080969645288,1.85573190002338e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,-0.0542013235708066,0.00768795874577602,-0.0692697227125276,-0.0391329244290856,1.8758991945525e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37959,-0.0244022074409831,0.00346679832052257,-0.0311971321492074,-0.0176072827327589,2.03216326872575e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FEN1,Flap endonuclease 1,39980,-0.0403861537527058,0.00573888425594788,-0.0516343668943637,-0.029137940611048,2.04224263876341e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ISM1,Isthmin-1,40341,-0.0253784605481802,0.00360643055342361,-0.0324470644328905,-0.01830985666347,2.04444708180384e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,-0.02608081387116,0.00371035484947581,-0.0333531093761326,-0.0188085183661874,2.17710227265673e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGA4,Pepsin A-4,37987,-0.0442880587290728,0.0063053837098846,-0.0566466108004467,-0.031929506657699,2.26146530855714e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEXIM1,Protein HEXIM1,40341,-0.0530286892233223,0.00755098743713581,-0.0678286246001085,-0.0382287538465361,2.2636152515616e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD248,Endosialin,37998,0.0259632678380673,0.0036994262003273,0.0187123924854258,0.0332141431907088,2.35454406537678e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,-0.0485869678881071,0.00692406891861869,-0.0621581429685997,-0.0350157928076144,2.37575773755996e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,40335,-0.0291548393855453,0.00415874731956371,-0.0373059841318902,-0.0210036946392004,2.47053632887425e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,-0.0234475341847927,0.00334859459086385,-0.0300107795828858,-0.0168842887866995,2.64215348140902e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,40396,-0.0335263523470142,0.00478955108350702,-0.042913872470688,-0.0241388322233404,2.66366406260357e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRIP2,Cysteine-rich protein 2,40228,-0.0232979110600909,0.00334329875198933,-0.02985077661399,-0.0167450455061918,3.32921895139838e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OGFR,Opioid growth factor receptor,40305,-0.0213057956854462,0.00305834376356295,-0.0273001494620296,-0.0153114419088628,3.37826547255762e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPP1,Osteopontin,40497,0.0307446795245634,0.00441360469166839,0.0220940143288933,0.0393953447202334,3.39013258937308e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,-0.0487716906604155,0.0070046933139173,-0.0625008895556934,-0.0350424917651376,3.46896397050645e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH2,Cadherin-2,40359,-0.0226875155203367,0.00326406953530768,-0.0290850918095398,-0.0162899392311337,3.77641263832088e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD274,Programmed cell death 1 ligand 1,40228,-0.0223634495617447,0.00321751305325456,-0.0286697751461237,-0.0160571239773658,3.7814789518826e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37900,-0.0510988321342769,0.00735093100958253,-0.0655066569130587,-0.0366910073554951,3.78513310860651e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COMP,Cartilage oligomeric matrix protein,40198,0.0217968877466615,0.00313670757061594,0.0156489409082543,0.0279448345850688,3.82390689504625e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,-0.0349992870099729,0.00504524138906103,-0.0448879601325325,-0.0251106138874133,4.16009627167363e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL12A_IL12B,Interleukin-12,40305,-0.0501672023313966,0.00726030461654817,-0.064397399379831,-0.0359370052829622,5.03840997953621e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GZMA,Granzyme A,40516,-0.022493289193921,0.00325575834550916,-0.0288745755511189,-0.016112002836723,5.07223955836577e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F12,Coagulation factor XII,38013,-0.0266931973762415,0.00386820857706792,-0.0342748861872946,-0.0191115085651884,5.40591899714846e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL12B,Interleukin-12 subunit beta,40516,-0.0346321609087882,0.00502056893674203,-0.0444724760248026,-0.0247918457927738,5.46863753477354e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39961,-0.035311707585142,0.00512531091271631,-0.0453573169740659,-0.025266098196218,5.8073446341598e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPEP1,Dipeptidase 1,40192,0.0323891888212245,0.00470657813756634,0.0231642956715944,0.0416140819708545,6.13805167672931e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFP,Properdin,38013,0.0139247788511385,0.00202369174858191,0.00995834302391795,0.017891214678359,6.20951392132308e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD99L2,CD99 antigen-like protein 2,40332,-0.0150959319545755,0.00219934224663412,-0.0194066427579783,-0.0107852211511726,6.95149233880151e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,-0.0189351642700516,0.00276223365339196,-0.0243491422306999,-0.0135211863094034,7.4412117279647e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RFC4,Replication factor C subunit 4,37900,-0.0129708390674995,0.0018955917547536,-0.0166861989068166,-0.00925547922818243,8.11166116129039e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSC,Dipeptidyl peptidase 1,40349,-0.0269486201212264,0.00394189787527626,-0.0346747399567678,-0.0192225002856849,8.41286013979172e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39961,-0.0499142868303372,0.00730926264650899,-0.0642404416174948,-0.0355881320431796,8.87414133972671e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,0.01296808319267,0.00189910663943932,0.00924583417936892,0.0166903322059711,8.95578832677866e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,40411,0.0151191119810093,0.00221484262134049,0.0107780204431819,0.0194602035188366,9.02911187872385e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD302,CD302 antigen,40305,-0.0190217768744466,0.00278739997337789,-0.0244850808222673,-0.013558472926626,9.16193312356133e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP20,Centrosomal protein 20,39980,-0.0463958191927008,0.00681137082467569,-0.0597461060090651,-0.0330455323763364,1.00116410213133e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37671,-0.0263897428950739,0.00387535623311576,-0.0339854411119808,-0.018794044678167,1.02078414863876e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,-0.0452999772634076,0.0066707516455455,-0.0583746504886768,-0.0322253040381385,1.16168162287965e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TADA3,Transcriptional adapter 3,37900,-0.0243742483917957,0.00359200390540529,-0.0314145760463901,-0.0173339207372013,1.20365065982052e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COMMD1,COMM domain-containing protein 1,37628,-0.0385839729099052,0.00569728932413777,-0.0497506599852152,-0.0274172858345952,1.32091958657267e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VCAN,Versican core protein,40471,0.0188182721465872,0.00278165988621208,0.0133662187696115,0.0242703255235628,1.37807808602359e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,40422,0.0176803890454219,0.00261535949937841,0.0125542844266403,0.0228064936642036,1.42560563104749e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD200,OX-2 membrane glycoprotein,40341,0.0162738597477484,0.00240751373159191,0.0115551328338283,0.0209925866616685,1.43176481109219e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN4,CCN family member 4,40489,-0.0255811849666255,0.00378484555640286,-0.0329994822571751,-0.0181628876760759,1.43889148270819e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,-0.086883495681477,0.0128744698667764,-0.112117456620359,-0.0616495347425954,1.55488668846699e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EREG,Proepiregulin,40192,-0.0500987112778843,0.00742623741647993,-0.064654136614185,-0.0355432859415837,1.57082752449933e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,40234,-0.0184807004424567,0.0027395216129412,-0.0238501628038214,-0.0131112380810919,1.57303721078027e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOXO1,Forkhead box protein O1,40341,-0.0526870348797057,0.00782048249411592,-0.0680151805681729,-0.0373588891912385,1.67177453352319e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS8,Galectin-8,40471,-0.0376171368621342,0.00558365553353179,-0.0485611017078565,-0.0266731720164119,1.67186714484585e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,-0.0257781273187629,0.00383345430651391,-0.0332916977595301,-0.0182645568779956,1.82157991283644e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,-0.0295755783566174,0.00440145928605548,-0.0382024385572861,-0.0209487181559486,1.8969938636776e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYOC,Myocilin,40332,0.0285199621476241,0.00424530301921973,0.0201991682299534,0.0368407560652947,1.90490192671093e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,-0.0473280274278382,0.00704587309793098,-0.0611379386997829,-0.0335181161558935,1.91646646678136e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EZR,Ezrin,40471,-0.0146199159191209,0.00218728550525443,-0.0189069955094195,-0.0103328363288222,2.40105978754024e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37958,0.00912966305555499,0.00136640303903092,0.00645151309905439,0.0118078130120556,2.45727622249495e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNST,Consortin,40359,-0.0666576173628535,0.00998330578648431,-0.0862248967043627,-0.0470903380213442,2.52113008238658e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PALM2,Paralemmin-2,37942,-0.0227816284974712,0.0034136883478721,-0.0294724576593005,-0.0160907993356419,2.59331881388167e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,40291,-0.017923476374784,0.00268834214454026,-0.0231926269780829,-0.0126543257714851,2.69509595037353e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,40332,0.0324869660294198,0.00487947270800254,0.0229231995217348,0.0420507325371047,2.86903762712916e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHRDL1,Chordin-like protein 1,40396,0.0188116667973731,0.00282549297417311,0.0132737005679938,0.0243496330267524,2.86962608240744e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R9B,Neurabin-2,40516,-0.0577506935842776,0.00867784521440929,-0.0747592702045198,-0.0407421169640354,2.92547451850141e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGRN,Agrin,40422,-0.0204198850612829,0.00306907722093084,-0.0264352764143074,-0.0144044937082585,2.95652124341085e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,-0.0687108955679159,0.0103306705357902,-0.0889590098180646,-0.0484627813177672,3.00381644900905e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VNN1,Pantetheinase,37987,-0.0445647915175884,0.00670491556372338,-0.0577064260224862,-0.0314231570126906,3.11459505141521e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALPP,"Alkaline phosphatase, placental type",40305,-0.0634389232064365,0.00955034551533209,-0.0821576004164874,-0.0447202459963856,3.18271948576933e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,-0.0311950186154248,0.00470186747851369,-0.0404106788733117,-0.021979358357538,3.37832252716779e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINH1,Serpin H1,37714,-0.0790018703792479,0.0119086241669055,-0.102342773746383,-0.0556609670121132,3.3937695301767e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PENK,Proenkephalin-A,37671,-0.0189494258594964,0.00285702418690635,-0.0245491932658328,-0.0133496584531599,3.42714338871496e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,-0.0633925661455085,0.00958375360824712,-0.0821767232176728,-0.0446084090733441,3.84426021244104e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39961,-0.0374981279941908,0.00566912471781775,-0.0486096124411135,-0.026386643547268,3.85143116151941e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40536,0.00951545596940992,0.00143865601443824,0.00669569018111096,0.0123352217577089,3.85528722644072e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RETN,Resistin,40283,-0.0253020273632375,0.0038382566068568,-0.0328250103126768,-0.0177790444137981,4.47470291729079e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRLB,Fc receptor-like B,39980,-0.0372872621263511,0.00565633857780515,-0.0483736857388492,-0.026200838513853,4.47568913311005e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL18,Interleukin-18,40292,-0.0288625419229283,0.00438045887210317,-0.0374482413122505,-0.0202768425336061,4.56974312463979e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",37541,-0.0376200764993958,0.00570977395647706,-0.0488112334540908,-0.0264289195447008,4.60625609663291e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,-0.0468771085729964,0.00711746544301267,-0.0608273408413013,-0.0329268763046916,4.67861021481209e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,-0.0581561808039284,0.00885031668452866,-0.0755028015056046,-0.0408095601022522,5.17817949375678e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40489,0.0372172045083111,0.00567048208148168,0.026103059628607,0.0483313493880152,5.42353827547718e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,40332,-0.0208946565312869,0.00318668559291215,-0.0271405602933947,-0.0146487527691791,5.66472866884221e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KITLG,Kit ligand,40359,0.0220478855929117,0.00337276261477299,0.0154372708679566,0.0286585003178667,6.46575345627205e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37572,-0.0435095086172149,0.0066593377878539,-0.0565618106814085,-0.0304572065530212,6.65739549856838e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37671,-0.0446745097903812,0.00684155087629106,-0.0580839495079116,-0.0312650700728507,6.82284648000038e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSC2,Desmocollin-2,40177,-0.0203366854142852,0.003123755658085,-0.0264592465041318,-0.0142141243244386,7.7256440910248e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,-0.0187855735285115,0.00288562696821034,-0.0244414023862038,-0.0131297446708192,7.73566325798598e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,-0.0622108871920702,0.00958274065591532,-0.0809930588776642,-0.0434287155064762,8.72309771712717e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GASK1A,Golgi-associated kinase 1A,37562,-0.0259532523932254,0.0040040944676501,-0.0338012775498196,-0.0181052272366312,9.39548129061357e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,-0.0412949186629761,0.00638878754512748,-0.0538169422514259,-0.0287728950745262,1.0523852772301e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,-0.0264099684599529,0.00408738241349812,-0.0344212379904092,-0.0183986989294965,1.06765354952285e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTD,Biotinidase,38013,-0.0123145022692552,0.00191281701239018,-0.0160636236135399,-0.00856538092497042,1.25225934279054e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,-0.0250612402713147,0.00389773743275477,-0.0327008056395141,-0.0174216749031154,1.3151516183038e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH5,Cadherin-5,40536,0.0180849620180542,0.0028154502584314,0.0125666795115287,0.0236032445245798,1.36941076479512e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,0.0268643767223035,0.00418463815025185,0.0186624859478099,0.0350662674967971,1.40326894949735e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLIN1,Perilipin-1,39961,-0.0210819484024686,0.00328633319426676,-0.0275231614632314,-0.0146407353417057,1.44868129465379e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STC1,Stanniocalcin-1,40471,-0.0245469781789884,0.00382715448253095,-0.0320482009647491,-0.0170457553932278,1.45819863844227e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP43,Centrosomal protein 43,39934,-0.0409070952675147,0.00639147226499133,-0.0534343809068977,-0.0283798096281317,1.5957210369145e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37998,-0.0294357977827234,0.00459975599619655,-0.0384513195352686,-0.0204202760301782,1.61095565229362e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PZP,Pregnancy zone protein,38013,-0.0386622823474189,0.0060417573394259,-0.0505041267326936,-0.0268204379621441,1.61350480114731e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDHR2,Cadherin-related family member 2,40305,-0.0454552378631099,0.00711386032433562,-0.0593984040988077,-0.031512071627412,1.70879013914455e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37900,-0.0673036035122106,0.0105394775848525,-0.0879609795785215,-0.0466462274458997,1.76043423930065e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,40451,-0.0252967572315178,0.00396311533709775,-0.0330644632922293,-0.0175290511708062,1.78375393849852e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37942,-0.0522097867901643,0.00818360132632639,-0.068249645389764,-0.0361699281905646,1.83102429475896e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37671,-0.01326067216431,0.00208201581536031,-0.0173414231624162,-0.00917992116620383,1.96371660080149e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,-0.0344935554222406,0.00542496536199,-0.045126487531741,-0.0238606233127402,2.10708315511374e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,40264,-0.0157067736882942,0.00247157614802846,-0.02055106293843,-0.0108624844381584,2.14184286977099e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB27B,Ras-related protein Rab-27B,37990,-0.0481595574145664,0.00757815359798112,-0.0630127384666093,-0.0333063763625234,2.15031779581557e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN2,CCN family member 2,40358,-0.0338582262060831,0.0053304844400819,-0.0443059757086436,-0.0234104767035226,2.18574387665455e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,-0.0455888604303035,0.00717769283576132,-0.0596571383883956,-0.0315205824722113,2.20282201859871e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37901,-0.0486273856760044,0.00768514717407442,-0.0636902741371903,-0.0335644972148186,2.57146609275877e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39980,-0.0205505277443433,0.00324943320449326,-0.02691941682515,-0.0141816386635365,2.6126960486183e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C19orf12,Protein C19orf12,39961,-0.0364129727024718,0.00576164538169973,-0.0477057976506033,-0.0251201477543404,2.68895694949418e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,-0.0336617437259706,0.00532770425678772,-0.0441040440692745,-0.0232194433826667,2.71643342489046e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THOP1,Thimet oligopeptidase,40288,-0.0174870995939994,0.00277325964184727,-0.0229226884920201,-0.0120515106959788,2.94664628474107e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSTB,Cystatin-B,40097,-0.0243456516241239,0.00387320753602028,-0.0319371383947237,-0.0167541648535242,3.35121177390308e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,0.0238392941172661,0.00379434570168777,0.016402376541958,0.0312762116925741,3.41171877532669e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHB4,Ephrin type-B receptor 4,40536,-0.0143384915440377,0.0022833161847668,-0.0188137912661807,-0.00986319182189478,3.4798201173054e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37998,0.0191145693892877,0.00304771839975984,0.0131410413257584,0.025088097452817,3.67828924265304e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLA2,Src-like-adapter 2,37959,-0.0597040739121141,0.00952924574037415,-0.0783813955632475,-0.0410267522609808,3.83276242610858e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APP,Amyloid-beta precursor protein,40309,-0.0387947040857922,0.00619695388550264,-0.0509407337013774,-0.0266486744702071,3.94156221168271e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DKK4,Dickkopf-related protein 4,40203,-0.026407351208684,0.0042211582008592,-0.034680821282368,-0.018133881135,4.05309553645218e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,40152,-0.0672126682315264,0.0107628394299464,-0.0883078335142213,-0.0461175029488315,4.35031508949624e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DKK1,Dickkopf-related protein 1,40471,-0.0344173230235929,0.00551310328458307,-0.0452230054613757,-0.0236116405858101,4.40566512500193e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39980,-0.0233238912075198,0.00373829733798648,-0.0306509539899733,-0.0159968284250664,4.51288748711617e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SRPK2,SRSF protein kinase 2,40341,-0.0475571930419463,0.00764541336490746,-0.0625422032371649,-0.0325721828467277,5.08443240453317e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,-0.0641056137183503,0.0103248569581232,-0.0843423333562718,-0.0438688940804288,5.49617345788175e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37901,-0.0484998251704194,0.00781197254535023,-0.0638112913593058,-0.033188358981533,5.51017617908755e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39980,-0.0317215661604556,0.00511047616527977,-0.0417380994444039,-0.0217050328765072,5.5319626419475e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40489,-0.0309980524684354,0.00499578875676365,-0.0407897984316922,-0.0212063065051786,5.60981304495713e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MDK,Midkine,40352,-0.0290670681194254,0.00468719401748225,-0.0382539683936906,-0.0198801678451602,5.73535531627215e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG1A,Lithostathine-1-alpha,40274,-0.0280335049357228,0.00452341778105035,-0.0368994037865814,-0.0191676060848641,5.88192605834209e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXNA4,Plexin-A4,40341,-0.0472458294102316,0.0076320437644658,-0.0622046351885846,-0.0322870236318786,6.14637175303137e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,-0.0394247769136288,0.00636820496683464,-0.0519064586486247,-0.0269430951786329,6.15644899536159e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,-0.0331531303373472,0.0053569316498607,-0.0436527163710742,-0.0226535443036202,6.21390310070619e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAG1,Dystroglycan,40422,-0.0270900693137596,0.00437767775979062,-0.0356703177229492,-0.01850982090457,6.23285910432183e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLAT,Tissue-type plasminogen activator,40490,-0.0280713681522526,0.00453686076678163,-0.0369636152551446,-0.0191791210493606,6.26500421802764e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,-0.0541785110026431,0.00876205925507563,-0.0713521471425914,-0.0370048748626949,6.43176973985602e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,-0.0127206920428779,0.00205816793462934,-0.0167547011947514,-0.00868668289100441,6.56953570503392e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST7,Cystatin-F,40376,-0.0525442574018679,0.00851493376285102,-0.0692335275770559,-0.0358549872266799,6.95737426522431e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL5,C-C motif chemokine 5,40403,-0.0572234190754316,0.00928104191876629,-0.0754142612362136,-0.0390325769146497,7.18958059438496e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37959,-0.0296443560799847,0.00481054543541235,-0.0390730251333929,-0.0202156870265765,7.37017883399371e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL2L15,Bcl-2-like protein 15,37598,-0.0321961340099764,0.00522658296985541,-0.042440236630893,-0.0219520313890598,7.48325727883609e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NBN,Nibrin,40044,-0.0289925299394642,0.00471961326364311,-0.0382429719362047,-0.0197420879427237,8.29495451407972e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,-0.059143622242387,0.00965091808936391,-0.0780594216975403,-0.0402278227872338,9.09335465105158e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,40330,-0.0414697583847184,0.00676888237165352,-0.0547367678331593,-0.0282027489362775,9.19351443662263e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,-0.024798334054283,0.00404983696363276,-0.0327360145030033,-0.0168606536055628,9.38591817722327e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37981,0.010563300312255,0.00172521144778682,0.00718188587459281,0.0139447147499171,9.44286545786488e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G1B,Phospholipase A2,40514,0.0237831705921502,0.00388837955887371,0.0161619466567577,0.0314043945275427,9.78849699155626e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RASSF2,Ras association domain-containing protein 2,39980,-0.0311381742310806,0.00509221458705697,-0.0411189148217122,-0.0211574336404489,9.89564870643817e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,40009,-0.0293141896807928,0.00479493815850591,-0.0387122684714644,-0.0199161108901212,9.97532245888149e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRAP,BRCA1-associated protein,37778,-0.0616932278144056,0.0101045262789247,-0.0814980993210979,-0.0418883563077133,1.05323529299058e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37671,-0.0379880980733677,0.00622967186801161,-0.0501982549346704,-0.0257779412120649,1.10446116254775e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTRC,Chymotrypsin-C,40360,0.035428793606568,0.00581359773037982,0.0240341420550236,0.0468234451581124,1.12574473523507e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37942,-0.016412850011365,0.00269525433736558,-0.0216955485126015,-0.0111301515101285,1.16313134213482e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40471,-0.0461373665330222,0.00758655354553233,-0.0610070114822655,-0.0312677215837788,1.21793034805742e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EHBP1,EH domain-binding protein 1,37990,-0.0419272814197012,0.00689490749440855,-0.055441300108742,-0.0284132627306605,1.22721350434623e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KAZN,Kazrin,37901,-0.0582046102518158,0.00958141478370536,-0.0769841832278784,-0.0394250372757533,1.27538854592878e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOLR1,Folate receptor alpha,40299,-0.0159389569662048,0.00262605091332353,-0.0210860167563189,-0.0107918971760907,1.31188214640624e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FRZB,Secreted frizzled-related protein 3,40176,0.0149660233130817,0.00246953146707657,0.0101257416376117,0.0198063049885518,1.38996126726662e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,-0.0488137075105867,0.00807531030360166,-0.064641315705646,-0.0329860993155274,1.52919912903445e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCR,Breakpoint cluster region protein,40341,-0.0508582347766723,0.00841715251448963,-0.067355853705072,-0.0343606158482726,1.55406739869091e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A16,Protein S100-A16,39934,-0.0348887079185486,0.00577718618955901,-0.0462119928500843,-0.0235654229870129,1.5857020534128e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40489,0.032337386936952,0.00536235573208493,0.0218271697020655,0.0428476041718384,1.67097431233757e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37598,-0.0271072263859355,0.00449554250641043,-0.0359184896984999,-0.0182959630733711,1.68563251091369e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,40422,-0.0696309847506017,0.0115586958621704,-0.0922860286404557,-0.0469759408607477,1.73762167131212e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,40380,-0.0264612961355437,0.00439672589435044,-0.0350788788884706,-0.0178437133826169,1.80000460351565e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37987,0.0144459612308103,0.00240156012704712,0.0097389033817979,0.0191530190798226,1.84251686794893e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFX1,Transcriptional repressor NF-X1,37562,-0.0376211860303074,0.00626945550451938,-0.0499093188191654,-0.0253330532414494,2.01638435055899e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,-0.0388471811619973,0.00647839591259076,-0.0515448371506752,-0.0261495251733194,2.06116137551391e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,40434,-0.0400665611498927,0.00668821548440759,-0.0531754634993315,-0.0269576588004538,2.13526175656682e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD63,CD63 antigen,40203,-0.028898282415437,0.00482708345266507,-0.0383593659826605,-0.0194371988482135,2.18795974297828e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,-0.0553227209334381,0.00924678443275197,-0.073446418421632,-0.0371990234452442,2.23833747577169e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DOK2,Docking protein 2,40359,-0.0668407161373581,0.0111750219855161,-0.0887437592289696,-0.0449376730457465,2.26160746112972e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39865,-0.0209101671422857,0.00350239914132255,-0.0277748694592779,-0.0140454648252935,2.42104471455938e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,-0.0444065126058035,0.00745092033019517,-0.059010316452986,-0.0298027087586209,2.58898583565471e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPBP,Platelet basic protein,37934,-0.046243868027362,0.00777359061921738,-0.0614801056410281,-0.0310076304136959,2.76736656692415e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FIS1,Mitochondrial fission 1 protein,40354,-0.0424049336711511,0.00713801569943825,-0.0563954444420501,-0.0284144229002522,2.8969793157346e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCF2,Neutrophil cytosol factor 2,40324,-0.0457114308558048,0.00769598953908525,-0.0607955703524119,-0.0306272913591977,2.91609749363079e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,-0.0244296636078278,0.00411988791831015,-0.0325046439277157,-0.0163546832879399,3.09943336722648e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD58,Lymphocyte function-associated antigen 3,40335,0.00971145381080813,0.00163857585578469,0.00649984513347014,0.0129230624881461,3.1535504596931e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,0.0245761580315509,0.00415154638616879,0.0164391271146601,0.0327131889484417,3.29021552651074e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRTAC1,Cartilage acidic protein 1,40536,0.0160542604110403,0.00271531601691583,0.0107322410178852,0.0213762798041953,3.43809475837483e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL18BP,Interleukin-18-binding protein,40403,-0.0166999504494901,0.00282851511962059,-0.0222438400839464,-0.0111560608150337,3.61686020246844e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD36,Platelet glycoprotein 4,37598,-0.0242089261574528,0.00410049985803019,-0.0322459058791919,-0.0161719464357136,3.63774172824515e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL7,C-C motif chemokine 7,40341,-0.0331715483213727,0.00562682162706852,-0.044200118710427,-0.0221429779323184,3.81682118172188e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB8,Serpin B8,40516,-0.0297561421472705,0.00504764410479943,-0.0396495245926774,-0.0198627597018636,3.82059176954505e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OGA,Protein O-GlcNAcase,37901,-0.0382131728001049,0.00648210073412933,-0.0509180902389983,-0.0255082553612114,3.83236789078137e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCK2,Cytoplasmic protein NCK2,40422,-0.0569303911367085,0.00966267626675001,-0.0758692366195385,-0.0379915456538785,3.89733348951921e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6AP2,Renin receptor,39980,-0.0227240262992721,0.00386230248412827,-0.0302941391681635,-0.0151539134303807,4.09834884198907e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,-0.024267708118196,0.0041487856040896,-0.0323993279022117,-0.0161360883341804,5.05229845982048e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNMBP,Dynamin-binding protein,40228,-0.0332658846680915,0.00570402888982173,-0.0444457812921421,-0.0220859880440409,5.58387782732007e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,0.0327833655876976,0.00562340759842552,0.0217614866947836,0.0438052444806116,5.65684116341121e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,-0.0335492122772411,0.00576205319170061,-0.0448428365329743,-0.0222555880215079,5.93142574305536e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,-0.0174287722886751,0.00299385687285522,-0.0232967317594713,-0.0115608128178789,5.94448225596166e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTYMK,Thymidylate kinase,37990,-0.0372348125863604,0.00639796211598101,-0.0497748183336831,-0.0246948068390376,6.02544179626367e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,-0.0308349508775287,0.00532820616573259,-0.0412782349623646,-0.0203916667926928,7.2952222399764e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPT1,Angiopoietin-1,40263,-0.0454228553669075,0.00786056638078878,-0.0608295654732535,-0.0300161452605615,7.67549757587312e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERBIN,Erbin,40305,-0.0547278022713944,0.0094841876940401,-0.073316810151713,-0.0361387943910758,8.0547605882204e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FMNL1,Formin-like protein 1,39961,-0.0320454495106936,0.00555709328911435,-0.0429373523573577,-0.0211535466640295,8.24339701375842e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100G,Protein S100-G,37959,0.0237230540480312,0.00411975875340205,0.0156483268913632,0.0317977812046992,8.67834026705324e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCD5,Programmed cell death protein 5,40471,-0.0310014496494579,0.00539260762562517,-0.0415709605956833,-0.0204319387032326,9.14724589207284e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD22,B-cell receptor CD22,40516,0.021792192152929,0.0037924245828546,0.014359039970534,0.029225344335324,9.29017959619967e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,-0.0153949164861732,0.00268290244262652,-0.0206534052737211,-0.0101364276986252,9.77617226548926e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,-0.0407513010665304,0.00710957746725133,-0.054686072902343,-0.0268165292307177,1.01441512345238e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,-0.0228335506688276,0.00398746970421926,-0.0306489912890973,-0.0150181100485578,1.04874596649618e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,-0.0361515069828777,0.00631497472533725,-0.0485288574445387,-0.0237741565212167,1.05868987433494e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,-0.0412567904286651,0.00722081602724841,-0.055409589842072,-0.0271039910152582,1.12612841715578e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAP,Prolyl endopeptidase FAP,40536,0.0143069424004383,0.00250741072141566,0.00939241738646363,0.019221467414413,1.17792830304083e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,-0.027139062848914,0.0047706038952823,-0.0364894464836673,-0.0177886792141607,1.30233311130735e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37671,-0.0415839195700987,0.00731140892330866,-0.0559142810597837,-0.0272535580804138,1.31614055642286e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH3,Cadherin-3,40471,-0.0186306726114739,0.00328075624352976,-0.0250609548487922,-0.0122003903741556,1.38017543717352e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40489,0.0310395831331563,0.00546990341113703,0.0203185724473277,0.0417605938189848,1.4140492167457e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,40332,-0.0277241708949996,0.00488716645687238,-0.0373030171504695,-0.0181453246395298,1.42887872623332e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,40341,0.0247750052734792,0.00436741226936243,0.0162148772255289,0.0333351333214296,1.43015641838932e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WASHC3,WASH complex subunit 3,37942,-0.0392806856450368,0.00692655782616573,-0.0528567389843216,-0.0257046323057519,1.44858174288362e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELP,P-selectin,40403,-0.0302803538602101,0.00534204947019637,-0.040750770821795,-0.0198099368986252,1.46713834099929e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,40341,-0.028359630774859,0.00500821821351052,-0.0381757384733396,-0.0185435230763784,1.51659033018814e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,0.0172053310892229,0.00304207375196861,0.0112428665353645,0.0231677956430814,1.5780791825026e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,40457,-0.0136823967749827,0.00241938214270729,-0.018424385774689,-0.0089404077752764,1.58207784026214e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,-0.0235811570821375,0.00416993781928976,-0.0317542352079454,-0.0154080789563296,1.5851240321168e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AZI2,5-azacytidine-induced protein 2,37959,-0.0287926457585452,0.00509314483918266,-0.0387752096433433,-0.0188100818737472,1.60661441637292e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37990,-0.0248358262337876,0.00439765073552444,-0.0334552216754155,-0.0162164307921597,1.66052316813988e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OLFM4,Olfactomedin-4,37177,-0.064597262900141,0.0114394154487298,-0.0870185171796514,-0.0421760086206306,1.66861289970725e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,-0.0338815122458381,0.0060032260483545,-0.0456478353006129,-0.0221151891910633,1.69614437291386e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37942,-0.0187413677850325,0.00332075031414164,-0.0252500384007501,-0.0122326971693149,1.69770703748863e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,-0.015399732736015,0.00272901192267412,-0.0207485961044563,-0.0100508693675737,1.70014270376329e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB33A,Ras-related protein Rab-33A,37562,-0.0347648598333698,0.006162215965938,-0.0468428031266083,-0.0226869165401313,1.7194716035434e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QL2,Complement C1q-like protein 2,37598,0.0224379397536934,0.00397833512236826,0.0146404029138517,0.0302354765935352,1.73522879166843e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37959,-0.0329341126792529,0.00584198869894803,-0.0443844105291911,-0.0214838148293148,1.76008682243999e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB6A,Ras-related protein Rab-6A,40341,0.0248816540889353,0.00442192023414729,0.0162146904300067,0.033548617747864,1.8658529290068e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,-0.0190499688930695,0.00338895390303111,-0.0256923185430105,-0.0124076192431285,1.93491303995316e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,-0.0557089166016964,0.00991129539708224,-0.0751350555799775,-0.0362827776234152,1.93897707967962e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CMIP,C-Maf-inducing protein,37900,-0.0425846246377265,0.00757941217091588,-0.0574402724927216,-0.0277289767827314,1.96490897338656e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,-0.0478999769482377,0.00854003083650327,-0.0646384373877841,-0.0311615165086913,2.07103822433401e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HPSE,Heparanase,37848,-0.0481408141731211,0.00858321631749634,-0.0649639181554139,-0.0313177101908283,2.07868296456594e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,40405,-0.0264556568857898,0.00472524616766324,-0.0357171393744097,-0.0171941743971699,2.19411781851334e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37562,-0.0328708077138578,0.00587204494708372,-0.0443800158101419,-0.0213615996175737,2.21386817046409e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37671,0.0138703722389677,0.00247797474371764,0.0090135417412811,0.0187272027366542,2.21839637973314e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL32,Interleukin-32,40341,0.022105556284234,0.00395305061733045,0.0143575770742664,0.0298535354942017,2.28133575360124e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",40359,0.0400584402872384,0.00716691445474676,0.0260112879559348,0.0541055926185421,2.31655080752162e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300E,CMRF35-like molecule 2,40436,-0.0206402232079602,0.00369499559979608,-0.0278824145835605,-0.0133980318323599,2.36155523968781e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD70,CD70 antigen,40341,0.0215001523311893,0.00385076118977577,0.0139526603992288,0.0290476442631498,2.39789855763683e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL6,Interleukin-6,40305,-0.037769855425391,0.00676577146123842,-0.0510307674894183,-0.0245089433613637,2.40986451750052e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37628,-0.0530679394670159,0.00951909615058448,-0.0717253679221614,-0.0344105110118703,2.52550028622061e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COMMD9,COMM domain-containing protein 9,37900,-0.0202365178685929,0.00363083108364138,-0.02735294679253,-0.0131200889446558,2.54441072719882e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,40341,0.0175710195310457,0.00315340478035442,0.0113903461615511,0.0237516929005404,2.55806039607955e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,40357,-0.0259282544230345,0.00465893653636559,-0.0350597700343111,-0.016796738811758,2.65968691349894e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPT,Dermatopontin,40536,0.0136495474806142,0.00245505586475787,0.00883763798568878,0.0184614569755396,2.74425962512563e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP5,Fatty acid-binding protein 5,40432,-0.0354742093442753,0.00639173341367148,-0.0480020068350714,-0.0229464118534792,2.90188690241263e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,-0.0496320302140762,0.00894295452762542,-0.0671602210882221,-0.0321038393399304,2.90579661443658e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,40305,-0.0707317301622283,0.0127512185047206,-0.0957241184314807,-0.0457393418929758,2.95165640158793e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,-0.0340800816290484,0.00615325076490297,-0.0461404531282582,-0.0220197101298386,3.10791681083409e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD69,Early activation antigen CD69,40288,-0.0450737532714342,0.00813941442633384,-0.0610270055470486,-0.0291205009958199,3.11318917095537e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,0.0184520185552076,0.00333574992138032,0.0119139487093021,0.024990088401113,3.22343440331155e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,-0.0277201416450935,0.00502513723184729,-0.0375694106195142,-0.0178708726706729,3.51665387148966e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,-0.0352829696169686,0.00641588833004661,-0.04785811074386,-0.0227078284900772,3.8717225639306e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLIN3,Perilipin-3,40359,-0.0216232876869793,0.00393408199103687,-0.0293340883894116,-0.0139124869845471,3.93584327085494e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37978,-0.0123673233661549,0.00225365564075108,-0.016784488422027,-0.00795015831028276,4.14593481018603e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37990,-0.032160633729106,0.00586137945594374,-0.0436489374627557,-0.0206723299954563,4.16466398738235e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40490,-0.0162552915024218,0.00296776432239743,-0.0220721095743207,-0.0104384734305228,4.38399497177125e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTDH,Protein LYRIC,37598,-0.046300386411061,0.00845576047460594,-0.0628736769412886,-0.0297270958808333,4.44029885793321e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DGKA,Diacylglycerol kinase alpha,37598,-0.0274761663635415,0.00502085317060337,-0.0373170385779241,-0.0176352941491589,4.52089011027992e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RALY,RNA-binding protein Raly,37900,-0.0244088186098088,0.004461728975343,-0.0331538074014811,-0.0156638298181365,4.56255399095262e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN2,Contactin-2,40489,0.0226518503184047,0.0041511518263836,0.0145155927386928,0.0307881078981165,4.92084059031821e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL10,C-X-C motif chemokine 10,40422,-0.0339634423318552,0.00624633592349216,-0.0462062607418999,-0.0217206239218106,5.48765757217836e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,40332,-0.0262522171977335,0.00482848368658615,-0.0357160452234424,-0.0167883891720247,5.50010662296125e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37990,-0.0367623371751391,0.0067681419526388,-0.0500278954023111,-0.023496778947967,5.67922644052663e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,-0.0229976956500351,0.00423580417022776,-0.0312998718236815,-0.0146955194763886,5.73877798117622e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA7,Thyroxine-binding globulin,38013,-0.00940558182464251,0.00173414516263684,-0.0128045063434107,-0.00600665730587432,5.93597737977134e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,40359,-0.0155819744795522,0.00287333348461881,-0.0212137081094051,-0.00995024084969932,5.94752973318715e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,-0.0136780336586683,0.00252458691325943,-0.0186262240086568,-0.00872984330867987,6.13312143796034e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,-0.0396811259775441,0.00732597637637472,-0.0540400396752386,-0.0253222122798497,6.18189017856801e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COCH,Cochlin,37990,-0.0233329631570368,0.00431082293828156,-0.0317821761160686,-0.0148837501980049,6.3157798528767e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,0.0137454478989746,0.00254541470917121,0.008756435068999,0.0187344607289501,6.75560040505052e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCD6,Programmed cell death protein 6,40359,0.0348954918707384,0.00647308341628816,0.0222082483748136,0.0475827353666632,7.11207737149253e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,40396,0.0227623192356679,0.00422603481596895,0.0144792909963687,0.031045347474967,7.29782743526698e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS53,Serine protease 53,37942,0.0182986609039911,0.00339801903247868,0.0116385436003329,0.0249587782076493,7.36192982453857e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPP7,Dipeptidyl peptidase 2,40251,-0.0289681235614707,0.00538022258884679,-0.0395133598356104,-0.018422887287331,7.38126123921972e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37687,-0.0320552143694184,0.0059543585442888,-0.0437257571162244,-0.0203846716226123,7.43031264006864e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARF1,Scavenger receptor class F member 1,40536,-0.0211038248476184,0.00392421602671274,-0.0287952882599754,-0.0134123614352614,7.64357102164129e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WDR46,WD repeat-containing protein 46,37900,-0.0176696854643734,0.00328730185145554,-0.0241127970932262,-0.0112265738355205,7.78034628850713e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPARC,SPARC,40411,-0.0351501417760683,0.00654909399793648,-0.0479863660120238,-0.0223139175401128,8.10961790153222e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,-0.0325794087714704,0.00607054112756665,-0.044477669381501,-0.0206811481614397,8.14676082278733e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40516,-0.0336681526104044,0.00628271348360649,-0.0459822710382732,-0.0213540341825357,8.49061685328972e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37942,0.0325259971307175,0.00607227156689272,0.0206243448596078,0.0444276494018273,8.62522293250079e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,40403,0.0136668497974747,0.00255336669070173,0.00866225108369932,0.0186714485112501,8.79555167389126e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40536,-0.0356400687872792,0.00665954316282022,-0.0486927733864069,-0.0225873641881516,8.83119243530818e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37901,-0.0195806707436071,0.00365844559375401,-0.0267512241073649,-0.0124101173798492,8.83258160758471e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37959,-0.0374797104380109,0.00700714171664499,-0.0512137082026351,-0.0237457126733867,8.99891247496332e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F11,Coagulation factor XI,37810,0.0150284007321613,0.00281042059688235,0.00951997636227185,0.0205368251020507,9.07037511628262e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,-0.0175366356039381,0.00328374063013457,-0.0239727672390019,-0.0111005039688743,9.39828910881373e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GOLGA3,Golgin subfamily A member 3,37959,-0.0386571212476586,0.00724528117321114,-0.0528578723471524,-0.0244563701481648,9.68256535311883e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,-0.0207666738247128,0.00390452533734744,-0.0284195434859138,-0.0131138041635119,1.06257337691831e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADD1,Alpha-adducin,37671,-0.0345843468872778,0.0065041696182145,-0.0473325193389783,-0.0218361744355774,1.07057839292124e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39961,-0.0327940052617201,0.00616832659603771,-0.044883925389954,-0.0207040851334862,1.07238671461013e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP9,Matrix metalloproteinase-9,40312,-0.0300468092003448,0.00566370384242041,-0.0411476687314888,-0.0189459496692008,1.14091721741763e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40471,-0.0328442848334413,0.00619873546371457,-0.0449938063423219,-0.0206947633245607,1.18273581864576e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH2B3,SH2B adapter protein 3,39980,-0.0479105903701448,0.00904268099048564,-0.0656342451114967,-0.030186935628793,1.18499536304032e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UNC5D,Netrin receptor UNC5D,37598,0.0131299067915039,0.00247839450715728,0.0082722535574756,0.0179875600255321,1.19132483009056e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,40422,-0.0419833940606206,0.00792807458141785,-0.0575224202401995,-0.0264443678810416,1.20240792424419e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,-0.050134502500123,0.00947482014309312,-0.0687051499805855,-0.0315638550196605,1.2332906559995e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,-0.0193293418323433,0.00365322060393496,-0.0264896542160558,-0.0121690294486308,1.23524836544081e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CR1,Complement receptor type 1,37959,0.0177090612478898,0.00336163552495009,0.0111202556189876,0.024297866876792,1.40044961098104e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17C,Interleukin-17C,40044,-0.0342376089349883,0.00651398464816507,-0.0470050188453918,-0.0214701990245847,1.49149699547176e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NADK,NAD kinase,40359,-0.0260538473598911,0.00496289498772507,-0.0357811215358322,-0.0163265731839499,1.54282884551049e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,40422,-0.0125520029410822,0.00239324014989982,-0.0172427536348859,-0.00786125224727856,1.58471010124516e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,-0.0462277042617091,0.00881590835303556,-0.0635068846336588,-0.0289485238897594,1.59423065626498e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA4C,Semaphorin-4C,40305,0.0137749407493713,0.00262728433274981,0.00862546345718168,0.0189244180415609,1.59985517193142e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,40332,-0.0145171309640637,0.00277134147883524,-0.0199489602625807,-0.00908530166554659,1.64128193728759e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OPLAH,5-oxoprolinase,37628,-0.0329429988815506,0.00630852622792491,-0.0453077102882834,-0.0205782874748178,1.79714775435107e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINE2,Glia-derived nexin,37990,-0.0309942897510448,0.00593670199240123,-0.0426302256561512,-0.0193583538459384,1.80795882127103e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BGN,Biglycan,39956,0.0587428588754951,0.0112594606529121,0.0366743159957874,0.0808114017552028,1.83987569857509e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,-0.0133923011957401,0.00256769092723313,-0.0184249754131171,-0.00835962697836321,1.85824559895701e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,-0.030025779534742,0.00575981005312725,-0.0413150072388715,-0.0187365518306126,1.88574317981299e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAEP,Glycodelin,40228,-0.0633955552328325,0.0121923082336956,-0.0872924793708759,-0.0394986310947892,2.02174321789152e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEP,Leptin,40359,-0.0306877890897893,0.00591793832056776,-0.0422869481981021,-0.0190886299814765,2.18013692018024e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,-0.0297140662967538,0.00572989280916605,-0.0409446562027193,-0.0184834763907883,2.18295081866242e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBS,Cystathionine beta-synthase,37628,-0.0243849052139453,0.00470612289342763,-0.0336089060850634,-0.0151609043428271,2.2332656074969e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,-0.0306865317718582,0.00593640427411031,-0.0423218841491144,-0.019051179394602,2.38003185282339e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDCP1,CUB domain-containing protein 1,40228,-0.0232130427110448,0.00449814721942263,-0.0320294112611132,-0.0143966741609765,2.49174096835595e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,-0.0169501005968808,0.00329005333123012,-0.0233986051260918,-0.0105015960676698,2.61561902194763e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL9,C-X-C motif chemokine 9,40422,-0.0322957322576467,0.00627203734016126,-0.0445889254443628,-0.0200025390709306,2.6476219214058e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL19,Interleukin-19,39924,-0.0324377978915385,0.00630741286793498,-0.0448003271126911,-0.0200752686703859,2.73969385114453e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,-0.0180330720100923,0.00350857810150825,-0.0249098850890484,-0.0111562589311361,2.78427828381092e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,-0.0151261968439779,0.00294328714690832,-0.0208950396519182,-0.00935735403603756,2.79737324735737e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH15,Cadherin-15,40435,-0.0210530845814207,0.00409981493523499,-0.0290887218544813,-0.0130174473083601,2.8525991341725e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37942,0.0288199230080662,0.00561559781357333,0.0178133512934624,0.0398264947226699,2.90477677814862e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37901,-0.0361752770761099,0.00705136552519879,-0.0499959535054995,-0.0223546006467203,2.93383251208773e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCTN3,Tectonic-3,37990,-0.013828750641927,0.00269824848613398,-0.0191173176747496,-0.00854018360910443,3.01501042700092e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PODXL2,Podocalyxin-like protein 2,40411,0.0129533859888812,0.0025277715217616,0.00799895380622842,0.0179078181715339,3.01922827870445e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPL14,60S ribosomal protein L14,37628,-0.019625932296564,0.00383255477925188,-0.0271377396638977,-0.0121141249292303,3.08455232271192e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39980,-0.0222227211826039,0.0043418044425764,-0.0307326578900536,-0.0137127844751541,3.11958274813936e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,-0.0168944868475846,0.00330138848917756,-0.0233652082863726,-0.0104237654087966,3.14172349160737e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,-0.019292284370973,0.00378188658597874,-0.0267047820794913,-0.0118797866624546,3.41408605415996e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,40228,-0.0107077348015114,0.00210081868600343,-0.0148253394260782,-0.00659013017694471,3.4918862293006e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOXJ3,Forkhead box protein J3,37598,-0.0205815602527219,0.00403890148467578,-0.0284978071626865,-0.0126653133427574,3.52031706176106e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDHD2,Phospholipase DDHD2,37959,-0.0311837044691997,0.00611960932986938,-0.0431781387557437,-0.0191892701826557,3.52142231830478e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNRD2,Protein ZNRD2,37901,-0.0320321617649911,0.0062869735365748,-0.0443546298966777,-0.0197096936333045,3.53457801715e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CETN2,Centrin-2,39961,-0.0317381570383968,0.00623117248184448,-0.043951255102812,-0.0195250589739817,3.55732315244483e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39961,-0.0284127467372257,0.00557896648379738,-0.0393475210454686,-0.0174779724289828,3.56887150746028e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEZ6,Seizure protein 6 homolog,37572,0.0147663953558584,0.00290304731916632,0.00907642261029244,0.0204563681014244,3.69735938399796e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL11,Eotaxin,40516,-0.0176576548350445,0.00348324935454324,-0.0244848235699492,-0.0108304861001397,4.037080090063e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLSCR3,Phospholipid scramblase 3,37919,-0.0280234291851515,0.00553345956513035,-0.038869009932807,-0.017177848437496,4.15192623370788e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,40333,-0.0454864067933488,0.00899251143908289,-0.0631117292139513,-0.0278610843727463,4.27829937393314e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MITD1,MIT domain-containing protein 1,40228,-0.0452472552834232,0.00894810069247331,-0.0627855326406709,-0.0277089779261755,4.31508202074419e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBKS,Ribokinase,39991,-0.0232367918173062,0.00460687024298656,-0.0322662574935598,-0.0142073261410525,4.61174693102523e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,-0.0432922418453535,0.00858476318956455,-0.0601183776969,-0.0264661059938069,4.64434356558645e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38484,0.0146501661957762,0.00290983569607368,0.00894688823147176,0.0203534441600806,4.84517654571197e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VEGFC,Vascular endothelial growth factor C,40411,-0.0259933043389852,0.00516567817975861,-0.0361180335713121,-0.0158685751066584,4.90858891581273e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CX3CL1,Fractalkine,40228,0.0159407554532999,0.00316890189057792,0.00972970774776723,0.0221518031588327,4.94906771052354e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLU,Clusterin,38013,0.0154223960116461,0.00306958188295403,0.00940601552105619,0.021438776502236,5.11794191412636e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,-0.0129623101131398,0.00258301120895703,-0.0180250120826956,-0.00789960814358399,5.26950043599981e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL2,C-C motif chemokine 2,40203,-0.024515369425058,0.00490247282318066,-0.0341242161584921,-0.0149065226916239,5.77628301246643e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAMR1,Inactive serine protease PAMR1,40332,0.0129173337341306,0.00258470881373802,0.00785130445920407,0.0179833630090571,5.86667191867466e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,-0.0284894653196558,0.00570725824173476,-0.0396756914734559,-0.0173032391658557,6.04686924325092e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARSB,Arylsulfatase B,40305,-0.0253859712682092,0.00508804582236042,-0.0353585410800356,-0.0154134014563827,6.12287648434863e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LARP1,La-related protein 1,37900,-0.0292353200737822,0.00586365791906145,-0.0407280895951426,-0.0177425505524217,6.24585885996573e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300C,CMRF35-like molecule 6,40471,-0.0157342383218365,0.00315643973381577,-0.0219208602001154,-0.00954761644355758,6.26719019811208e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSS,Cathepsin S,37057,-0.0114226735209444,0.00229234702220952,-0.0159156736844751,-0.00692967335741374,6.34497251658569e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,-0.0394417022090706,0.007919267275787,-0.0549634660696131,-0.0239199383485281,6.42313341073028e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39980,-0.0427333989756013,0.008590331999037,-0.0595704496937139,-0.0258963482574888,6.60840788859235e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP10,Caspase-10,39961,-0.0330822993076361,0.00665645136056487,-0.0461289439743432,-0.0200356546409289,6.76807582720237e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCG3,Secretogranin-3,40379,0.0153676653851369,0.00309231832661719,0.0093067214649672,0.0214286093053066,6.77785467574918e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37987,-0.0124637648140233,0.00250832083160309,-0.0173800736439654,-0.00754745598408126,6.81327266765038e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,-0.0692302135354896,0.0139354402050152,-0.0965436763373194,-0.0419167507336598,6.83765817485351e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COLEC12,Collectin-12,40357,-0.0117514790592733,0.00236756737221997,-0.0163919111088244,-0.00711104700972211,6.99414341102775e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40489,0.0148971293635291,0.00300406119859662,0.00900916941427971,0.0207850893127785,7.15826576007819e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,0.022941379231054,0.0046275231736481,0.0138714338107038,0.0320113246514043,7.21067433025154e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37901,-0.0214176059207929,0.00432787650181709,-0.0299002438643544,-0.0129349679772314,7.5593232467048e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,-0.016018660954717,0.00324504140282657,-0.0223789421042571,-0.00965837980517693,8.05522921233305e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSME2,Proteasome activator complex subunit 2,40152,-0.0169247952118907,0.00343183508667253,-0.0236511919817689,-0.0101983984420126,8.2348721438021e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOXO3,Forkhead box protein O3,39980,-0.0442920720830328,0.00898309121773614,-0.0618989308697957,-0.02668521329627,8.282213964278e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOD3,Extracellular superoxide dismutase,37987,0.0270501892224382,0.00548843487140997,0.0162928568744747,0.0378075215704017,8.38100190516881e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPXM1,Probable carboxypeptidase X1,40411,-0.0313205856220326,0.00636194583630622,-0.0437899994611927,-0.0188511717828724,8.60286172039628e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLB,Beta-klotho,39961,0.0335950864899278,0.00682837397793136,0.0202114734931823,0.0469786994866732,8.74653080436202e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFRA2,GDNF family receptor alpha-2,40305,0.00968021562565678,0.00196967428297893,0.00581965403101808,0.0135407772202955,8.98399686620487e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,-0.0298292029557923,0.00607672425099982,-0.0417395824877519,-0.0179188234238326,9.25828813381057e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,0.0139242792085539,0.0028372852218612,0.00836320017370597,0.0194853582434019,9.31059864277278e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLF4,Krueppel-like factor 4,37541,-0.0177847743577063,0.00362376174792779,-0.0248873473836448,-0.0106822013317678,9.32030361513384e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,-0.0202770911489922,0.00413249404198545,-0.0283767794712837,-0.0121774028267007,9.37076778480578e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LY96,Lymphocyte antigen 96,40228,-0.0157249623836374,0.00321801509794072,-0.0220322719756012,-0.00941765279167362,1.03630634919356e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYDGF,Myeloid-derived growth factor,37990,-0.0453522972579334,0.00928135153981318,-0.0635437462759672,-0.0271608482398996,1.03877715378431e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37562,-0.0306820468433501,0.00627985388329735,-0.0429905604546129,-0.0183735332320873,1.04232386290995e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,-0.0497071739048254,0.0101821640839329,-0.0696642155093339,-0.0297501323003169,1.06145246979427e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPTXR,Neuronal pentraxin receptor,40359,0.0153716006081087,0.00314942538576922,0.00919872685200106,0.0215444743642164,1.06700206142277e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAG6,Large proline-rich protein BAG6,40042,-0.0162478661878758,0.00333075853159693,-0.0227761529098058,-0.00971957946594584,1.0815454190119e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,-0.0172049007572371,0.00352927113129256,-0.0241222721745705,-0.0102875293399036,1.09926247524531e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFC1,Cryptic protein,39980,-0.0208185911994316,0.00427973858014917,-0.029206878816524,-0.0124303035823392,1.15898337469796e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,0.0142087880778942,0.00292379585311796,0.00847814820578298,0.0199394279500054,1.18680865637126e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,-0.0344599980503501,0.00709308586420201,-0.0483624463441861,-0.0205575497565142,1.19551625125424e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39980,-0.0204512473289545,0.00421158777872885,-0.0287059593752631,-0.012196535282646,1.20979296755223e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADA,Adenosine deaminase,40516,-0.0152783261255178,0.00314878598555824,-0.021449946657212,-0.00910670559382369,1.23287055877493e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,-0.0212381720563984,0.00438032170292856,-0.0298236025941383,-0.0126527415186584,1.25757233955598e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BID,BH3-interacting domain death agonist,40341,-0.0300190535093872,0.00619585392738062,-0.0421629272070533,-0.0178751798117212,1.27791245587769e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NGRN,Neugrin,37942,-0.00986817377891007,0.00203692065527594,-0.0138605382632509,-0.00587580929456924,1.28242740902669e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PKD2,Polycystin-2,37562,-0.0266590719491626,0.00550679073394432,-0.0374523817876935,-0.0158657621106317,1.30577457439955e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLGN,Calmegin,37572,-0.0199548995733234,0.00412208855698608,-0.0280341931450162,-0.0118756060016307,1.30680390669033e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAX,Apoptosis regulator BAX,39934,-0.0401310800895654,0.0082923041155639,-0.0563839961560707,-0.0238781640230602,1.31383057154003e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,40359,0.00784083115892786,0.00162090818085046,0.00466385112446097,0.0110178111933948,1.32842162274738e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,-0.0236044018894271,0.00488061668233381,-0.0331704105868014,-0.0140383931920529,1.33725906209248e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37598,-0.0343175301417491,0.00710201448803822,-0.048237478538304,-0.0203975817451942,1.36636932080376e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUSD5,Sushi domain-containing protein 5,37604,0.0153436250146638,0.00317737490970652,0.00911597019163905,0.0215712798376886,1.38747510091184e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOB,Apolipoprotein B-100,37987,0.00997157591099706,0.00207253080845902,0.00590941552641738,0.0140337362955767,1.51565866721885e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,-0.0381236184714177,0.0079310939116757,-0.0536685625383021,-0.0225786744045333,1.54758520764682e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DKK3,Dickkopf-related protein 3,40536,0.0131270757332379,0.00273125083825283,0.00777382409026237,0.0184803273762135,1.55176322434146e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB7,Integrin beta-7,40489,0.0202534217379956,0.00421515117187699,0.0119917254411167,0.0285151180348745,1.56222265634522e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AAMDC,Mth938 domain-containing protein,37628,-0.0238680365522724,0.00497073158936026,-0.0336106704674185,-0.0141254026371263,1.5904210626904e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS22,Brain-specific serine protease 4,37598,-0.0156974281650629,0.00327288458743668,-0.0221122819564388,-0.00928257437368697,1.63473187502967e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNC,Tenascin,40403,0.0210310114201328,0.00438639322839192,0.0124336806924846,0.029628342147781,1.6446862068289e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYN,Tyrosine-protein kinase Lyn,40305,-0.0372491620527547,0.00777357168456555,-0.0524853625545032,-0.0220129615510063,1.66814520227522e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37598,-0.0254153183002532,0.00532003857212264,-0.0358425939016136,-0.0149880426988929,1.7960141434974e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCXR,L-xylulose reductase,40411,-0.0230803740042132,0.00483532949559221,-0.0325576198155739,-0.0136031281928525,1.82857758741668e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37653,-0.0240298384538678,0.0050402881323702,-0.0339088031933133,-0.0141508737144222,1.88468131466324e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GH1,Somatotropin,40330,0.0773521408361167,0.0162290688896209,0.0455431658124598,0.109161115859774,1.89329549404724e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,-0.047910535534995,0.0100538581200451,-0.0676160974502834,-0.0282049736197067,1.90462037057879e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,0.0165352895427446,0.00347040781206909,0.00973329023108919,0.0233372888544,1.90921245368016e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RRAS,Ras-related protein R-Ras,37572,-0.0575234356943488,0.0120834603534862,-0.0812070179871818,-0.0338398534015158,1.95166692401827e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA12,Carbonic anhydrase 12,40305,-0.0142180157385383,0.00299603903327156,-0.0200902522437505,-0.00834577923332602,2.09698911825512e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN5,CCN family member 5,40332,-0.0172435888960746,0.00363514864138612,-0.0243684802331913,-0.0101186975589578,2.1180869995241e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEMIP2,Cell surface hyaluronidase,37598,-0.0148139257750568,0.00312529419674961,-0.0209395024006861,-0.0086883491494276,2.15948031028635e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,0.018200828265407,0.00384400011459134,0.010666588040808,0.0257350684900061,2.21081404606329e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QA,Complement C1q subcomponent subunit A,40442,-0.00995677570311641,0.00210318645403906,-0.014079021153033,-0.00583453025319984,2.21873215880237e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PF4,Platelet factor 4,37934,-0.0425093511674801,0.00901266538901513,-0.0601741753299497,-0.0248445270050104,2.42195189741385e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ING1,Inhibitor of growth protein 1,39925,-0.0195195479931863,0.00414055046664897,-0.0276350269078183,-0.0114040690785543,2.44729416201308e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,-0.0275188993365882,0.00583954714346776,-0.038964411737785,-0.0160733869353914,2.46767049814472e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,METAP2,Methionine aminopeptidase 2,40453,-0.0256356674777592,0.00544259276485416,-0.0363031492968733,-0.014968185658645,2.49559952827514e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLG,Plasminogen,37705,-0.00980946324087379,0.00208276771976295,-0.0138916879716092,-0.00572723851013841,2.50449731818841e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37990,-0.0204548281780288,0.00434609327762999,-0.0289731710021836,-0.0119364853538741,2.54518962138414e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,-0.0165175814106005,0.00351446262443002,-0.0234059281544833,-0.00962923466671763,2.62465427873118e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,-0.0155276231724294,0.00330398257706632,-0.0220034290234794,-0.00905181732137939,2.6323449579696e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,0.00982497612090663,0.00209122206077109,0.0057261808817953,0.013923771360018,2.6465996707062e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37628,-0.0102354939843801,0.00217866276794708,-0.0145056730095564,-0.00596531495920382,2.65295461836027e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MARCO,Macrophage receptor MARCO,40359,0.011554682153203,0.00246348192394813,0.00672625758226467,0.0163831067241413,2.74956564125962e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",40411,-0.0266026204713121,0.00568112305878049,-0.0377376216665218,-0.0154676192761023,2.85543680305938e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,-0.0274894023266392,0.00587080984339891,-0.0389961896197011,-0.0159826150335774,2.85953037561169e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HS1BP3,HCLS1-binding protein 3,37628,-0.0387563486358301,0.0082836566955481,-0.0549923157591044,-0.0225203815125558,2.91639093872344e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,-0.0151961172892522,0.0032503433228229,-0.0215667902019851,-0.00882544437651934,2.96077822383553e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A4,Protein S100-A4,40411,-0.0249578065897371,0.00534099871949404,-0.0354261640799454,-0.0144894490995287,2.99441966762709e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPON2,Spondin-2,40267,-0.0149604217778322,0.0032025626304723,-0.0212374445335579,-0.00868339902210651,3.01629889118149e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EBI3_IL27,Interleukin-27,40453,-0.0134849036820453,0.00288689156884612,-0.0191432111569837,-0.00782659620710695,3.02056261499183e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,-0.0289476176966348,0.00620089919207897,-0.0411013801131096,-0.01679385528016,3.06251867037426e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37900,-0.0125142786452689,0.00268063634038023,-0.0177683258724141,-0.00726023141812362,3.06489916770167e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,-0.0161625621612144,0.00346671847149933,-0.0229573303653531,-0.00936779395707576,3.15378933954119e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL14,C-C motif chemokine 14,40309,-0.0168574557735677,0.00361718127347515,-0.023947131069579,-0.0097677804775564,3.18187071599399e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD226,CD226 antigen,37598,-0.0180549204498958,0.0038751156136995,-0.0256501470527468,-0.0104596938470448,3.20562334826509e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF2,Fibroblast growth factor 2,40341,-0.0285237147723736,0.00612934203751162,-0.0405372251658964,-0.0165102043788508,3.28768824861968e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNG,Interferon gamma,40044,-0.0490565441098056,0.0105461632026527,-0.0697270239870048,-0.0283860642326063,3.32073538824704e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNM3,Dynamin-3,37959,-0.0235694150474408,0.0050730928961559,-0.0335126771239064,-0.0136261529709752,3.41685990119375e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBLN4,Cerebellin-4,40489,0.0135420175363608,0.0029154694471039,0.00782769742003718,0.0192563376526845,3.42969942442814e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,-0.0309661284520731,0.00666965732481376,-0.0440386568087081,-0.0178936000954382,3.46408498874345e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,-0.00913209562410644,0.00196865735781211,-0.0129906640454182,-0.0052735272027947,3.5389704893771e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL17,C-X-C motif chemokine 17,40516,-0.0177550995927139,0.00383123168273589,-0.0252643136908762,-0.0102458854945515,3.60951842902007e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLSTN3,Calsyntenin-3,37942,0.0130891356988611,0.00282775243469875,0.00754674092685155,0.0186315304708706,3.7119692754589e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPP,Lipoma-preferred partner,37562,-0.0286715997706007,0.00620422060981256,-0.0408318721658333,-0.0165113273753681,3.84967826000792e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,40359,-0.0339292421577269,0.00734617541634007,-0.0483277459737534,-0.0195307383417003,3.89314376179968e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,40422,0.00879638192258269,0.00190848179028166,0.00505575761363063,0.0125370062315347,4.07548203563499e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL11,C-X-C motif chemokine 11,40471,-0.0338801285546292,0.00735475628853619,-0.0482954508801601,-0.0194648062290983,4.12537251450293e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,P4HB,Protein disulfide-isomerase,40266,-0.016453011720571,0.00357513741626607,-0.0234602810564525,-0.00944574238468954,4.21575752254295e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD7,T-cell antigen CD7,37567,-0.0182827059991654,0.00397380705867397,-0.0260713678341664,-0.0104940441641644,4.24806665539348e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,-0.0445077973490943,0.00967563845889645,-0.0634720487285313,-0.0255435459696572,4.25783024148291e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,-0.0205716098777756,0.00447481884920107,-0.0293422548222097,-0.0118009649333415,4.3149136468874e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BSG,Basigin,40502,-0.0085903129835437,0.00186985512552473,-0.0122552290295722,-0.00492539693751523,4.37914173858358e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYL3,Myosin light chain 3,37628,-0.0291053630429157,0.00634208102251811,-0.0415358418470512,-0.0166748842387802,4.48960309848125e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,0.0136541990504065,0.00297892694362787,0.0078155022408959,0.0194928958599172,4.60594168630072e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37598,-0.0380557763135565,0.0083064862915147,-0.0543364894449254,-0.0217750631821877,4.66002526432996e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRKL,Crk-like protein,40374,-0.0450970872723554,0.00985841866412111,-0.0644195878540328,-0.025774586690678,4.81017444929497e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA2,Annexin A2,37441,-0.0303264979205246,0.00663783840335169,-0.0433366611910939,-0.0173163346499553,4.95204376541201e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,-0.0424476832642437,0.00929958731866084,-0.0606748744088189,-0.0242204921196684,5.04512347180861e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,-0.0150161483932441,0.00329849976840136,-0.0214812079393107,-0.00855108884717738,5.34273295613365e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLO1,Lactoylglutathione lyase,40042,-0.0250064422049744,0.00549528792938858,-0.035777206546576,-0.0142356778633728,5.39164091459393e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,-0.0147817573051365,0.0032498045280167,-0.0211513741800493,-0.00841214043022381,5.4518926333002e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AZU1,Azurocidin,39809,-0.0327960440102438,0.00721302173311426,-0.0469335666071478,-0.0186585214133398,5.48883649988473e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAMBP,STAM-binding protein,40192,-0.0272248032416347,0.00598805082492846,-0.0389613828584945,-0.0154882236247749,5.49462311042559e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37628,-0.0134782320101143,0.00296924509990015,-0.0192979524059186,-0.00765851161430998,5.69466815722648e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,40228,-0.0248631247029137,0.00548588234445599,-0.0356154540980474,-0.0141107953077799,5.88009346886216e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,40044,0.0170006923821186,0.00375484520180785,0.00964119578657525,0.024360188977662,6.00798075920021e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,-0.0321840023932883,0.00711492078356008,-0.046129247129066,-0.0182387576575105,6.13597982688646e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37942,-0.0125993849502136,0.00278820849622286,-0.0180642736028105,-0.00713449629761684,6.27166151262202e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HNMT,Histamine N-methyltransferase,40147,-0.0194225012413347,0.00429895802227643,-0.0278484589649966,-0.0109965435176729,6.28951370053562e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37990,-0.016213395475454,0.00359061495631564,-0.0232510007898326,-0.00917579016107531,6.37031608346729e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASAH1,Acid ceramidase,37882,-0.0191684196370628,0.00426730387299154,-0.0275323352281262,-0.0108045040459994,7.11703220297759e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37959,-0.0297825772676968,0.00663835501831023,-0.0427937531035848,-0.0167714014318087,7.30212857427871e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37598,-0.040543530722251,0.00903741438153838,-0.0582568629100663,-0.0228301985344358,7.31241531777311e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,40422,-0.0159078552411139,0.00354677997049733,-0.0228595439832887,-0.00895616649893914,7.33692069353089e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLAMF6,SLAM family member 6,39980,-0.0157776016061648,0.00352282355402554,-0.0226823357720548,-0.00887286744027471,7.56414226935668e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA9,Serpin A9,40228,-0.0299363203636269,0.00668530456670976,-0.043039517314378,-0.0168331234128758,7.5899291959022e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300A,CMRF35-like molecule 8,37671,-0.0122766155057481,0.00274399445036252,-0.0176548446284587,-0.00689838638303758,7.7412651297654e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP8,Neutrophil collagenase,40442,-0.0303046880314747,0.00677897632471514,-0.0435914816279163,-0.017017894435033,7.86128571271879e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA10,Annexin A10,39961,-0.0342837066127472,0.00767089319291964,-0.0493186572708697,-0.0192487559546247,7.9023018246608e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSAP,Prosaposin,37901,-0.0117364827246627,0.0026281413946218,-0.0168876398581215,-0.00658532559120401,8.04586876454004e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,40042,-0.0229531915036992,0.0051486297097855,-0.0330445057348788,-0.0128618772725196,8.32599611147015e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,QDPR,Dihydropteridine reductase,40290,-0.0180797589596694,0.00405679245709518,-0.026031072175576,-0.0101284457437629,8.38162269520689e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BST2,Bone marrow stromal antigen 2,40471,-0.0220481958634708,0.00495635601348392,-0.0317626536498993,-0.0123337380770423,8.70670442299271e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PI3,Elafin,40074,-0.0220741332835742,0.00496388569365951,-0.0318033492431469,-0.0123449173240016,8.77003862502849e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH17,Protocadherin-17,40359,-0.0143574116800992,0.00323305753453513,-0.0206942044477881,-0.00802061891241037,9.02225203234874e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SORT1,Sortilin,40330,-0.0149464979246906,0.00336599999141384,-0.0215438579078617,-0.0083491379415195,9.03838451052622e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,40422,-0.0427980062654486,0.00966213536509599,-0.0617357915810368,-0.0238602209498605,9.50988136762741e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,-0.0163931674758163,0.00370595045754954,-0.0236568303726134,-0.00912950457901922,9.78851762848732e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,40044,-0.0146178017699832,0.00330688466575424,-0.0210992957148616,-0.00813630782510495,9.91770360876311e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NIT1,Deaminated glutathione amidase,37628,-0.020317200005185,0.00459599513209659,-0.0293253504640943,-0.0113090495462756,9.92000900194556e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BIN2,Bridging integrator 2,40332,-0.037087327525673,0.00839834072809641,-0.053548075352742,-0.0206265796986041,1.01194129166213e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,-0.0424447936810284,0.00962395797190716,-0.0613077513059664,-0.0235818360560904,1.04030552654163e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,-0.0268934124733496,0.00610169987753223,-0.0388527442333128,-0.0149340807133864,1.05236847614607e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37959,-0.0253164630836819,0.0057491379111979,-0.0365847733896298,-0.014048152777734,1.07325485604748e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEC31A,Protein transport protein Sec31A,37628,-0.0312064900235093,0.00708781249445271,-0.0450986025126366,-0.017314377534382,1.0768541689205e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NIT2,Omega-amidase NIT2,37936,-0.0307462689128861,0.00698689310692968,-0.0444405794024683,-0.017051958423304,1.08799176473146e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL19,C-C motif chemokine 19,40471,-0.0533210367914567,0.0121255437141243,-0.0770871024711403,-0.0295549711117731,1.10254145613064e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMTN,Smoothelin,37905,-0.0391484611257453,0.00890238629494951,-0.0565971382638463,-0.0216997839876442,1.10333181233236e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEPR,Leptin receptor,40359,0.0124931806707426,0.00284353502294694,0.00691985202576658,0.0180665093157186,1.12241680853058e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,40400,-0.0289839465090735,0.0065982456290772,-0.0419165079420649,-0.0160513850760822,1.12686332881624e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL16,C-X-C motif chemokine 16,40517,-0.00963736465021939,0.00220189402048666,-0.0139530769303732,-0.00532165237006554,1.21165475142274e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFRAL,GDNF family receptor alpha-like,37477,0.0251489277134258,0.00574859405349343,0.0138816833685786,0.0364161720582729,1.22490914928035e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOS1,"Nitric oxide synthase, brain",39961,-0.0202722290224516,0.00463461664493756,-0.0293560776465292,-0.011188380398374,1.22735547498933e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANG,Angiogenin,40309,-0.0139636982432919,0.00319611515568602,-0.0202280839484365,-0.00769931253814732,1.25632566857868e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37572,-0.0245231983073378,0.00561529709512432,-0.0355291806137815,-0.0135172160008942,1.26806836913133e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL5,C-X-C motif chemokine 5,40309,-0.0464411090905605,0.0106349246701093,-0.0672855614439748,-0.0255966567371463,1.26850837916813e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,0.0115536721715769,0.00265048141934531,0.00635872858966012,0.0167486157534937,1.31604358443535e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,40306,-0.0145398468080273,0.00333576936707153,-0.0210779547674875,-0.00800173884856711,1.31619663415167e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL4,C-C motif chemokine 4,40376,-0.0272810841478379,0.00625957761814933,-0.0395498562794106,-0.0150123120162652,1.31900939774553e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBP2,Retinol-binding protein 2,40305,0.0307613944543675,0.00705990482329092,0.0169239810007173,0.0445988079080177,1.32567018715001e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,40341,0.016172420579531,0.00371934867053003,0.00888249718529214,0.0234623439737698,1.38122240771306e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPPB,Natriuretic peptides B,40042,-0.0517912507025792,0.0119196414679883,-0.0751537479798363,-0.0284287534253221,1.40134690482888e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JAM2,Junctional adhesion molecule B,40471,-0.0105017996647908,0.00241727373690883,-0.0152396561891321,-0.00576394314044952,1.40464240448303e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL22,Interleukin-22,37900,-0.0261935318624462,0.00603797042022733,-0.0380279538860918,-0.0143591098388007,1.44744415600705e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCT,Secretin,37572,-0.0184632507948953,0.0042639624987159,-0.0268206172923784,-0.0101058842974121,1.50168900939637e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,37419,-0.0215334616135878,0.0049742781836264,-0.0312830468534956,-0.0117838763736801,1.5093746186132e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,-0.0114293247963472,0.0026418283156813,-0.0166073082950825,-0.00625134129761183,1.52761476998768e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LXN,Latexin,40183,0.0265939631066172,0.0061545542336863,0.0145310368085921,0.0386568894046424,1.56261396027607e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPI,Glucose-6-phosphate isomerase,37987,-0.0187600964162614,0.00434149500045204,-0.0272694266171474,-0.0102507662153754,1.56350929494349e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GTPBP2,GTP-binding protein 2,37572,-0.031961445248486,0.00740127703923078,-0.0464679482453783,-0.0174549422515937,1.58340864522003e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,-0.025618754903163,0.00593547606187608,-0.0372522879844401,-0.0139852218218859,1.59690925108642e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOBR,Apolipoprotein B receptor,37628,0.0169552665016938,0.00393206563345455,0.00924841786012285,0.0246621151432647,1.62923517498198e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL12,Stromal cell-derived factor 1,40044,0.0162439122790757,0.00377062003190865,0.00885349701653476,0.0236343275416167,1.65729553750097e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,-0.0335412962443516,0.00778645447621196,-0.048802747017727,-0.0182798454709762,1.66191825335155e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37901,-0.0255390263244916,0.00593846952376951,-0.0371784265910798,-0.0138996260579034,1.71531704747909e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,40330,-0.0193912837913256,0.00451084769793895,-0.0282325452792859,-0.0105500223033652,1.72740100062322e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39957,0.011247049160047,0.00261956194496939,0.006112707747907,0.016381390572187,1.76959156785473e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,-0.013088560606496,0.00305128420973543,-0.0190690776575774,-0.00710804355541453,1.80101791931036e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSC22D1,TSC22 domain family protein 1,37959,-0.0266901848138176,0.00622637795898764,-0.0388938856134334,-0.0144864840142018,1.82661225141684e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAB2,Disabled homolog 2,40489,-0.0436757671025197,0.0101935042867299,-0.0636550355045103,-0.0236964987005291,1.84080072781076e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40516,-0.0221475113838219,0.00517641757220087,-0.0322932898253356,-0.0120017329423082,1.89211496502815e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL24,C-C motif chemokine 24,40396,0.0328494316380204,0.00767862847799119,0.0177993198211577,0.0478995434548832,1.89650261131727e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFH,Complement factor H,37301,-0.00919935078187995,0.00215073775838366,-0.0134147967883119,-0.00498390477544799,1.90541517421121e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,-0.0425967242909207,0.00997278362735029,-0.0621433802005273,-0.0230500683813142,1.95674291168665e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37901,-0.0204434739875297,0.0047904993033088,-0.029832852622015,-0.0110540953530445,1.99025817785258e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STK11,Serine/threonine-protein kinase STK11,40042,-0.0288129564572817,0.00676354451414541,-0.0420695037050067,-0.0155564092095567,2.05590954870978e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37942,0.0122342688201919,0.00287199965212466,0.00660514950202757,0.0178633881383562,2.05956987728825e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL1,Fc receptor-like protein 1,40359,0.0177804208761133,0.00417599155843065,0.00959547742158925,0.0259653643306374,2.07658556140159e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,-0.0163292199809497,0.00383713381665361,-0.0238500022615907,-0.0088084377003086,2.09947288432478e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NID2,Nidogen-2,40332,-0.0290699733636032,0.00683324969812271,-0.0424631427719237,-0.0156768039552827,2.1100455094845e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37671,-0.0123676435682964,0.00291020118831759,-0.0180716378973989,-0.00666364923919392,2.15471214946842e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37900,-0.0170700996858279,0.00402247037489499,-0.0249541416206221,-0.00918605775103377,2.21352068664598e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,-0.0386799711705398,0.00915462985736803,-0.0566230456909812,-0.0207368966500985,2.40110951197094e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DOK1,Docking protein 1,37942,-0.0531003966097212,0.0125992009204814,-0.0777948304138648,-0.0284059628055776,2.51867135404864e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDN1,Endothelin-1,37628,-0.0113692223309534,0.00269924068077112,-0.0166597340652648,-0.00607871059664197,2.54793775075102e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLK1,Protein delta homolog 1,40536,-0.02067960880682,0.0049134799050667,-0.0303100294207508,-0.0110491881928893,2.58181069097138e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBC1D23,TBC1 domain family member 23,40305,-0.0348687488193544,0.00830491791888819,-0.0511463879403753,-0.0185911096983336,2.70075849519954e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A12,Protein S100-A12,40139,-0.029825409156162,0.00710404097595835,-0.0437493294690404,-0.0159014888432837,2.70322567689617e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39980,-0.0200771041689566,0.00478268115148859,-0.0294511592258742,-0.0107030491120389,2.70929694906374e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPR,Nucleoprotein TPR,37562,-0.0182325132261001,0.00434340512848905,-0.0267455872779386,-0.00971943917426155,2.71362470930163e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37628,-0.0221498372487676,0.00528278599098811,-0.0325040977911043,-0.0117955767064309,2.77292741946367e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,40042,-0.0290403048322842,0.00693118812967699,-0.0426254335664511,-0.0154551760981173,2.80735078698363e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TALDO1,Transaldolase,37966,-0.0172368421876014,0.00412182497171006,-0.0253156191321531,-0.00915806524304967,2.90973817277802e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,38013,0.00990749772534122,0.00237192762447404,0.0052585195813721,0.0145564758693103,2.97251360721621e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM13A,Protein FAM13A,37901,-0.0259604916794259,0.00622249622317977,-0.0381565842768582,-0.0137643990819935,3.03783099934378e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGF,Pro-epidermal growth factor,40324,-0.0396499600148331,0.0095158901291764,-0.0583011046680189,-0.0209988153616474,3.10662465694893e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37959,-0.0190601603752335,0.00457951049270277,-0.0280360009409309,-0.010084319809536,3.17355089021503e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,-0.041453295160175,0.00996440433366512,-0.0609835276541586,-0.0219230626661913,3.20023092045285e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",40359,-0.0278955213275649,0.00671520504155701,-0.0410573232090167,-0.0147337194461132,3.28299546141272e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37572,-0.0311806874412093,0.00751049353974929,-0.0459012547791179,-0.0164601201033007,3.32221621302702e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMSB10,Thymosin beta-10,40332,-0.0291160039775728,0.007027052811404,-0.0428890274879247,-0.015342980467221,3.43942585948843e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,0.0136786816280194,0.00330498133534093,0.00720091821075113,0.0201564450452876,3.51227295588603e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,0.018086325895453,0.0043799634788639,0.0095015974768798,0.0266710543140263,3.66005553186312e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUB1,NEDD8 ultimate buster 1,40341,-0.03189248899414,0.00772719422097752,-0.0470377896672559,-0.016747188321024,3.6891121895509e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,-0.0169018287925165,0.0040977204735528,-0.0249333609206799,-0.00887029666435298,3.73126838556506e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYTL1,Cytokine-like protein 1,37998,0.00876491125110517,0.00212613452331134,0.00459768758541494,0.0129321349167954,3.77075904090905e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA12,Serpin A12,39903,-0.0437143276657282,0.0106200558772246,-0.0645296371850885,-0.022899018146368,3.87161425520024e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DENR,Density-regulated protein,37598,-0.0219337718882741,0.00532916541530217,-0.0323789361022664,-0.0114886076742819,3.88195440382125e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD93,Complement component C1q receptor,39725,0.0120440372852159,0.00292903112996562,0.0063031362704833,0.0177849382999486,3.94379450258033e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USO1,General vesicular transport factor p115,40305,-0.0344952061458792,0.00839608486741616,-0.0509515324860149,-0.0180388798057436,4.00260389619845e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COMT,Catechol O-methyltransferase,39877,-0.0323671047941805,0.00789062592790897,-0.0478327316128821,-0.0169014779754789,4.11751352476835e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,-0.0360456524490246,0.00879266571635063,-0.0532792772530718,-0.0188120276449774,4.16092332679775e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37628,-0.0191255137382204,0.00466952812251487,-0.0282777888583495,-0.00997323861809122,4.23203739433413e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,-0.01267723101715,0.00309659715221394,-0.0187465614354893,-0.00660790059881068,4.2622732962958e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,0.0076535522974285,0.0018721239101903,0.00398418943345551,0.0113229151614015,4.37391169809784e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,40044,-0.0227743697492231,0.00557678325145368,-0.0337048649220724,-0.0118438745763739,4.45297216646824e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,40314,-0.0106719125090303,0.00261896446080926,-0.0158050828522164,-0.00553874216584412,4.62661922489572e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPTN,Neuroplastin,39980,0.0319568158479729,0.00784259495688185,0.0165853297324845,0.0473283019634614,4.62876773337739e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFRP1,Secreted frizzled-related protein 1,40178,0.0164550329168292,0.00403900432005194,0.00853858444952741,0.024371481384131,4.6432774905491e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,40307,-0.0246849776440877,0.00606202232798438,-0.0365665414069371,-0.0128034138812383,4.68235141176198e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37959,-0.0445500552277976,0.0109483458808122,-0.0660088131541895,-0.0230912973014058,4.74608419418383e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,40424,0.0079285668198035,0.00194954866616588,0.00410745143411838,0.0117496822054886,4.7876779187302e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,-0.0114863563716036,0.00282641569454345,-0.0170261311329088,-0.00594658161029847,4.85256820444451e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37572,-0.0162161971414784,0.00399894176654092,-0.0240541230038986,-0.00837827127905821,5.03976701926286e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,0.0258767196484504,0.00639560515091531,0.0133413335526564,0.0384121057442444,5.2387876725333e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37562,-0.0235719254300956,0.00582602828160002,-0.0349909408620316,-0.0121529099981596,5.24060521099394e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37863,-0.0198928706220523,0.0049212061601008,-0.0295384346958499,-0.0102473065482547,5.32306557708604e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,0.0153328927709491,0.00379940594059415,0.00788605712738452,0.0227797284145136,5.4763759303036e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBPL,FK506-binding protein-like,37901,-0.0219761429064951,0.0054470061832651,-0.0326522750256947,-0.0113000107872955,5.50127757845625e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,-0.0366718770285153,0.00909783318659014,-0.0545036300742319,-0.0188401239827986,5.58375496255196e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TG,Thyroglobulin,37900,0.0437960376090656,0.0108707200994318,0.0224894262141793,0.0651026490039519,5.63688317254681e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,40373,-0.0100407872799367,0.00249430924646939,-0.0149296334030167,-0.00515194115685669,5.71228945463023e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF19,Fibroblast growth factor 19,40422,-0.0285226262999682,0.00709416932985276,-0.0424271981864796,-0.0146180544134568,5.83234372401169e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,-0.0176579470628102,0.00439280839912352,-0.0262678515250923,-0.00904804260052815,5.85787363173976e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,-0.0122296743546001,0.00304538556603852,-0.0181986300640356,-0.00626071864516465,5.956506195808e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,40305,-0.0120537561497392,0.00300268275675216,-0.0179390143529735,-0.00616849794650499,5.98894379034529e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGFLAM,Pikachurin,37901,-0.0114291664589217,0.00284703582333904,-0.0170093566726663,-0.00584897624517721,5.9918210302003e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MGLL,Monoglyceride lipase,40396,-0.0320480777330009,0.00798893684887354,-0.047706393956793,-0.0163897615092088,6.05947371374028e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK11,Kallikrein-11,40260,-0.0110053261011221,0.00275243180289755,-0.0164000924348013,-0.00561055976744288,6.40616642988751e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PODXL,Podocalyxin,40305,0.00563736853738577,0.00141018809817808,0.00287339986495673,0.0084013372098148,6.42776048776508e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRGN,Neurogranin,37987,-0.0335745179670348,0.00839943507488433,-0.0500374107138081,-0.0171116252202615,6.44264846878254e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37557,-0.0312823701130072,0.00783026483574728,-0.0466296891910719,-0.0159350510349425,6.50317041721556e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,40403,-0.0169399484172161,0.00424061221820158,-0.0252515483648912,-0.00862834846954096,6.50685737968765e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFNA1,Ephrin-A1,40303,-0.0100894054162156,0.00253021293910899,-0.0150486227768692,-0.00513018805556196,6.70524964166494e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DBNL,Drebrin-like protein,40422,-0.0340321892076514,0.00854291715033704,-0.050776306822312,-0.0172880715929908,6.81592234932054e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37910,-0.0151156210846847,0.00379891819847635,-0.0225615007536983,-0.00766974141567107,6.95896430134472e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPHS1,Nephrin,37598,0.0127763544640319,0.003212950626952,0.00647897123520595,0.0190737376928578,7.03062737019057e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,0.0186052006437042,0.00468117502430208,0.00943009759607214,0.0277803036913363,7.08494455018919e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,40291,-0.0159134091007541,0.0040044809423072,-0.0237621917476762,-0.00806462645383197,7.10184056007807e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL10,Interleukin-10,40044,-0.0316691808140279,0.00798865524509685,-0.0473269450944177,-0.016011416533638,7.39494840821039e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,-0.021418902393281,0.00540982402629572,-0.0320221574848207,-0.0108156473017414,7.55675610088235e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,-0.0260912505590694,0.00660193694088963,-0.039031046963213,-0.0131514541549257,7.78843406140427e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEXN,Nexilin,37987,-0.0250313932680719,0.00633381623757461,-0.0374456730937181,-0.0126171134424256,7.78866295748136e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICA1,Islet cell autoantigen 1,40044,-0.0290251325806333,0.00734798890252052,-0.0434271908295735,-0.0146230743316931,7.84693560772598e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THY1,Thy-1 membrane glycoprotein,40471,-0.0102355108633934,0.00259416457489137,-0.0153200734301804,-0.00515094829660628,7.99430494948169e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,40437,-0.0296662118732917,0.00752975067935621,-0.0444245232048298,-0.0149079005417535,8.18734842571878e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,0.0113109860814988,0.00287178029611271,0.00568229670111785,0.0169396754618797,8.22936604785372e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALB2,Calretinin,39961,-0.0115122106020666,0.00292365015916181,-0.0172425649140237,-0.00578185629010943,8.26550048536384e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPC5,Glypican-5,40228,0.020399105331149,0.00518990668608971,0.0102268882264132,0.0305713224358849,8.51191028048215e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELENOP,Selenoprotein P,38013,0.00824228570852351,0.00209711261292068,0.00413194498719897,0.0123526264298481,8.52605058371643e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS3,Galectin-3,40374,-0.0107562809616168,0.0027389611589006,-0.016124644833062,-0.00538791709017162,8.63246624756611e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,40341,-0.0171105546380303,0.00435896336634026,-0.0256541228360572,-0.00856698644000342,8.69607854343724e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRAF2,TNF receptor-associated factor 2,40341,-0.0258373555995244,0.00658939260963533,-0.0387525651144096,-0.0129221460846391,8.85331783440457e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSG4,Desmoglein-4,40250,0.0184892696331348,0.00472237481789823,0.00923341499005425,0.0277451242762153,9.06905168274748e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MICALL2,MICAL-like protein 2,37572,-0.024839805012979,0.00634462330651789,-0.0372752666937541,-0.012404343332204,9.08255458886932e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBCC,Tubulin-specific chaperone C,40228,-0.0294447647014443,0.00752672247275919,-0.0441971407480523,-0.0146923886548363,9.19072145310069e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,0.0146627718800005,0.00374811233338261,0.00731647170657055,0.0220090720534304,9.19771294174418e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSHB,Thyrotropin subunit beta,40359,0.030366510737433,0.00777931154518743,0.0151190601088656,0.0456139613660003,9.52041317722096e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFRA1,GDNF family receptor alpha-1,40453,-0.0100307771826424,0.00257570676488003,-0.0150791624418073,-0.00498239192347755,9.8850835837956e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37628,-0.0297052521680455,0.00762919497448629,-0.0446584743180386,-0.0147520300180524,9.92428897257049e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,40228,-0.0285107436911197,0.00736068321988404,-0.0429376828020925,-0.014083804580147,0.000107768455996192
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,40341,-0.040040195573305,0.0103402226121985,-0.0603070318932141,-0.0197733592533959,0.000108255588634903
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB2,Integrin beta-2,40221,0.0103040393716819,0.00266235506254168,0.00508582344910025,0.0155222552942636,0.000109151649448241
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH22,Cadherin-22,37714,0.0105970864624955,0.00273835710385505,0.00522990653893966,0.0159642663860514,0.000109414736819757
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,-0.0112968601273802,0.00292478477501737,-0.0170294382864143,-0.00556428196834617,0.00011269716216318
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OPHN1,Oligophrenin-1,37942,-0.0381539867601744,0.00987874974187291,-0.0575163362542453,-0.0187916372661035,0.000112882447781033
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37598,-0.0316735375229035,0.00820138223661123,-0.0477482467066615,-0.0155988283391455,0.000113012969483653
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AP2B1,AP-2 complex subunit beta,37572,-0.0174604671627216,0.00453477089595223,-0.026348618118788,-0.00857231620665524,0.000118507954213693
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37900,-0.0180323593151557,0.00468504758542157,-0.027215052582582,-0.00884966604772943,0.00011919003259899
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARF2,Scavenger receptor class F member 2,40471,0.0105836353575698,0.0027528007575408,0.00518814587278988,0.0159791248423498,0.00012117705177767
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRD1,Natural killer cells antigen CD94,40516,-0.016207247955457,0.00422364736167158,-0.0244855967843333,-0.0079288991265807,0.000124889149466974
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DMD,Dystrophin,37628,-0.0184693271719095,0.00482204996541714,-0.0279205451041271,-0.00901810923969195,0.000128642279307984
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACYBP,Calcyclin-binding protein,37642,-0.0363771253392007,0.00949791569496281,-0.0549930401013278,-0.0177612105770736,0.000128730573529155
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,0.0123516643844939,0.00322992760088736,0.00602100628675468,0.0186823224822331,0.00013173757382411
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB6,Serpin B6,40433,-0.0210751956481378,0.00552475809060247,-0.0319037215057186,-0.0102466697905569,0.000136871457889559
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMED8,Protein TMED8,37901,-0.0361571040382935,0.00948687737936299,-0.054751383701845,-0.0175628243747421,0.000138867757280637
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TWF2,Twinfilin-2,37998,-0.0291497368635153,0.00765393051162101,-0.0441514406662924,-0.0141480330607381,0.000140448437604928
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,0.0212732598434594,0.00558886224128165,0.0103190898505474,0.0322274298363714,0.000141554690459155
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MATN2,Matrilin-2,40379,0.0104656021007672,0.00275036713692714,0.00507488251238997,0.0158563216891444,0.000142239430490417
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PI16,Peptidase inhibitor 16,37987,0.0086956610329593,0.00228723422865712,0.00421268194479135,0.0131786401211273,0.000144265199109011
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39961,-0.0237709419727245,0.00626783957459618,-0.036055907538933,-0.011485976406516,0.000149688533086835
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAB2,Stabilin-2,37998,-0.00979021952908548,0.0025815003504995,-0.0148499602160645,-0.00473047884210646,0.000149814195851138
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,0.0127674256513649,0.00336921267487291,0.00616376880861395,0.0193710824941158,0.000151660153823434
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F2R,Proteinase-activated receptor 1,40396,-0.020152298944055,0.00532156451856593,-0.0305825654004442,-0.00972203248766581,0.000153090454453046
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSL,Cathepsin L1,40359,-0.00850803830347838,0.0022476979000885,-0.0129135261876518,-0.00410255041930492,0.000154134486507879
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,40411,-0.0116221410896399,0.0030784629540414,-0.0176559284795611,-0.00558835369971879,0.000160390129189194
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,-0.0235669081790389,0.00624965097739281,-0.0358162240947288,-0.011317592263349,0.000163363968990643
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NSFL1C,NSFL1 cofactor p47,40471,-0.0232591846445291,0.00616871376993157,-0.0353498636335949,-0.0111685056554632,0.000163500867277302
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,-0.0202095867876572,0.0053605236125754,-0.030716213068305,-0.0097029605070094,0.000163801791557568
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCAM,Basal cell adhesion molecule,40332,0.0082751172839594,0.0021955410372677,0.00397185685091471,0.0125783777170041,0.000164459077669985
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,0.0189114294474066,0.00502465837445096,0.0090630990334827,0.0287597598613305,0.000168017606931819
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,-0.0278663922330924,0.00741561360713842,-0.0424009949030837,-0.0133317895631011,0.000172026873242743
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YWHAQ,14-3-3 protein theta,37671,-0.0256864664295595,0.00683952598671455,-0.03909193736352,-0.012280995495599,0.000173674393155578
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40536,0.00878852602575212,0.00234206833885157,0.00419807208160304,0.0133789799699012,0.00017572063259297
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37990,-0.0371213408160406,0.00989855961458103,-0.0565225176606194,-0.0177201639714618,0.000177446702610846
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATOX1,Copper transport protein ATOX1,40411,-0.0248792859459462,0.00663855738838995,-0.0378908584271905,-0.0118677134647019,0.000179096369861013
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYO9B,Unconventional myosin-IXb,40044,-0.0229905466447152,0.00614844985591699,-0.0350415083623125,-0.0109395849271179,0.000185235672015563
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,-0.0275667754284065,0.00737216564166695,-0.0420162200860737,-0.0131173307707393,0.000185312909321594
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,40042,-0.0119207283199327,0.00318879454839806,-0.0181707656347929,-0.00567069100507251,0.000185917630296903
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IMPACT,Protein IMPACT,37942,-0.019638421827947,0.00525973168268181,-0.0299474959260033,-0.00932934772989063,0.000189440067436963
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRAP2,GRB2-related adapter protein 2,40359,-0.0438883518255143,0.0117566270412528,-0.0669313408263699,-0.0208453628246587,0.000189816558866288
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD160,CD160 antigen,40516,-0.0157833447406621,0.00423354988463612,-0.0240811025145489,-0.00748558696677533,0.000193546347498707
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,-0.0188719618708083,0.00506872247061768,-0.028806657913219,-0.00893726582839766,0.000197391408240526
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX8,Syntaxin-8,40341,-0.0168002149828954,0.00452247668809142,-0.0256642692915546,-0.00793616067423625,0.000204039795654873
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,40203,0.0115424150954539,0.00311609861905589,0.00543486180210438,0.0176499683888035,0.000212847579840413
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK13,Kallikrein-13,40032,-0.0149060368418679,0.00402667549063181,-0.0227983208035063,-0.00701375288022956,0.000214794441073428
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1R1,Interleukin-1 receptor type 1,40303,-0.0076596973801673,0.00206967222700377,-0.0117162549450947,-0.00360313981523992,0.000215543870647167
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST5,Cystatin-D,40070,-0.0189112327962494,0.00511057710509041,-0.0289279639222266,-0.00889450167027215,0.000215990160721009
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESYT2,Extended synaptotagmin-2,37942,-0.0278833666159547,0.00754066505248454,-0.0426630701188245,-0.013103663113085,0.000218396031023174
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATXN2L,Ataxin-2-like protein,37959,-0.0165142293801689,0.00446605634644851,-0.0252676998192079,-0.0077607589411298,0.000218405508950472
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,-0.0311051051541397,0.00841336940995177,-0.0475953091976451,-0.0146149011106342,0.000218936833658213
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,-0.0195985435799764,0.00530191887941298,-0.0299903045836258,-0.00920678257632692,0.000219321057477475
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39961,-0.0221120703212576,0.00598740675347352,-0.0338473875580657,-0.0103767530844495,0.000222300375810445
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37990,0.0111764518537698,0.00302697362525035,0.00524358354827907,0.0171093201592604,0.000223120763356893
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37790,-0.0191801423179546,0.00519642145144083,-0.0293651283627787,-0.00899515627313062,0.000224238317984748
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CETN3,Centrin-3,37901,-0.0261421694427257,0.00709351995505719,-0.0400454685546378,-0.0122388703308136,0.000229277243983748
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,-0.0158913758550417,0.00431330590552177,-0.0243454554298644,-0.00743729628021909,0.000230140803362122
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFHR5,Complement factor H-related protein 5,37785,0.0142880563945431,0.00387810747706832,0.00668696573948917,0.021889147049597,0.000230252401303527
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,40341,-0.0187920765426532,0.00510868662034143,-0.0288051023185223,-0.00877905076678396,0.00023542504731259
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,-0.0279821267466007,0.00761699465323477,-0.0429114362669409,-0.0130528172262606,0.000240043865972651
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH7,Protocadherin-7,37901,-0.0118349559677203,0.00322495759968431,-0.0181558728631015,-0.00551403907233907,0.000243676722395746
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPART,Spartin,37671,-0.0262357383393989,0.00715376336283078,-0.0402571145305472,-0.0122143621482505,0.000245987094957853
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INSL4,Early placenta insulin-like peptide,37900,-0.0183667735395449,0.00501202320172588,-0.0281903390149276,-0.00854320806416214,0.000248733566559714
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STK24,Serine/threonine-protein kinase 24,39961,-0.0209971996583279,0.00573093277186676,-0.0322298278911867,-0.00976457142546905,0.000249293286814221
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDC,Nuclear migration protein nudC,40516,-0.0214277452334625,0.00585448591722664,-0.0329025376312267,-0.0099529528356983,0.000252968126458841
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37900,-0.0136577851287773,0.00373329605404595,-0.0209750453947074,-0.00634052486284729,0.000254792455860568
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATG4A,Cysteine protease ATG4A,39980,-0.0201585642824428,0.00551700238270001,-0.0309718889525348,-0.00934523961235077,0.000259139498710664
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSNAX,Translin-associated protein X,37562,-0.0132935557495322,0.00365064810502082,-0.020448826035373,-0.00613828546369143,0.000272179077713769
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,-0.0178717818869078,0.0049139907209783,-0.0275032037000253,-0.00824036007379035,0.000276974565888589
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,0.0393684060015021,0.0108332753892574,0.0181351862385576,0.0606016257644467,0.000279918750143645
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17A,Interleukin-17A,40028,-0.014403187745086,0.00396351014348737,-0.0221716676263213,-0.00663470786385079,0.000280015463612874
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLC,Galectin-10,40333,0.0221619812225827,0.00610383852045074,0.0101984577224993,0.0341255047226662,0.000283402963426289
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,-0.021654758809743,0.00597008782640443,-0.0333561309494956,-0.00995338666999028,0.000287553974752721
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHGA,Chromogranin-A,37998,-0.0302883198677787,0.00835140978739034,-0.0466570830510638,-0.0139195566844936,0.000288085494312389
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,-0.0326943454087973,0.00904472532779557,-0.0504220070512766,-0.014966683766318,0.000301768157477088
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,40042,-0.0370432680130327,0.0102550676429015,-0.0571432005931195,-0.0169433354329458,0.00030457421434175
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37598,-0.030862806584619,0.00854651033644444,-0.0476139668440501,-0.0141116463251879,0.000305966711557445
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,-0.00883626314291903,0.00244714353495087,-0.0136326644714227,-0.00403986181441532,0.000306132387633891
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37990,-0.00998174498596117,0.00276501686453396,-0.0154011780404477,-0.00456231193147459,0.000307287969570057
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BGLAP,Osteocalcin,37998,0.0304424758851925,0.00843403063531597,0.0139117758399732,0.0469731759304118,0.000307916410763856
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A13,Protein S100-A13,37598,0.011648369464572,0.0032271447475086,0.00532316575945513,0.0179735731696888,0.000307931439608069
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SYT1,Synaptotagmin-1,37942,0.0130711346132414,0.0036232757125803,0.00596951421658398,0.0201727550098988,0.000310223675815676
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,0.00857201336122725,0.00237889598840349,0.00390937722395642,0.0132346494984981,0.000315295895885858
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LY75,Lymphocyte antigen 75,40341,0.0129721354278127,0.00360501683663385,0.00590630242801039,0.0200379684276151,0.000321207720208837
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39980,0.0125332339042206,0.00348531676435489,0.00570201304608497,0.0193644547623561,0.000324137751077773
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAPG,Macrophage-capping protein,40185,-0.0193361340886279,0.00537775142026223,-0.0298765268723419,-0.00879574130491394,0.000324660430896979
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGAM,Integrin alpha-M,40332,0.0105388029087854,0.00293605474156336,0.00478413561532123,0.0162934702022496,0.000332382792437925
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX4,Syntaxin-4,40305,-0.019835999592358,0.00553669506144923,-0.0306879219127985,-0.00898407727191751,0.000341154956085615
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,-0.0259962737325433,0.00725878956651968,-0.0402235012829219,-0.0117690461821648,0.000342866203624334
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OGN,Mimecan,40332,-0.0135168753055274,0.00377451331467104,-0.0209149214022826,-0.00611882920877218,0.000343184363886072
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,-0.0168270567114981,0.00471134706741925,-0.0260612969636399,-0.00759281645935641,0.000355842238826658
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,-0.00947359434241957,0.00265348764888654,-0.0146744301342372,-0.00427275855060196,0.000357920983899966
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKAP12,A-kinase anchor protein 12,37671,0.00722379346867065,0.00202444048381573,0.00325589012039182,0.0111916968169495,0.000360588933543336
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,-0.0255704289907911,0.00717036232171609,-0.0396243391413546,-0.0115165188402275,0.000363359726395226
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37628,-0.0308033108943622,0.00864245934824809,-0.0477425312169284,-0.0138640905717959,0.000366281417802059
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37993,-0.00639865245772336,0.00179790431666043,-0.0099225449183778,-0.00287475999706892,0.000373613969629271
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,-0.0256907840656118,0.00722420787188394,-0.0398502314945043,-0.0115313366367192,0.000377366350906618
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RWDD1,RWD domain-containing protein 1,40471,-0.0211525954146998,0.00596008074451523,-0.0328343536739496,-0.00947083715544996,0.00038773754877306
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,0.0112912675950349,0.00318150270087859,0.00505552230131283,0.0175270128887569,0.000387998986700114
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37990,-0.00823162490750693,0.00232733029845975,-0.012793192292488,-0.00367005752252581,0.000406147266668781
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,-0.0102311547231264,0.00289942923143986,-0.0159140360167486,-0.00454827342950431,0.000419062319591042
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DBI,Acyl-CoA-binding protein,40270,-0.0257335069374533,0.00730834702071437,-0.0400578670980535,-0.0114091467768531,0.000430950885599618
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37901,-0.0152011568664399,0.00432103503166868,-0.0236703855285105,-0.00673192820436927,0.000436340072424365
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,-0.0217977250736204,0.00620252819644501,-0.0339546803386526,-0.00964076980858821,0.000442352959741223
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEPACAM2,HEPACAM family member 2,37942,0.013233499638435,0.00376815778608584,0.00584791037770676,0.0206190888991632,0.000446322263551828
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37998,0.00840841286428397,0.0023967988592827,0.00371068710008987,0.0131061386284781,0.00045263864336383
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,-0.0312842749430528,0.00891904461480532,-0.0487656023880712,-0.0138029474980344,0.000453448922246175
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,0.0088636987449409,0.00253187082877832,0.0039012319205354,0.0138261655693464,0.000465039077207497
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,-0.0160304437154909,0.00457954153716931,-0.0250063451283427,-0.00705454230263903,0.000466048358965755
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UNC79,Protein unc-79 homolog,37482,-0.0183179193972916,0.00524200531704211,-0.0285922498186942,-0.00804358897588908,0.000476619586989066
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN8,Septin-8,37921,-0.0102911552319606,0.00294882784565175,-0.016070857809438,-0.00451145265448318,0.000484721315356263
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDT,D-dopachrome decarboxylase,37998,-0.0131916184491063,0.00378110655969306,-0.0206025873061047,-0.00578064959210789,0.00048668973837398
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,-0.0128195731332823,0.00367560576996149,-0.0200237604424068,-0.0056153858241578,0.000488663349962829
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37942,-0.0171319521999866,0.00491351367794676,-0.0267624390087622,-0.00750146539121091,0.000490574047610055
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,-0.0115315923355751,0.00330858841668333,-0.0180164256322744,-0.00504675903887575,0.000493098546585612
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GMPR2,GMP reductase 2,37671,-0.0219069366472646,0.00628677667561852,-0.0342290189314768,-0.00958485436305227,0.000494459907299518
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,-0.0170934275545132,0.00490976729330471,-0.0267165714493904,-0.00747028365963597,0.000500168653059834
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD46,Membrane cofactor protein,40250,-0.00921605328634416,0.00265879497649939,-0.014427291440283,-0.00400481513240535,0.000529171074063227
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,0.0185317076451355,0.00534840084154504,0.00804884199570722,0.0290145732945638,0.000532123238087083
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,-0.0158194362860506,0.00456936739625265,-0.0247753963827058,-0.00686347618939543,0.000537742009400208
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LMNB2,Lamin-B2,37942,-0.00875948656058519,0.00253092460316617,-0.0137200987827909,-0.00379887433837949,0.000539873009495306
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40536,0.0111792388839379,0.00323126592267121,0.00484595767550237,0.0175125200923735,0.000542161667313281
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39961,-0.0123978097776048,0.00358436420726802,-0.0194231636238501,-0.00537245593135948,0.000543926086418439
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASC3,Protein CASC3,37572,-0.0131100809376628,0.00379910225795015,-0.0205563213632451,-0.00566384051208056,0.000560611118666763
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,0.00904062279914071,0.00262025655314276,0.0039049199549809,0.0141763256433005,0.000561455068361941
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,-0.00774504519738246,0.00224493570194028,-0.0121451191731854,-0.00334497122157952,0.00056203911490296
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBCB,Tubulin-folding cofactor B,40228,-0.0322982210540727,0.00936936607149647,-0.0506621785542058,-0.0139342635539396,0.000567874000669334
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LIF,Leukemia inhibitory factor,39961,-0.0168390957481308,0.00489166206800182,-0.0264267534014144,-0.00725143809484727,0.000578081554903373
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL8,Interleukin-8,40209,-0.0216037037479846,0.00627757718468588,-0.0339077550299689,-0.00929965246600023,0.000580196610858587
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,-0.0149928230627249,0.00436699182983144,-0.0235521270491946,-0.00643351907625531,0.000597976814337553
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,0.0165208376003258,0.00482786540516962,0.0070582214061933,0.0259834537944582,0.000623577091542242
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDZD2,PDZ domain-containing protein 2,37562,-0.019410617210064,0.00568232975308152,-0.0305479835261037,-0.00827325089402417,0.000637501248576464
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,-0.0465120482083344,0.0136225957635261,-0.0732123359048456,-0.0198117605118233,0.000641276150777762
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DHPS,Deoxyhypusine synthase,37900,-0.0129764767898682,0.00380830337213353,-0.0204407513992499,-0.00551220218048651,0.000657730316280786
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,-0.0175785109779582,0.00516602462181388,-0.0277039192367134,-0.00745310271920297,0.000668847044695883
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YJU2,Splicing factor YJU2,37900,-0.0100608167907881,0.00295813320171606,-0.0158587578661516,-0.00426287571542463,0.000673180294701063
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPON1,Spondin-1,40379,0.0103718937516925,0.00305055387354579,0.00439280815954278,0.0163509793438423,0.000675503153581725
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABO,Histo-blood group ABO system transferase,37987,0.0455463911634463,0.0133971400882474,0.0192879965904813,0.0718047857364113,0.000676520619657378
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CR2,Complement receptor type 2,40403,0.0146684263598824,0.00431620611850611,0.00620866236761038,0.0231281903521543,0.000679336744340304
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSV,Cathepsin L2,40444,0.0133544417026737,0.00392980038724748,0.0056520329436686,0.0210568504616787,0.00067983956929388
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFRC,Transferrin receptor protein 1,40391,0.0124785477576285,0.00367327931957621,0.00527892029125911,0.0196781752239979,0.000682670670764403
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLL1,Delta-like protein 1,40411,-0.00920515043173158,0.00271302351511409,-0.0145226765213552,-0.00388762434210798,0.000693125004541083
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFRA3,GDNF family receptor alpha-3,40194,0.0089818453689861,0.00264793004735244,0.00379190247617531,0.0141717882617969,0.000695487773893747
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,-0.0193851504857291,0.00571599764752551,-0.0305885058748791,-0.00818179509657911,0.000697391114188452
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,-0.030301540754935,0.00893640478889232,-0.047816894141164,-0.0127861873687061,0.000698893822347366
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37900,-0.0104168436689218,0.00307332393187761,-0.0164405585754019,-0.00439312876244168,0.000702369964694883
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS7_LGALS7B,Galectin-7,40270,-0.0126076511769255,0.00372404699267774,-0.0199067832825739,-0.00530851907127715,0.000712291036292776
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39961,-0.0229993689721159,0.00679803528626342,-0.0363235181331922,-0.00967521981103957,0.000718138135374248
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD6,T-cell differentiation antigen CD6,40502,-0.0166238951537672,0.00491769957172899,-0.0262625863143561,-0.00698520399317843,0.000725473181849888
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TUBB3,Tubulin beta-3 chain,37541,0.00871162076430963,0.00258408098665186,0.00364682203047199,0.0137764194981473,0.00075040418542592
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,-0.0330814687763529,0.00983992415545908,-0.0523677201210527,-0.0137952174316531,0.00077608980397135
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RLN1,Prorelaxin H1,37959,-0.0256939034297238,0.00765180012360304,-0.0406914316719858,-0.0106963751874619,0.000787568010558514
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,-0.0360542970891871,0.0107436542923939,-0.0571118595022791,-0.014996734676095,0.000793017788788312
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39980,-0.0163973296312838,0.00488783523282542,-0.0259774866876216,-0.00681717257494594,0.000796349062291673
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,-0.00587668296853176,0.00175495870120697,-0.00931640202289742,-0.0024369639141661,0.000814053413765663
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39980,-0.0184188701700846,0.00550193352470416,-0.0292026598785047,-0.00763508046166443,0.000816762095579111
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,40332,0.0100790781007098,0.00301209277685416,0.00417537625807568,0.015982779943344,0.000821159685471402
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,40357,0.00825211226361104,0.00246611325373439,0.00341853028629164,0.0130856942409304,0.000821164803537099
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,-0.0115264428793207,0.00345097905135619,-0.0182903618199788,-0.00476252393866255,0.000839565376435323
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,40287,-0.0274949841105973,0.00823670882633161,-0.0436389334102072,-0.0113510348109873,0.000845468288334159
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37959,-0.0210874585413686,0.00632037275370493,-0.0334753891386303,-0.00869952794410696,0.000850917980545107
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBM17,Splicing factor 45,37959,-0.0235423880457327,0.00706117109660682,-0.0373822833950821,-0.00970249269638336,0.000858175764695169
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST1,Cystatin-SN,36179,-0.0322450296331658,0.00967284776607499,-0.0512038112546728,-0.0132862480116588,0.000860073828116995
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37901,0.0156107926422977,0.00468310956445087,0.00643189789597404,0.0247896873886214,0.000860155306005051
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37628,-0.0226710986318433,0.00680505413287442,-0.0360090047322772,-0.00933319253140946,0.000866140693143206
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,-0.010709251785084,0.0032147752896021,-0.0170102113527041,-0.0044082922174639,0.000866513892102219
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB44,Ras-related protein Rab-44,37900,-0.0122629456498673,0.00368740281723644,-0.0194902551716507,-0.0050356361280839,0.000884543889434884
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,40341,0.0140628132839542,0.00423083525219227,0.00577037618965738,0.0223552503782511,0.000889732401798065
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FBLN2,Fibulin-2,37998,0.00947354163669899,0.00285358694623643,0.00388051122207559,0.0150665720513224,0.000902967216871782
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,-0.0138753038320803,0.00418361174487331,-0.022075182852032,-0.00567542481212859,0.000913292242964193
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPQ,Carboxypeptidase Q,37986,-0.0111984372168125,0.00337696492612006,-0.0178172884720079,-0.00457958596161722,0.000915152604856206
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECM1,Extracellular matrix protein 1,37655,0.01141238150714,0.00344303680784903,0.00466402936375594,0.0181607336505241,0.000920127495149463
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37562,-0.0207164591710473,0.00625502013961254,-0.0329762986446879,-0.00845661969740669,0.000928909428689734
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37572,0.00991448245489653,0.00299830462046252,0.00403780539878999,0.0157911595110031,0.000946568162330974
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB10,Ras-related protein Rab-10,37990,-0.0163998512836646,0.00496567980922141,-0.0261325837097386,-0.00666711885759066,0.000960275778705983
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCN,Decorin,40042,0.00698945866538729,0.00211788357847719,0.002838406851572,0.0111405104792026,0.000968296177799967
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37598,0.0135557910888779,0.00410789538106846,0.00550431614198372,0.0216072660357721,0.000969642571787272
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STEAP4,Metalloreductase STEAP4,37541,0.0230890931520413,0.00700145474137631,0.00936624185894377,0.0368119444451389,0.000977204117762387
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATXN3,Ataxin-3,37942,-0.0189823782277593,0.00576366583617821,-0.0302791632666685,-0.00768559318884998,0.000992186650561759
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37990,-0.0098571586668295,0.00299586289807867,-0.0157290499470637,-0.00398526738659531,0.00100351754648393
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK7,Kallikrein-7,37352,0.0118150587359057,0.00359834318011177,0.00476230610288659,0.0188678113689247,0.00102809794728093
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRR3,Small proline-rich protein 3,37942,-0.0216065133654639,0.00658797158258696,-0.0345189376673343,-0.00869408906359342,0.00104184094058527
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,40305,-0.0170577898912141,0.0052029393531873,-0.0272555510234612,-0.00686002875896699,0.00104588436315885
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN4B,Sodium channel subunit beta-4,37628,-0.0127449567181223,0.00388995206689823,-0.0203692627692428,-0.00512065066700174,0.00105419236047096
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,-0.0171720518695122,0.00524392980598627,-0.0274501542892453,-0.00689394944977913,0.00106065317635124
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD109,CD109 antigen,40332,0.0101377655391646,0.0030977153252678,0.00406624350163972,0.0162092875766895,0.00106768520299767
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37901,-0.0264770190753558,0.00810363901048542,-0.0423601515359072,-0.0105938866148044,0.00108850772258422
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GET3,ATPase GET3,37990,-0.0169188972882385,0.00519882211629252,-0.0271085886361719,-0.0067292059403052,0.0011392254543437
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBP4,Guanylate-binding protein 4,39961,-0.0149063399552967,0.00458060998564594,-0.0238843355271628,-0.00592834438343067,0.00113945307703925
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA4,Carbonic anhydrase 4,40536,0.00705207540613237,0.00216722708485489,0.00280431031981678,0.011299840492448,0.00114042295031423
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,-0.0252934790939403,0.00778214880170765,-0.0405464907452873,-0.0100404674425933,0.00115566753171547
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37990,-0.0270414518536479,0.00832566085224292,-0.0433597471240441,-0.0107231565832518,0.00116516900373249
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,-0.0136725185020013,0.00421043769000043,-0.0219249763744021,-0.00542006062960042,0.00116794504004657
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,0.0109734760760346,0.00338209979101147,0.00434456048565213,0.0176023916664171,0.00117866629616777
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37959,-0.0341916703374231,0.0105472753990229,-0.054864330119508,-0.0135190105553382,0.00119084633028796
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL17,C-C motif chemokine 17,40333,-0.0271283954493744,0.0083809342593643,-0.0435550265977284,-0.0107017643010204,0.00121075977037819
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,-0.0169549826633231,0.00525029824679996,-0.027245567227051,-0.00666439809959519,0.00124329699802064
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,0.0208561117184814,0.00646267163184384,0.00818927532006747,0.0335229481168953,0.00125278295543549
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,-0.0175330662517594,0.00543399062209147,-0.0281836878710586,-0.00688244463246007,0.00125546012040343
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SYAP1,Synapse-associated protein 1,37671,-0.0168727450522423,0.00523764158566719,-0.02713852256015,-0.00660696754433458,0.00127857176343545
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRH,Corticoliberin,39947,-0.0259692496923024,0.00806216315725347,-0.0417710894805192,-0.0101674099040856,0.00127951213008076
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP3,Caspase-3,40536,-0.0262832968505755,0.00816162169789303,-0.0422800753784458,-0.0102865183227051,0.00128287537422865
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERI1,3'-5' exoribonuclease 1,37714,-0.0100234186537822,0.00311683185805707,-0.0161324090955741,-0.00391442821199039,0.00130348033753085
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,-0.0250067457883132,0.00777804388266611,-0.0402517117983388,-0.00976177977828765,0.00130692071244592
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,-0.00906759955614323,0.00282230905309073,-0.0145993253002011,-0.00353587381208539,0.00131750781749196
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP7,Caspase-7,37942,-0.0248719972008883,0.00774191903579259,-0.0400461585110417,-0.0096978358907348,0.00131829957329871
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPAG1,Sperm-associated antigen 1,37959,-0.0171133004810837,0.00533168279319371,-0.0275633987557434,-0.006663202206424,0.00133166927592841
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCRIB,Protein scribble homolog,37628,-0.0276807219222189,0.00862839624197653,-0.0445923785564929,-0.0107690652879449,0.00133936536598575
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37628,-0.0229771635701609,0.00716458615952958,-0.0370197524428389,-0.00893457469748296,0.00134425492495463
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37998,-0.017423797051405,0.00544956278501071,-0.028104940110026,-0.00674265399278402,0.00139047244685544
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,-0.0219392541236699,0.00686848540926588,-0.035401485525831,-0.00847702272150875,0.00140499562465941
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,40396,0.0250735600493279,0.00785664143412012,0.00967454283845247,0.0404725772602033,0.00141867415894397
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RLN2,Prorelaxin H2,37643,-0.0417792593377677,0.0130940420948566,-0.0674435818436866,-0.0161149368318487,0.00142257166527428
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGCC,Regulator of cell cycle RGCC,37959,-0.0220834619861064,0.00692850346325185,-0.03566332877408,-0.00850359519813276,0.00143917400377897
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,-0.0352752948211477,0.0110777921487704,-0.0569877674327378,-0.0135628222095577,0.00145370982265169
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLG4,Disks large homolog 4,37942,-0.0206174775692897,0.00648175769671883,-0.0333217226548586,-0.00791323248372084,0.00147177714241795
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,0.007456650741603,0.00234443331657342,0.00286156144111909,0.0120517400420869,0.00147261812980024
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PADI2,Protein-arginine deiminase type-2,40044,-0.0165518138613009,0.00520865233860967,-0.0267607724449758,-0.00634285527762594,0.00148710421952795
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40516,-0.0172127476920273,0.00542947233224713,-0.0278545134632317,-0.00657098192082295,0.00152597362974358
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,37541,0.00978103686643426,0.00308824215208047,0.00372808224835654,0.015833991484512,0.001542753632216
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX18,Sorting nexin-18,37901,-0.0133291243188448,0.0042085669964445,-0.0215779156318761,-0.00508033300581362,0.00154289773256568
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAP3,Cytosol aminopeptidase,40044,-0.0144110191966555,0.00455599868996001,-0.0233407766289771,-0.00548126176433383,0.00156405253252176
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINI2,Serpin I2,37901,-0.0163678330973091,0.00517583428038583,-0.0265124682868654,-0.00622319790775291,0.00156845636753975
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP2,Microtubule-associated protein 2,37942,-0.0133951319541748,0.00423951663458784,-0.021704584557967,-0.00508567935038262,0.00158340511703401
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TLR4,Toll-like receptor 4,37598,0.00832724420979452,0.00263656999176246,0.00315956702594009,0.0134949213936489,0.00159017088799833
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGH,Gamma-glutamyl hydrolase,40077,0.0100177955063873,0.00317401754470049,0.00379672111877436,0.0162388698940003,0.00160149432656822
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,-0.0285649287590686,0.00905914266970256,-0.0463208483916856,-0.0108090091264515,0.00161865868823695
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRY2,Protein sprouty homolog 2,40044,-0.0269106584690876,0.00853623583367138,-0.0436416807030835,-0.0101796362350917,0.00162174166057585
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX16,Syntaxin-16,39980,-0.0172675399280069,0.00547875040705076,-0.0280058907258264,-0.00652918913018737,0.00162615017995047
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GMPR,GMP reductase 1,40516,-0.0148893687578617,0.00472574496717272,-0.0241518288935202,-0.00562690862220318,0.00163182860234032
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,40042,-0.00964445015153342,0.00307048891737158,-0.0156626084295817,-0.00362629187348512,0.00168678506697164
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMEM106A,Transmembrane protein 106A,37900,-0.0203005234516555,0.00647501733208926,-0.0329915574225505,-0.00760948948076056,0.00172102291640333
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,0.00853949673453861,0.00272774802723141,0.00319311060116505,0.0138858828679122,0.00174829844973023
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,-0.0246956410520067,0.00789646967496125,-0.0401727216149308,-0.0092185604890827,0.00176661349777713
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP3R1,Calcineurin subunit B type 1,40228,-0.0119643169048941,0.00382964208117442,-0.019470415383996,-0.00445821842579224,0.00178651963348077
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37714,-0.0100681859759578,0.00322282069389019,-0.0163849145359826,-0.00375145741593305,0.00178777146881448
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUSD1,Sushi domain-containing protein 1,40042,-0.0142687892316689,0.00456907797664652,-0.0232241820658961,-0.0053133963974417,0.00179404288730855
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTGES2,Prostaglandin E synthase 2,37484,-0.0157680905668428,0.00506159355659929,-0.0256888139377774,-0.0058473671959082,0.00184192721749737
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,37541,0.0178659381950999,0.00573808901037487,0.00661928373476514,0.0291125926554346,0.00185237665788149
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPAN1,Tetraspanin-1,40042,-0.00878357702390136,0.00283538218134564,-0.0143409260993388,-0.00322622794846391,0.00195279181938827
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,-0.00801633269998232,0.0025902580156833,-0.0130932384107216,-0.00293942698924306,0.00197359820189047
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA9,Carbonic anhydrase 9,40489,-0.012888537152725,0.00416945932500113,-0.0210606774297272,-0.00471639687572274,0.00199706385714015
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRNN,Cornulin,39857,0.0190079018158067,0.00615800715742659,0.00693820778725063,0.0310775958443628,0.00202753038060865
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAGED1,Melanoma-associated antigen D1,39980,-0.0139070327839664,0.00450763088286898,-0.0227419893143896,-0.00507207625354316,0.00203759172114935
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAL,Galanin peptides,40422,0.017850777001786,0.00578626990241553,0.0065096879930516,0.0291918660105205,0.00203884019293721
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,-0.0298935896940193,0.00969337380596529,-0.0488926023537113,-0.0108945770343273,0.00204645377475796
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PEPD,Xaa-Pro dipeptidase,37987,0.00737442846856615,0.00239686862159421,0.0026765659702415,0.0120722909668908,0.00209728714200775
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MIF,Macrophage migration inhibitory factor,40307,-0.0196026643304469,0.00638210577890431,-0.0321115916570993,-0.00709373700379443,0.00213343893188497
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CIT,Citron Rho-interacting kinase,37572,-0.0128429585030235,0.00418155058158205,-0.0210387976429243,-0.00464711936312265,0.00213537273502466
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,40411,-0.0237794217891404,0.00774753630691061,-0.0389645929506852,-0.00859425062759563,0.00214929534585502
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF20,Fibroblast growth factor 20,37598,0.0127155014328905,0.00414824862461497,0.00458493412864517,0.0208460687371359,0.00217914611987802
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39980,-0.0152649726377472,0.0049913873422718,-0.0250480918285999,-0.00548185344689446,0.00223003391964025
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UROS,Uroporphyrinogen-III synthase,37572,-0.0199116164000906,0.00651692356289907,-0.0326847865833727,-0.00713844621680841,0.00225233878182222
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,40403,0.00940460501093538,0.00308600656036672,0.0033560321526166,0.0154531778692542,0.00231130942774539
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNPO1,Transportin-1,37714,0.0100422845434311,0.00329644591225392,0.00358125055541339,0.0165033185314487,0.00232056492224381
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,40296,0.0134999659350133,0.00444246599643144,0.00479273258200766,0.0222071992880189,0.0023787395483555
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,0.0186114947999278,0.00612535581643552,0.00660579739971419,0.0306171922001414,0.00238278301402108
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37608,-0.0159318080412816,0.00524714567898278,-0.0262162135720878,-0.00564740251047534,0.00239984794067022
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL2L1,Bcl-2-like protein 1,37942,-0.0280075364672004,0.00922581041312076,-0.0460901248769171,-0.00992494805748376,0.0024037138464905
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37562,-0.0197532887600841,0.00651599521271221,-0.0325246393770001,-0.00698193814316821,0.00243810886018072
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RILP,Rab-interacting lysosomal protein,40434,-0.0168810713357021,0.00557197143377467,-0.0278021353459005,-0.00596000732550373,0.0024523603114624
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,0.0118491766773606,0.00392106885446203,0.00416388172261498,0.0195344716321061,0.0025164309005556
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BOLA1,BolA-like protein 1,37541,-0.0153562210994163,0.00508323033069351,-0.0253193525475755,-0.00539308965125698,0.00252463480712465
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PADI4,Protein-arginine deiminase type-4,39934,-0.0194784795483355,0.00645685471205862,-0.0321339147839704,-0.00682304431270065,0.00255946276077701
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,-0.0076751801237443,0.00254467772984383,-0.0126627484742382,-0.0026876117732504,0.00256395933201468
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37598,-0.0244496875694407,0.0081062483191884,-0.0403379342750499,-0.00856144086383141,0.0025649305348416
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,37482,0.00846095925160576,0.00280558771079575,0.00296200733844609,0.0139599111647654,0.00256836099805228
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,-0.00943936224356622,0.00313128248524821,-0.0155766759146527,-0.00330204857247972,0.00257775454978166
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37959,-0.0251375720280648,0.00835574596884654,-0.041514834127004,-0.0087603099291256,0.0026309603161889
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMCN2,Hemicentin-2,37648,-0.0159660089071975,0.00530942696819443,-0.0263724857648586,-0.00555953204953641,0.00264244566686771
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP2,Caspase-2,40341,-0.0188162103498597,0.00625772911042164,-0.0310813594062861,-0.00655106129343326,0.00264360762764174
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,40044,-0.0166158076001872,0.00552665642265785,-0.0274480541885966,-0.00578356101177784,0.0026470826211275
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC1,Sialoadhesin,40422,-0.0120558588455985,0.00401370448011435,-0.0199227196266226,-0.00418899806457434,0.00267154463434403
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39836,-0.0335848385598928,0.0111938070061005,-0.0555247002918498,-0.0116449768279357,0.00270141149700678
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA6,Carbonic anhydrase 6,40295,0.0177104631713127,0.00590984089416609,0.00612717501874714,0.0292937513238782,0.00273274638076511
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37671,-0.0195166737345872,0.00652434818032107,-0.0323043961680165,-0.00672895130115787,0.00278250099514059
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37562,0.0111617927354299,0.00373531544121671,0.00384057447064511,0.0184830110002146,0.0028116457165234
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,-0.0202747676093311,0.00678645555522982,-0.0335762204975815,-0.00697331472108062,0.00281752433228448
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPAN15,Tetraspanin-15,37562,0.0141362220117792,0.00473444525370829,0.00485670931451095,0.0234157347090474,0.00283337361088739
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,-0.00706388727387432,0.00237094443757965,-0.0117109383715304,-0.00241683617621821,0.00289294877426288
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39980,-0.00938049996102804,0.0031511337454816,-0.015556722102172,-0.0032042778198841,0.00291661259250684
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,-0.0234890557984022,0.00790791582614687,-0.0389885708176501,-0.00798954077915433,0.00298011069806086
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,0.0134024525046488,0.00451235130508071,0.00455824394669062,0.022246661062607,0.00298170839303592
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENG,Endoglin,40536,0.00469551432707667,0.00158200277763519,0.00159478888291171,0.00779623977124164,0.00300105537425984
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRTN3,Myeloblastin,39897,-0.012927955418677,0.00436361939751721,-0.0214806494378108,-0.00437526139954328,0.0030545006831297
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL6,Fc receptor-like protein 6,40341,-0.0185414701722734,0.0062585853108733,-0.030808297381585,-0.00627464296296173,0.00305538506372341
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD164,Sialomucin core protein 24,40332,-0.00727378445772698,0.00245840382277532,-0.0120922559503666,-0.00245531296508735,0.00309352424418414
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TLR3,Toll-like receptor 3,40516,-0.0166712754486097,0.00564170288272955,-0.0277290130987596,-0.00561353779845981,0.00313114991609561
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP53,Cellular tumor antigen p53,39980,-0.0117367937847119,0.00399277929168937,-0.0195626411964231,-0.00391094637300075,0.0032922139140363
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNAP25,Synaptosomal-associated protein 25,37541,0.0127512096437814,0.00433844405680708,0.00424785929243953,0.0212545599951233,0.00329720019717443
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37628,0.0106530422855038,0.00362939103581694,0.00353943585530255,0.017766648715705,0.00333892397685781
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRG3,Proteoglycan 3,37998,0.013602802681624,0.0046351965996968,0.00451781734621825,0.0226877880170297,0.00334455968158226
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DBH,Dopamine beta-hydroxylase,37967,0.028726594253063,0.00980479393526455,0.00950919813994447,0.0479439903661815,0.00339690658340866
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TJP3,Tight junction protein ZO-3,37541,0.0119512340033941,0.00408479994953426,0.00394502610230698,0.0199574419044813,0.00344181927023247
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37714,-0.0209160464645009,0.0071546723560937,-0.0349392042824446,-0.00689288864655727,0.00346804696525318
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,-0.0258085576729751,0.00882949523213405,-0.0431143683279579,-0.00850274701799238,0.00347177210104754
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX15,Sorting nexin-15,37671,-0.0146872394385322,0.00502551081414631,-0.024537240634259,-0.00483723824280544,0.00347780988475021
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,-0.0254622699300825,0.00872085267957139,-0.0425551411820425,-0.00836939867812262,0.00350950381812967
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PREB,Prolactin regulatory element-binding protein,40044,-0.00801966862276644,0.00275276309550593,-0.0134150842899581,-0.00262425295557482,0.00358120332261271
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37598,-0.0245692173154219,0.00843642168704846,-0.0411046038220368,-0.00803383080880686,0.00359404997410287
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWC2,Brorin,40167,-0.0104701514384669,0.00360449020857452,-0.017534952247273,-0.00340535062966089,0.00368056034902689
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGB1A1,Uteroglobin,40384,0.0152287424373361,0.00525991328789377,0.00491931239306431,0.0255381724816079,0.00379376284767481
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37562,-0.0186223144549034,0.00643375128060328,-0.0312324669648858,-0.00601216194492094,0.0038042294068238
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,0.0198259776103546,0.00685268165890191,0.00639472155890685,0.0332572336618024,0.00381994818936628
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,-0.0116931973935731,0.00405081119523785,-0.0196327873362393,-0.00375360745090693,0.00390007818918045
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP6,Platelet glycoprotein VI,40311,-0.0235031703250192,0.00814457536612752,-0.0394665380426291,-0.00753980260740924,0.00391014586403533
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37959,-0.0163467436083074,0.00566717022901473,-0.0274543972571762,-0.00523908995943849,0.00392701512043115
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,0.00693231673763434,0.00240587979353579,0.00221679234230419,0.0116478411329645,0.00396544329556868
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXNB3,Plexin-B3,40310,-0.0124628741709749,0.00432555804533794,-0.0209409679398373,-0.00398478040211255,0.00396673207178968
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,0.0164300020203377,0.00570791689761403,0.00524248490101417,0.0276175191396612,0.00400270881291301
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL13,C-C motif chemokine 13,40483,-0.0184984845761354,0.00645336078942396,-0.0311470717234063,-0.00584989742886441,0.00415593654629384
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40490,-0.0120158211701056,0.00420271404083369,-0.0202531406901397,-0.00377850165007159,0.00425443195860701
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,0.015339458964898,0.00536629871609281,0.00482151348135608,0.0258574044484399,0.00426347637001333
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,0.0143184022935381,0.005014933288425,0.00448913304822506,0.0241476715388511,0.00430836065838218
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCND2,G1/S-specific cyclin-D2,37714,0.00972728602350409,0.00340824508443515,0.0030471256580112,0.016407446388997,0.0043233252919163
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD72,B-cell differentiation antigen CD72,37671,-0.0111930788910328,0.0039294147075029,-0.0188947317177385,-0.00349142606432715,0.00439886949027588
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,-0.0152780107085384,0.00536834374239833,-0.0257999644436392,-0.00475605697343773,0.00443378442020932
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX5,Sorting nexin-5,37628,-0.00790799164299307,0.00278077552911763,-0.0133583116800636,-0.0024576716059225,0.00446465271102854
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIMAP8,GTPase IMAP family member 8,37482,-0.0136428673136197,0.00480074906460669,-0.0230523354802489,-0.00423339914699064,0.00449263832916777
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37671,-0.0216620416887455,0.00762720528227603,-0.0366113640420065,-0.0067127193354845,0.00451679713651486
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,-0.0135572620766664,0.00478798941434122,-0.0229417213287752,-0.00417280282455765,0.00463969017662925
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,-0.00861961457831076,0.00304550194919682,-0.0145887983987365,-0.00265043075788499,0.00465763416369684
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37900,-0.0128527954901429,0.0045421564114898,-0.0217554220566629,-0.00395016892362293,0.0046665324983881
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFHR2,Complement factor H-related protein 2,37911,-0.0150028199448899,0.00530584185686913,-0.0254022699843534,-0.00460336990542643,0.00469670012313063
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BDNF,Brain-derived neurotrophic factor,37998,-0.0215707963252575,0.0076429842851765,-0.0365510455242034,-0.00659054712631158,0.00477499768481415
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD83,CD83 antigen,40341,-0.00878889735182047,0.00311476446446259,-0.0148938357021671,-0.0026839590014738,0.0047830725268784
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37539,-0.010758777598625,0.00381556757019392,-0.0182372900362051,-0.00328026516104494,0.00481399533073602
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD5L,CD5 antigen-like,37934,0.0121936337923312,0.00433063474886729,0.00370558968455128,0.020681677900111,0.00487464393193027
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRLF1,Cytokine receptor-like factor 1,40422,-0.00685226616524484,0.00243600139237721,-0.0116268288943042,-0.00207770343618551,0.00491544801653757
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTNNA1,Catenin alpha-1,37541,0.00948098266740628,0.00337209576202835,0.00287167497383072,0.0160902903609818,0.0049369153532544
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCOF1,Treacle protein,37990,-0.00786687681600761,0.00279881797290058,-0.0133525600428927,-0.00238119358912248,0.00494917111640149
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HBZ,Hemoglobin subunit zeta,37990,0.0273336489917488,0.00972882305975271,0.00826515579463349,0.0464021421888641,0.00496814118599707
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,-0.0232981481919154,0.00829339021935414,-0.0395531930218495,-0.00704310336198126,0.00497189367776745
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,40042,-0.0146136118192278,0.00520241173154669,-0.0248103388130593,-0.0044168848253963,0.00497563765501008
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPTX2,Neuronal pentraxin-2,37998,0.00847876691130358,0.00302170713314487,0.00255622093033964,0.0144013128922675,0.00502396412926914
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD59,CD59 glycoprotein,39665,-0.0058703233072541,0.00209316599959802,-0.00997292866646622,-0.00176771794804198,0.00504556431098898
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,40305,-0.0116858139995603,0.00416770787351887,-0.0198545214316572,-0.00351710656746328,0.00505507694389744
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GMFG,Glia maturation factor gamma,37990,-0.0185965593372951,0.00663581105286736,-0.0316027490009151,-0.00559036967367509,0.00507874149865915
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GM2A,Ganglioside GM2 activator,37714,-0.0099267020992011,0.00356273765167399,-0.0169096678964821,-0.00294373630192008,0.0053396350185824
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37562,0.00737917796243172,0.00265150518868156,0.00218222779261587,0.0125761281322476,0.00539334296452182
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,40359,-0.0175120263094203,0.00629650875817217,-0.0298531834754377,-0.0051708691434028,0.00542174081474217
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DBN1,Drebrin,37598,-0.0132950700018136,0.00478859760476109,-0.0226807213071453,-0.00390941869648185,0.00550420381946313
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C3,Complement C3,37360,-0.012156671969123,0.00438099437751775,-0.0207434209490578,-0.00356992298918822,0.00553038884375256
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,-0.0186882652000734,0.00673550496379652,-0.0318898549291146,-0.00548667547103223,0.00553355883677607
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADA2,Adenosine deaminase 2,40258,0.0107862680537851,0.00389004331826706,0.00316178314998162,0.0184107529575885,0.005564329208676
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB9,Serpin B9,40228,-0.00862423329740503,0.00311099429365453,-0.0147217821129679,-0.00252668448184215,0.00557476803815035
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,-0.0215636950323517,0.00777980132305963,-0.0368121056255486,-0.00631528443915485,0.0055831477835509
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL1,Growth-regulated alpha protein,40329,-0.024868119534973,0.00899946749356496,-0.0425070758223604,-0.00722916324758572,0.0057288168614526
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMS,Spermine synthase,37541,-0.0163325396619978,0.00592825426428842,-0.0279519180200031,-0.00471316130399247,0.00587672147430109
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THBS4,Thrombospondin-4,40355,0.0115249414462494,0.00418971858527443,0.00331309301911152,0.0197367898733873,0.00595230872957661
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AFP,Alpha-fetoprotein,40182,0.017718580732644,0.00644608566347867,0.00508425283222577,0.0303529086330622,0.00598939786992934
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,40305,0.00526223841964928,0.00191513592424355,0.00150857200813192,0.00901590483116663,0.00600808583026795
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRELP,Prolargin,40357,0.00589921375344217,0.00215177918698926,0.00168172654694323,0.0101167009599411,0.00612180756081868
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37628,-0.014237791655464,0.00519734597176521,-0.0244245897601238,-0.00405099355080422,0.0061627662536534
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS27,Serine protease 27,40314,-0.0102134843766655,0.00375115823726357,-0.0175657545217021,-0.00286121423162891,0.00648108376952421
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40536,0.00744916656060981,0.00273765897801895,0.00208335496369268,0.0128149781575269,0.00651550110129339
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37714,0.00734121036235305,0.00269827733331615,0.0020525867890534,0.0126298339356527,0.00652282624352284
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZBP1,Z-DNA-binding protein 1,37598,-0.0101257284077482,0.00372949017288175,-0.0174355291465964,-0.00281592766889993,0.00663535633049106
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,40044,-0.0171651518892605,0.00633013914047533,-0.0295722246045921,-0.0047580791739288,0.00670216436267484
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDIA5,Protein disulfide-isomerase A5,37482,-0.0154473434735321,0.00569696986671345,-0.0266134044122905,-0.00428128253477375,0.00670670106787514
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,0.00678009129525274,0.00250315018469822,0.00187391693324423,0.0116862656572612,0.00676477563396773
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,-0.00926198118803718,0.00342719908241789,-0.0159792913895762,-0.00254467098649813,0.00689092516492247
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,0.00856178552948011,0.00317118706513503,0.00234625888181545,0.0147773121771448,0.00694556135533647
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB37,Ras-related protein Rab-37,40044,-0.0208759707073908,0.00773804362147584,-0.0360425362054834,-0.00570940520929814,0.00698669551860496
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REST,RE1-silencing transcription factor,37482,0.00898254109463059,0.00333235800198334,0.00245111941074325,0.0155139627785179,0.00703625110174224
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,-0.0162574293552142,0.00604898023242244,-0.0281134306107622,-0.00440142809966619,0.00720385883635647
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,-0.0104916535482535,0.00390392257892936,-0.0181433418029551,-0.00283996529355196,0.00720714225022007
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EVPL,Envoplakin,37714,0.00859348002635954,0.00320626212510889,0.00230920626114611,0.014877753791573,0.00736652356792398
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,-0.0118585455620898,0.00442826101201664,-0.0205379371456424,-0.00317915397853715,0.00741697809512007
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATXN10,Ataxin-10,39961,-0.0179955622342924,0.00672907774830134,-0.031184554620963,-0.00480656984762181,0.00749642704241568
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSPN,Persephin,40341,-0.0246267383886685,0.00921207305107258,-0.0426824015687708,-0.00657107520856627,0.0075183276053592
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,-0.0214115897698975,0.00801027629038365,-0.0371117312990494,-0.00571144824074553,0.00752635802988436
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACHE,Acetylcholinesterase,37671,-0.00792097482726959,0.00296563904260753,-0.0137336273507803,-0.00210832230375884,0.0075737029770714
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F13B,Coagulation factor XIII B chain,37934,-0.00636941574456068,0.00239609923995684,-0.0110657702548761,-0.00167306123424528,0.00786417687028232
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD40LG,CD40 ligand,40516,-0.0188313223396536,0.00708886271321399,-0.032725493257553,-0.00493715142175417,0.00790424500833206
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37835,-0.0144076805671504,0.00542905611336403,-0.0250486305493439,-0.00376673058495685,0.00796828105014363
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,-0.00824896766250306,0.003112833249896,-0.0143501208322992,-0.0021478144927069,0.00805745789745092
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39980,0.0122068090466705,0.00461162477478097,0.00316802448809985,0.0212455936052412,0.00812997389087618
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,-0.00628905795358456,0.00238054538946763,-0.0109549269169411,-0.00162318899022799,0.00825479300560374
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,-0.0219417201654842,0.00830842360975139,-0.0382262304405969,-0.00565720989037149,0.00827809293925503
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,37482,-0.0100990415741394,0.00383420736852069,-0.01761408801644,-0.00258399513183887,0.00845021212454347
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,0.00869354863957853,0.00330231822373188,0.00222100492106405,0.015166092358093,0.00848407673722487
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37562,0.00800784801892723,0.00304206686579681,0.00204539696196548,0.013970299075889,0.00848906384681229
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMG3,Proteasome assembly chaperone 3,40341,-0.0124939582719837,0.00474668080971796,-0.0217974526590309,-0.00319046388493649,0.00849293407016442
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,40044,-0.0077779207024827,0.00295930800252653,-0.0135781643874347,-0.0019776770175307,0.00858993261595132
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,37541,-0.0242598714630375,0.00923579461156679,-0.0423620289017084,-0.00615771402436659,0.00863119845302385
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JUN,Transcription factor AP-1,40044,-0.0126410594584474,0.00481516683100286,-0.022078786447213,-0.0032033324696818,0.00866676090857489
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIFBP,KIF-binding protein,40305,-0.0200379310796118,0.00763553755600754,-0.0350035846893866,-0.00507227746983702,0.00869108412490401
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CIAPIN1,Anamorsin,40411,-0.0154667510548853,0.0059076515198444,-0.0270457480337803,-0.0038877540759903,0.00885075126163849
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,-0.0115404363495394,0.00440833951893905,-0.0201807818066599,-0.00290009089241882,0.00885805716329385
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA5,Annexin A5,39896,-0.00744472870712097,0.00284556551194353,-0.0130220371105303,-0.00186742030371164,0.0088986323590244
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK1,Kallikrein-1,40209,0.0308777361463692,0.0118112885495069,0.00772761058933576,0.0540278617034027,0.00895069858244391
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LACTB2,Endoribonuclease LACTB2,40359,-0.0159599123943522,0.0061213794985125,-0.0279578162114367,-0.00396200857726769,0.00913602550181182
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBC1D5,TBC1 domain family member 5,40341,-0.0188592680617971,0.00725589360905362,-0.0330808195355422,-0.00463771658805204,0.00935370835192857
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39961,-0.0117228348894254,0.00451964856359763,-0.0205813460740768,-0.0028643237047741,0.00950249334072283
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLMH,Bleomycin hydrolase,40536,0.00776865562635418,0.00299604628342806,0.00189640491083518,0.0136409063418732,0.00952374387919107
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATRN,"Attractin, Isoform 2",38013,-0.00392609064487886,0.00151655948287414,-0.00689854723131218,-0.00095363405844554,0.00964098764005421
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNW1,Interferon omega-1,37562,0.00883607313793149,0.00341330276205989,0.00214599972429411,0.0155261465515689,0.0096440745054385
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CENPF,Centromere protein F,37714,-0.0131015179150794,0.00506574813978649,-0.0230303842690609,-0.00317265156109787,0.00971194684553621
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,40305,-0.0128972963867275,0.00499036432106779,-0.0226784104560204,-0.00311618231743466,0.00976258582005289
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40471,-0.0106902798029172,0.00413961608887507,-0.0188039273371123,-0.00257663226872202,0.00981943959251345
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL20,C-C motif chemokine 20,40516,-0.0212113043857002,0.00821692041735007,-0.0373164684037064,-0.00510614036769412,0.00984832089870199
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,37541,0.0218281448411239,0.00846419052013631,0.00523833142165672,0.038417958260591,0.00992289173782948
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37562,-0.00917623943179986,0.00355957784115277,-0.0161530120004593,-0.00219946686314043,0.00995105985977682
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,-0.0236150986946282,0.00916483163430199,-0.0415781686978601,-0.00565202869139626,0.00998512058788352
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA3,Annexin A3,40442,-0.0166576557221402,0.00647656990395641,-0.0293517327338947,-0.00396357871038564,0.0101206046917748
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL21R,Interleukin-21 receptor,37598,0.01333299347199,0.00519741558593418,0.00314605892355899,0.023519928020421,0.0103192922797912
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,-0.0162243321624046,0.00632680806840221,-0.0286248759764729,-0.00382378834833623,0.010346780538029
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,-0.0214988782721817,0.00840259949628875,-0.0379679732849076,-0.00502978325945575,0.010520356324833
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FMR1,Synaptic functional regulator FMR1,39980,-0.0083286454355417,0.00326042982570724,-0.0147190878939279,-0.00193820297715551,0.0106446474219848
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLSTN1,Calsyntenin-1,39961,0.0124782512109043,0.00488735278580693,0.00289903975072268,0.0220574626710859,0.0106841694282799
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,-0.00658074463130504,0.00258102483362403,-0.0116395533052081,-0.00152193595740195,0.0107919443667044
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37942,0.00630534671372932,0.002474724354122,0.00145488697965019,0.0111558064478084,0.0108483880169269
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,0.0141418028853971,0.00555649600665761,0.00325107071234823,0.025032535058446,0.0109361991835211
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,0.00666945892739424,0.0026278173311829,0.00151893695827575,0.0118199808965127,0.0111576244164192
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,-0.0209866721627231,0.00828429681147335,-0.0372238939132109,-0.00474945041223536,0.0113108223490073
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AIF1,Allograft inflammatory factor 1,39980,-0.0123737025215088,0.00489077853869059,-0.0219596284573424,-0.00278777658567526,0.0114158362093938
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37671,-0.0277533101133033,0.0109848925990984,-0.0492836996075361,-0.00622292061907053,0.0115321744249351
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,-0.00636778264994918,0.00252333445901232,-0.0113135181896133,-0.00142204711028503,0.0116269287902403
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37998,-0.0140805401173955,0.00558696657253939,-0.0250309945995727,-0.00313008563521829,0.0117386204472799
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYM,Ketimine reductase mu-crystallin,37541,-0.0180101553963734,0.00714831340352298,-0.0320208496672785,-0.0039994611254684,0.0117640647289105
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNLZ,DNL-type zinc finger protein,37541,0.0222540715230503,0.00884349741075769,0.00492081659796524,0.0395873264481354,0.0118667913576161
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,40422,-0.0306623914109255,0.0122149609635554,-0.054603714899494,-0.006721067922357,0.0120749762096417
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,-0.0204591909289541,0.0081527048685635,-0.0364384924713386,-0.00447988938656966,0.0121003683421312
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDHR5,Cadherin-related family member 5,40359,-0.00905530379009157,0.00360953779930733,-0.0161299978767339,-0.0019806097034492,0.0121269649789466
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,-0.014203886904361,0.00566441379748201,-0.0253061379474257,-0.00310163586129625,0.0121665078049761
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,-0.0087032440029088,0.00347601604411087,-0.0155162354493661,-0.0018902525564515,0.0122985108050536
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THTPA,Thiamine-triphosphatase,37884,-0.0204606194815317,0.00818596822500432,-0.0365051172025402,-0.00441612176052327,0.0124495993985136
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,-0.00883280632720375,0.00353446620378196,-0.0157603600866164,-0.0019052525677911,0.0124645017737701
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTC,Probetacellulin,39980,-0.0174224661380163,0.0069868978785018,-0.0311167859798799,-0.00372814629615279,0.0126561381712442
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,40208,-0.00931309231693262,0.00373562839944994,-0.0166349239798545,-0.00199126065401074,0.0126754368721106
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLPS,Colipase,40311,0.0158304218686612,0.00635477834294174,0.00337505631649538,0.028285787420827,0.0127447818037902
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NECTIN4,Nectin-4,40411,-0.00705631909149653,0.00283277811985049,-0.0126085642064035,-0.00150407397658957,0.012750155063968
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37901,-0.013536543816298,0.0054418077662069,-0.0242024870380635,-0.00287060059453247,0.012876155080478
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39980,-0.0131966248892282,0.00530557480824894,-0.0235955515133961,-0.00279769826506028,0.012881627217422
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCLRE1C,Protein artemis,37482,0.00734077553216786,0.00295171429301816,0.00155541551785228,0.0131261355464834,0.012896650264357
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLAMF8,SLAM family member 8,39980,-0.0123300982942054,0.0049663210300173,-0.0220640875130393,-0.00259610907537149,0.0130479960513057
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL26,C-C motif chemokine 26,40341,0.0204215793942726,0.00823000045662507,0.00429077849928746,0.0365523802892578,0.0130985390775732
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,-0.0170413172480589,0.00687584029317911,-0.0305179642226899,-0.00356467027342782,0.013208141741125
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,-0.0204716158075637,0.00826184254971668,-0.0366648272050084,-0.00427840441011903,0.0132298126792515
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17D,Interleukin-17D,40044,0.00787806895955461,0.00318079290531926,0.00164371486512887,0.0141124230539804,0.0132685298772418
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,-0.0257382608434596,0.0104222744317328,-0.0461659187296559,-0.00531060295726333,0.013539240952089
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIMAP7,GTPase IMAP family member 7,37671,0.00743440128249159,0.00301121967558991,0.00153241071833538,0.0133363918466478,0.0135654452477509
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPD52L2,Tumor protein D54,37671,-0.0246914545631913,0.0100063600903193,-0.0443039203402172,-0.00507898878616543,0.0136157042363634
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN3B,Sodium channel subunit beta-3,37541,0.010515529183485,0.00426741293324708,0.00215139983432073,0.0188796585326493,0.0137467660883053
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,40359,-0.0151634977522899,0.00616313183105126,-0.0272432361411503,-0.00308375936342939,0.0138904804801463
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37598,-0.00714706542881128,0.00290799950194069,-0.012846744452615,-0.00144738640500754,0.0139948003914817
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYZL2,Lysozyme-like protein 2,37482,-0.00817747060730638,0.00332814231824069,-0.0147006295510581,-0.00165431166355463,0.0140205711560546
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MINK1,Misshapen-like kinase 1,37942,-0.0210040009706733,0.00856305490022779,-0.0377875885751197,-0.0042204133662268,0.0141849961792822
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,-0.0183691188836092,0.00749979216182675,-0.0330687115207896,-0.00366952624642875,0.0143247858464539
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,0.00858319572850511,0.00350924729467123,0.00170507103094949,0.0154613204260607,0.0144629857463643
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37928,-0.00923354830884506,0.00377720967212098,-0.0166368792662022,-0.00183021735148795,0.0145163345514802
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37671,-0.0123470044586197,0.00505512475369,-0.0222550489758521,-0.00243895994138727,0.0146000359335549
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH6,Cadherin-6,40359,0.00857025517090748,0.00351921093061487,0.00167260174690233,0.0154679085949126,0.014891284124573
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,-0.0138127778017567,0.00567278427549442,-0.0249314349817257,-0.0026941206217876,0.0149083037306379
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TTF2,Transcription termination factor 2,37572,-0.0109657016073878,0.00451298632493866,-0.0198111548042676,-0.00212024841050806,0.0151200431300493
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INHBB,Inhibin beta B chain,37671,0.0116000227334949,0.00478402610209899,0.00222333157338088,0.0209767138936089,0.0153326377546454
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37544,0.00908397036140102,0.00375167338776067,0.0017306905213901,0.0164372502014119,0.0154781164917128
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSNK1D,Casein kinase I isoform delta,37598,-0.0142834105766146,0.0059000591279619,-0.0258475264674199,-0.00271929468580923,0.015495897105128
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37598,0.00958269732214492,0.00395993906803234,0.00182121674880154,0.0173441778954883,0.0155378076458652
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NXPE4,NXPE family member 4,37562,0.00816268545167243,0.00337320702683845,0.00155119967906907,0.0147741712242758,0.0155400346690231
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37714,-0.0150655969036816,0.00623003459518691,-0.0272764647102479,-0.00285472909711525,0.0156100086062634
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,-0.0106933609325024,0.00443080824008412,-0.0193777450830672,-0.00200897678193748,0.0158172713775655
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40536,-0.00697747439944373,0.00289244825506207,-0.0126466729793654,-0.00130827581952207,0.0158630284214781
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,0.00659422287635277,0.00273383162284597,0.00123591289557466,0.0119525328571309,0.0158749709831256
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GC,Vitamin D-binding protein,38013,-0.00581219172017019,0.0024120038171967,-0.0105397192018757,-0.00108466423846465,0.015979127254793
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF9,Fibroblast growth factor 9,37457,0.00909344091456834,0.00377429687312568,0.001695819043242,0.0164910627858947,0.0159966405281813
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,-0.0210976909010683,0.00875932067170666,-0.0382659594176133,-0.00392942238452323,0.0160252182761333
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,40465,0.00904304904363384,0.00375604463738158,0.00168120155436594,0.0164048965329017,0.0160690474698485
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,-0.0229444777148641,0.00953517829165848,-0.0416334271665147,-0.00425552826321349,0.0161285273510916
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,40305,-0.00691384078495303,0.00287475889223991,-0.0125483682137433,-0.00127931335616281,0.0161831506172416
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,0.0092433688095535,0.00385444673541159,0.00168865320814679,0.0167980844109602,0.0164914541011247
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL8,C-C motif chemokine 8,40470,-0.0133546374574026,0.00558575334195816,-0.0243027140076405,-0.00240656090716456,0.0168213931981152
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACRBP,Acrosin-binding protein,37900,-0.0083650122082818,0.0035005008725138,-0.0152259939184089,-0.00150403049815475,0.0168775956465887
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPO,Lactoperoxidase,39831,-0.0131287985455262,0.00549465873806711,-0.0238983296721377,-0.00235926741891465,0.0168890538382231
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,40377,-0.00881289241727618,0.00369154300165319,-0.0160483167005164,-0.00157746813403593,0.0169833299622241
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,-0.00870464695757497,0.00364731585047031,-0.0158533860244968,-0.00155590789065316,0.0170191922114637
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37562,-0.0138424722104124,0.00580891330063232,-0.0252279422796518,-0.00245700214117307,0.0171877047575462
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDC4,Syndecan-4,40359,0.00996772168323969,0.00419510981210398,0.00174530645151589,0.0181901369149635,0.0175116422255806
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37562,-0.00905587861750591,0.00381885611720056,-0.016540836607219,-0.00157092062779281,0.0177371753707471
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XG,Glycoprotein Xg,40458,0.00657924550629127,0.00277796716267901,0.00113442986744041,0.0120240611451421,0.0178786166420847
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMPD3,AMP deaminase 3,37942,-0.0158867587979669,0.00671431295965202,-0.0290468121988848,-0.0027267053970489,0.0179904736195613
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,0.00723609924659091,0.0030589139888093,0.00124062782852468,0.0132315706646571,0.0180141230416023
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LIPF,Gastric triacylglycerol lipase,37628,-0.0131043338357645,0.00554257888834983,-0.0239677884569302,-0.00224087921459886,0.0180784676331691
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH12,Protocadherin-12,37959,-0.00561322489580822,0.0023742185657387,-0.0102666932846561,-0.000959756506960372,0.0180811204297222
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACTA2,"Actin, aortic smooth muscle",40042,-0.00958622154445925,0.0040576950611125,-0.0175393038642398,-0.00163313922467875,0.0181653559193729
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39925,-0.00960351666385287,0.00406697875019514,-0.0175747950142353,-0.00163223831347039,0.0182213847800957
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40536,0.00494479449810927,0.00209547387026869,0.000837665712382633,0.00905192328383591,0.0182991301587828
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HCG22,Protein PBMUCL2,37562,0.0116397660294515,0.00495413301162644,0.00192966532666365,0.0213498667322393,0.018813085932995
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,-0.0166626912292328,0.00709364380000541,-0.0305662330772434,-0.0027591493812222,0.0188383520725982
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP164,Centrosomal protein of 164 kDa,40044,-0.0139391116127841,0.00594291373560335,-0.0255872225345666,-0.0022910006910015,0.019013978698595
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39980,-0.0130672735752739,0.00557897217017546,-0.0240020590288178,-0.00213248812172998,0.0191811161517107
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,-0.0095058837520512,0.00406113066051547,-0.0174656998466615,-0.00154606765744088,0.0192602743274122
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSLN,Mesothelin,40271,-0.0117204243071878,0.00502889613208602,-0.0215770607260764,-0.00186378788829924,0.0197861366641994
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PXDNL,Peroxidasin-like protein,37900,0.0126339247619049,0.00542646641953466,0.00199805057961693,0.0232697989441928,0.0199159860180048
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40536,0.00713510373208994,0.00306669114614511,0.00112438908564554,0.0131458183785344,0.0199964862158044
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL5,Interleukin-5,40044,0.0315340339305155,0.0135540437915123,0.0049681080991513,0.0580999597618796,0.0200024731796338
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENOPH1,Enolase-phosphatase E1,37900,0.0123398599030008,0.00530957295997298,0.00193309690145375,0.0227466229045478,0.0201361541731513
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTD,Deoxycytidylate deaminase,37671,-0.0203370493831619,0.00875972829552045,-0.037506116842382,-0.00316798192394187,0.0202667497119588
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37562,-0.0110299672747955,0.00475095641797309,-0.0203418418540227,-0.0017180926955682,0.0202680656775176
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBX2,Chromobox protein homolog 2,37562,0.008854391589959,0.00381430520579451,0.00137835338660175,0.0163304297933162,0.0202824478546379
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,37541,0.00916785575016594,0.00395491824478558,0.00141621599038621,0.0169194955099457,0.0204597747431388
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPSG1,Tryptase gamma,37598,0.00585696279068524,0.00253289047503137,0.000892497459623753,0.0108214281217467,0.0207730449914431
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHCY,Adenosylhomocysteinase,40359,-0.0145002564062368,0.0062883422640345,-0.0268254072437444,-0.00217510556872917,0.0211293016416641
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,-0.0218895571651233,0.00949569717901932,-0.0405011236360011,-0.00327799069424542,0.0211703878202467
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37959,-0.00661972462148431,0.00287177831298956,-0.0122484101149438,-0.000991039128024777,0.0211762831884121
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37959,-0.014818121734694,0.00644580538973434,-0.0274519002985733,-0.00218434317081465,0.0215270455920796
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,-0.00776283778549094,0.00337917690370148,-0.0143860245167458,-0.00113965105423604,0.0216196639847662
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MESD,LRP chaperone MESD,40332,-0.0257033513422283,0.0112051022264154,-0.0476653517060024,-0.00374135097845418,0.0218094045417334
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,40328,-0.00771533446085364,0.00336525276371047,-0.0143112298777262,-0.00111943904398112,0.0218813889288601
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37714,-0.0125632193271813,0.00549318986824197,-0.0233298714689355,-0.00179656718542701,0.022208377016885
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELOB,Elongin-B,37562,-0.00849760989180606,0.00371579036112414,-0.0157805589996094,-0.00121466078400274,0.0222180124216766
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GH2,Growth hormone variant,39980,0.0358156421262995,0.0156732689085874,0.00509603506546816,0.0665352491871309,0.0223179328171288
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL5,Fc receptor-like protein 5,40332,-0.0118547995779688,0.00518878377034723,-0.0220248157678494,-0.00168478338808826,0.0223437189752254
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,40465,-0.0134731889189075,0.00591793740210158,-0.0250723462270266,-0.00187403161078841,0.0228190908998966
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALB1,Calbindin,40305,-0.00895731740430526,0.00393607592243953,-0.0166720262122867,-0.00124260859632379,0.0228774142037869
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP3,Stromelysin-1,40332,-0.0101736162571066,0.00447953161005274,-0.0189534982128099,-0.00139373430140319,0.0231521970610544
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAX,Protein max,39961,-0.0219781951595046,0.00969370810213974,-0.0409778630396985,-0.00297852727931074,0.0233878071695022
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,0.00481340109524485,0.00212384786127082,0.000650659287154047,0.00897614290333566,0.0234426550721708
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTP1,Glutathione S-transferase P,39871,0.0146706645833394,0.00649300183961548,0.00194438097769304,0.0273969481889857,0.0238688128248153
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYL4,Myosin light chain 4,37628,-0.011028803418381,0.00488474388757276,-0.0206029014380236,-0.00145470539873844,0.0239740596815131
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL36G,Interleukin-36 gamma,37551,-0.0144369494476665,0.00639754627400865,-0.0269761401447235,-0.0018977587506096,0.0240470813132148
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNM1,Dynamin-1,37901,0.0235951662450219,0.0104916098637603,0.00303161091205164,0.0441587215779921,0.0245314273133378
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLMP,CXADR-like membrane protein,40489,-0.00424357920130441,0.0018892188922653,-0.00794644823014439,-0.00054071017246442,0.0247042211940994
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF3,Granulocyte colony-stimulating factor,40044,-0.0101736489394762,0.00453437778570478,-0.0190610293994576,-0.00128626847949482,0.0248675980787213
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39980,0.0122127579054609,0.00544518782183796,0.0015401897746585,0.0228853260362633,0.0249203188157978
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37900,-0.0125811938168214,0.00560979012364022,-0.0235763824591563,-0.0015860051744866,0.0249310380839508
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,-0.00730949320135899,0.00325922842186713,-0.0136975809082186,-0.000921405494499414,0.0249323346514115
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UPK3A,Uroplakin-3a,37541,0.0104335580408958,0.00465431197831388,0.00131110656340055,0.019556009518391,0.0249976362449995
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XRCC4,DNA repair protein XRCC4,39961,-0.00774647569785326,0.00345960748527108,-0.0145273063689846,-0.000965645026721933,0.0251622411393237
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCHE,Cholinesterase,37748,-0.00587259448510868,0.00262350304557896,-0.0110146604544434,-0.000730528515773919,0.0252078567824736
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37628,-0.0101505242438929,0.00453681327679277,-0.0190426782664067,-0.00125837022137905,0.0252789005335938
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37598,0.0104454373169172,0.00468478781302781,0.0012632532033827,0.0196276214304517,0.0257875089636693
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,-0.0102264859761771,0.00458688332605433,-0.0192167772952436,-0.00123619465711064,0.0257941265853364
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,-0.0174737222873253,0.00783758078620459,-0.0328353806282863,-0.00211206394636434,0.0257962919292856
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,0.012942759955559,0.00580762613304246,0.00155981273479579,0.0243257071763222,0.0258587457124869
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECE1,Endothelin-converting enzyme 1,39961,0.00729500710733623,0.00327640670326386,0.00087324996893907,0.0137167642457334,0.025993226720434
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37942,-0.00582869946267113,0.00261838124615375,-0.0109607267051325,-0.000696672220209781,0.0260259605486992
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP350,Centrosome-associated protein 350,37482,0.00775035914674853,0.00348401376183364,0.000921692173554595,0.0145790261199425,0.0261285960399511
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,40042,-0.0129363288023993,0.00582289025214015,-0.024349193696594,-0.0015234639082046,0.0263223787896376
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CORO1A,Coronin-1A,39990,-0.0185144864521781,0.00833744220214421,-0.0348558731683808,-0.00217309973597549,0.0263894860549779
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GUK1,Guanylate kinase,37562,0.00826865957090594,0.00372451550793669,0.000968609175350035,0.0155687099664618,0.0264315191255354
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC39A14,Zinc transporter ZIP14,39961,-0.00689425260907181,0.00310574555826635,-0.0129815139032739,-0.000806991314869756,0.0264441578878306
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37942,-0.00946669697944811,0.0042686916527269,-0.0178333326187928,-0.00110006134010339,0.0265915792802442
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,-0.0164248995382606,0.00741215642322059,-0.030952726127773,-0.00189707294874827,0.0267121650940768
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNF,Tumor necrosis factor,40014,-0.00817954457953248,0.00369359354505904,-0.0154189879278482,-0.000940101231216759,0.0268073166375051
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39980,-0.00834514958218922,0.00376941234498644,-0.0157331977783626,-0.000957101386015786,0.0268492638969594
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37942,-0.0489123784026248,0.0220990189105709,-0.0922264554673438,-0.00559830133790582,0.026891707742173
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,-0.0135381200017535,0.00611782155184894,-0.0255290502433775,-0.00154718976012962,0.026921635082947
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STC2,Stanniocalcin-2,40309,-0.00556355998853596,0.00251721266180142,-0.0104972968056667,-0.000629823171405169,0.0271050551601292
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMA1,Laminin subunit alpha-1,37562,0.0114867418289695,0.00520653986480039,0.00128192369396073,0.0216915599639783,0.0273862871894129
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,0.0118499105369411,0.00538383486183237,0.0012975942077497,0.0224022268661326,0.027752234914513
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,-0.0180342196200007,0.00819509653505955,-0.0340966088287174,-0.00197183041128394,0.0277803982500952
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,0.00646839849508142,0.00294162402575134,0.000702815404608797,0.012233981585554,0.0279009793149626
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA1,Annexin A1,37608,-0.00845805649271717,0.00385168215041215,-0.016007353507525,-0.000908759477909343,0.0281137504773218
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,37541,0.0144933393117367,0.00660157811549262,0.00155424620537118,0.0274324324181023,0.0281498598755464
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,0.00655190024574654,0.00298587743518448,0.000699580472784964,0.0124042200187081,0.0282315738658
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,-0.0133278635967322,0.00607771317358002,-0.025240181416949,-0.00141554577651537,0.0283311010955869
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37714,-0.011257406565698,0.00513735020274316,-0.0213266129630746,-0.00118820016832142,0.0284483936246559
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,-0.0103961941694524,0.0047460274648381,-0.0196984080005351,-0.00109398033836972,0.0285024890506738
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBM25,RNA-binding protein 25,37482,0.00943270033791542,0.00430695551889741,0.000991067520876488,0.0178743331549544,0.0285340235713013
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,-0.0135999118097751,0.00621369587105019,-0.0257787557170335,-0.00142106790251675,0.028636281379976
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBXN1,UBX domain-containing protein 1,37671,-0.0140236787199128,0.00640831214164569,-0.0265839705175383,-0.00146338692228721,0.0286610020250849
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD48,CD48 antigen,40396,-0.00594623779838943,0.00272000402279849,-0.0112774456830745,-0.000615029913704402,0.0288217851707576
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL14,C-X-C motif chemokine 14,40044,-0.0124738901611538,0.00570833081562227,-0.0236622185597734,-0.00128556176253413,0.0288884297114139
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX6,Syntaxin-6,39980,-0.01395657923419,0.00638688938961527,-0.026474882437836,-0.00143827603054411,0.0288896678393807
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37628,-0.011328743381427,0.00518563581995634,-0.0214925895885414,-0.00116489717431254,0.0289328697490656
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37572,0.00914511931541779,0.00418769854218642,0.000937230172732409,0.0173530084581032,0.0289941885633006
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,-0.0134862837323677,0.00618131554977627,-0.0256016622099292,-0.00137090525480621,0.0291427937156817
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BSND,Barttin,37482,0.00695304173558148,0.00318781847208614,0.000704917530292642,0.0132011659408703,0.0291917299533458
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP9,Caspase-9,37598,-0.0126071353927043,0.00578344791310849,-0.0239426933023969,-0.00127157748301168,0.0292851549192498
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37567,-0.0120104742350838,0.00551062959111938,-0.0228113082336778,-0.0012096402364898,0.0293115055603122
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFB,Complement factor B,37770,-0.00664417431681961,0.0030503642973102,-0.0126228883395476,-0.00066546029409162,0.0294117835740152
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGA6,Integrin alpha-6,40341,-0.0107155030060198,0.00492314005479016,-0.0203648575134086,-0.00106614849863113,0.0295281893113473
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PALLD,Palladin,37598,0.00832904050086928,0.00385282843984832,0.000777496758766583,0.015880584242972,0.0306516631638921
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RCC1,Regulator of chromosome condensation,37900,-0.0101991198231406,0.00473063812010884,-0.0194711705385539,-0.000927069107727245,0.0311035885397416
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPAN7,Tetraspanin-7,37541,0.0183466612776161,0.00851661647851125,0.00165409297973406,0.0350392295754981,0.0312411559897783
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPEP,Glutamyl aminopeptidase,37562,0.00924297972740913,0.00430175961044046,0.000811530890945832,0.0176744285638724,0.0316803401893034
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK8,Kallikrein-8,39801,-0.00704775811373909,0.00328207896749662,-0.0134806328900325,-0.000614883337445714,0.0317813842468278
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37880,0.0173636831858215,0.00809355558010086,0.00150031424882378,0.0332270521228192,0.0319410378323798
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37990,-0.0140562889042096,0.00655667768604906,-0.0269073771688658,-0.00120520063955344,0.0320656562073478
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINI1,Neuroserpin,37642,0.00634720272252076,0.00296092105814302,0.00054379744856044,0.0121506079964811,0.0320785134687433
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGA5,Integrin alpha-5,40332,-0.00493735020438746,0.00230589442923797,-0.00945690328569387,-0.000417797123081041,0.0322741708416777
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,40128,0.034701787158218,0.0162324324553364,0.00288621954575879,0.0665173547706773,0.0325479340834258
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37755,0.00269236179428816,0.00125965170469603,0.000223444453083946,0.00516127913549238,0.0325847954925313
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37879,-0.0138978124046358,0.0065130365958177,-0.0266633641324385,-0.00113226067683314,0.0328735157493107
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASS1,Argininosuccinate synthase,37562,-0.0158336430232449,0.00743185230235822,-0.030400073535867,-0.0012672125106228,0.0331480092796374
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RTBDN,Retbindin,40305,-0.00577407330336114,0.00271385288818789,-0.0110932249642094,-0.000454921642512877,0.0333832070893059
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RCOR1,REST corepressor 1,40042,-0.00884111116574421,0.00416094960819182,-0.0169965723978002,-0.000685649933688243,0.0336204876793621
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,40332,-0.00619470629432669,0.00291623171610365,-0.0119105204578898,-0.000478892130763525,0.0336674876762114
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PITHD1,PITH domain-containing protein 1,37457,0.0162056323631637,0.00763256620597075,0.00124580259946104,0.0311654621268664,0.0337540857339866
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMOX1,Heme oxygenase 1,40184,-0.00923462230247019,0.00434972736352386,-0.017760087934977,-0.000709156669963427,0.0337665101725019
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,-0.00828339640338728,0.00390353450957677,-0.0159343240421577,-0.000632468764616806,0.0338513922419318
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,0.015450589807031,0.00729182549035275,0.00115861184593962,0.0297425677681224,0.0341183426695948
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,40044,-0.0130073441211065,0.00614295409469969,-0.0250475341467179,-0.000967154095495118,0.034238206605519
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TEX33,Testis-expressed protein 33,37714,0.00776681384838041,0.0036692094037029,0.000575163417122732,0.0149584642796381,0.034299298531938
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NINJ1,Ninjurin-1,39980,0.0110367336102444,0.00522944150428508,0.000787028261845596,0.0212864389586431,0.0348313025267333
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37875,0.0052967635191559,0.00251212262840488,0.000373003167482324,0.0102205238708295,0.0350078611536812
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,0.00897515592722486,0.00425838034838037,0.000628730444399331,0.0173215814100504,0.0350805531044228
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,-0.0183597471687178,0.0087155205942252,-0.0354421675333991,-0.00127732680403636,0.0351715758242075
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DXO,Decapping and exoribonuclease protein,37942,-0.00891935080701608,0.00423782859178034,-0.0172254948469056,-0.000613206767126607,0.0353360231609753
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFC,Platelet-derived growth factor C,39980,-0.00578761501997355,0.00275244927877115,-0.011182415606365,-0.000392814433582095,0.0355067873580537
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINC1,Antithrombin-III,37981,0.00286583020919528,0.00136646340686122,0.000187561931747289,0.00554409848664327,0.0359890017733073
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD101,Immunoglobulin superfamily member 2,37901,-0.00823025203362701,0.00393510021865183,-0.0159430484621846,-0.00051745560506942,0.0365022075235662
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAD1,Glutamate decarboxylase 1,37482,0.00502123864248826,0.00240317254134828,0.000311020461445625,0.0097314568235309,0.0366892094486966
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,-0.00883207540063334,0.00422846846453462,-0.0171198735911212,-0.000544277210145475,0.0367524153042775
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLHL41,Kelch-like protein 41,37959,-0.00917816876128765,0.00440419968835551,-0.0178104001504645,-0.000545937372110861,0.0371827033866342
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,-0.00970184538892588,0.00465765830142627,-0.0188308556597214,-0.000572835118130399,0.037271570921801
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPB1,Heat shock protein beta-1,40116,-0.0130627072448585,0.0062790210836786,-0.0253695885688686,-0.000755825920848488,0.0375075287475527
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37959,0.00667919209083305,0.00321736513209265,0.000373156431931445,0.0129852277497346,0.0379144871921125
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLINT1,Clathrin interactor 1,37482,0.00886227361112758,0.00426935130277259,0.000494345057693303,0.0172302021645619,0.0379330104813601
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37671,-0.0168075394132505,0.00809755042873653,-0.0326787382535741,-0.000936340572926912,0.0379472343610578
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF6,Fibroblast growth factor 6,37598,0.00828322164520107,0.00399217491231774,0.000458558817058296,0.0161078844733438,0.0380185098851577
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,-0.00569238699695214,0.00274899833725231,-0.0110804237379667,-0.000304350255937605,0.0384017050781282
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,0.00547235655367735,0.00265253342721663,0.000273391036332756,0.0106713220710219,0.0391221904868315
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLI2,Zinc finger protein GLI2,37598,0.00641901109278692,0.00312372272783647,0.000296514546227435,0.0125415076393464,0.0399061161765796
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37572,0.00718006072997655,0.00349781491621393,0.000324343494197259,0.0140357779657558,0.0401188075049954
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD177,CD177 antigen,40316,-0.0243176140298746,0.0118524201905606,-0.0475483576033734,-0.00108687045637587,0.040215177921672
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGMN,Legumain,40422,-0.00674563127329122,0.00328864825832045,-0.0131913818595993,-0.00029988068698315,0.0402650551866291
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH9,Protocadherin-9,37901,-0.00640369734045579,0.00312738233186205,-0.0125333667109054,-0.000274027970006163,0.04061641964878
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTF1,Cardiotrophin-1,40042,-0.0160605120635546,0.00784600982925577,-0.0314386913288959,-0.000682332798213253,0.0406781932662985
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCN2,Ficolin-2,40291,-0.00778882486654406,0.00380740734092116,-0.0152513432547495,-0.00032630647833859,0.0408020760985072
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PARK7,Parkinson disease protein 7,40332,-0.0101317567588383,0.00495748414859948,-0.0198484256900933,-0.000415087827583283,0.0409967384509922
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,40273,0.00638307632729076,0.00312330795729364,0.00026139273099522,0.0125047599235863,0.0410006102834464
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAMDC2,MAM domain-containing protein 2,37990,0.00642463644964553,0.00314748469171925,0.000255566453875796,0.0125937064454153,0.0412505955042343
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37572,-0.00935305482105975,0.00459524692339464,-0.0183597387909132,-0.000346370851206257,0.0418331196003884
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,37482,0.00888691305859467,0.00436731812428139,0.000326969535003149,0.0174468565821862,0.0418844230316625
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEG1,Protein LEG1 homolog,37231,0.0131658264453006,0.00647324800424427,0.000478260356981784,0.0258533925336193,0.0419840473214014
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STK4,Serine/threonine-protein kinase 4,40359,-0.0162072658061565,0.00797288219182809,-0.0318341149021395,-0.000580416710173441,0.0420894216237823
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BEX3,Protein BEX3,37482,0.00899255785398601,0.00444028906507707,0.000289591286434942,0.0176955244215371,0.0428652264469755
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,40359,-0.00596158970898418,0.00294395306777716,-0.0117317377218274,-0.000191441696140956,0.0428810772666812
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRK5,G protein-coupled receptor kinase 5,40042,-0.00988177590722265,0.00488672195862618,-0.01945975094613,-0.000303800868315329,0.0431759762413739
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37990,-0.00636594219475789,0.00315197440300693,-0.0125438120246515,-0.00018807236486431,0.0434374877419018
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39934,0.010063466147645,0.00498303830395384,0.000296711071895472,0.0198302212233945,0.04344788271315
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBLN1,Cerebellin-1,37541,0.0184155490030381,0.0091245221938454,0.00053148550310109,0.0362996125029751,0.0435857941005954
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRG2,Bone marrow proteoglycan,37998,0.00973665031757452,0.00482862822328202,0.000272538999941764,0.0192007616352073,0.0437734409974346
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMB1,Laminin subunit beta-1,37628,-0.00551365472980818,0.00273745569770522,-0.0108790678973104,-0.000148241562305937,0.0440137518866046
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,40422,-0.0162342768117154,0.00806283353922143,-0.0320374305485894,-0.000431123074841423,0.0440819075709045
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCN1,Transcobalamin-1,37766,0.00616277312751654,0.00306905466138978,0.00014742599119256,0.0121781202638405,0.0446595978157483
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,-0.0117093117897137,0.00583857190298494,-0.0231529127195641,-0.000265710859863181,0.044925367946759
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,-0.00564043704237089,0.00281759515180659,-0.0111629235399118,-0.000117950544829984,0.045316855015592
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40498,-0.00977429669549828,0.00488668128645271,-0.0193521920169456,-0.000196401374050971,0.0454964484111752
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLRX,Glutaredoxin-1,40260,-0.0104938394161468,0.00525189572715075,-0.0207875550413623,-0.000200123790931329,0.0457223717459717
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,40311,-0.0162018025531125,0.00812559272896502,-0.032127964301884,-0.000275640804341067,0.0461776142501737
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,0.00816066651629101,0.00409355949036227,0.000137289915180966,0.0161840431174011,0.0462232486112441
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EHD3,EH domain-containing protein 3,37628,-0.021641908894784,0.0108582039800244,-0.0429239886956317,-0.000359829093936174,0.046266824824851
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37562,0.00721579618225751,0.00362190653359372,0.000116859376413809,0.0143147329881012,0.0463627364047173
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP6,Gastrotropin,40017,0.0103236494507403,0.00518944972319244,0.000152327993283069,0.0204949709081974,0.0466796818584658
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,-0.00937043941640231,0.00472150931809782,-0.018624597679874,-0.000116281152930579,0.0472061656767348
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F2,Prothrombin,38013,0.00270682752472566,0.0013650465711228,3.13362453249729e-05,0.00538231880412634,0.0473924671439111
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37944,0.00406387375308001,0.00205606728467102,3.3981875124817e-05,0.0080937656310352,0.0481153842640438
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHNAK2,Protein AHNAK2,37628,-0.00525171316714243,0.0026573631801347,-0.0104601450002064,-4.32813340784221e-05,0.0481430677179068
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MB,Myoglobin,40536,-0.00900879097588975,0.00456011249185304,-0.0179466114599217,-7.09704918577855e-05,0.0482213228429619
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37562,0.0131673700516765,0.00667353968187814,8.72322751953314e-05,0.0262475078281576,0.0485084047934908
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,40359,0.00723691151368579,0.0036744856209972,3.49196965312715e-05,0.0144389033308403,0.0489126507428913
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,-0.00874331252460897,0.00444068232375018,-0.0174470498791593,-3.957517005862e-05,0.0489837021401401
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UNG,Uracil-DNA glycosylase,37900,0.00615888794584801,0.0031386650162959,7.10451390805496e-06,0.012310671377788,0.0497523989473582
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,0.0040687974065203,0.00207510766320235,1.58638664369496e-06,0.0081360084263969,0.0499239639555823
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NLGN2,Neuroligin-2,37541,0.00878878503890635,0.00449030247544948,-1.2207812974634e-05,0.0175897778907873,0.0503356278201061
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMOX2,Heme oxygenase 2,39961,-0.00826856833077943,0.00423379772374072,-0.0165668118693112,2.96752077523933e-05,0.0508386355622212
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37628,-0.0172859325405204,0.0088638454556478,-0.0346590696335901,8.72045525492429e-05,0.0511780178269575
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,-0.0181496490222911,0.00931507936747973,-0.0364072045825514,0.000107906537969164,0.0513827954544507
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39980,-0.00950340633765723,0.004878450290627,-0.0190651689072862,5.83562319716961e-05,0.0514284146549421
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL31,Interleukin-31,37598,0.0105156234662509,0.00540167085057113,-7.16514008685023e-05,0.0211028983333703,0.0515877447257893
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPME1,Protein phosphatase methylesterase 1,40305,-0.0110517456007256,0.00568627081740287,-0.0221968364028352,9.33452013839996e-05,0.0519632964679079
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RSPO1,R-spondin-1,40228,0.00638403889741848,0.00328595589144348,-5.64346498107297e-05,0.0128245124446477,0.0520550131584384
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLAMF7,SLAM family member 7,40341,-0.0103640851414511,0.00534921536039838,-0.0208485472478319,0.00012037696492974,0.0527023997465488
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,0.00743395650882086,0.00383711033933934,-8.67797562842422e-05,0.014954692773926,0.0527198965221261
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,0.0082773152380233,0.00427428847094003,-0.000100290165019149,0.0166549206410658,0.052819603068766
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGAL,Integrin alpha-L,37598,-0.00781833441656276,0.00403752999040583,-0.0157318931977582,9.52243646326605e-05,0.0528382756151504
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EXOSC10,Exosome component 10,37562,0.0112559469421374,0.00582719640122697,-0.000165358004267447,0.0226772518885423,0.0534275736590204
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,0.0102499648301197,0.00531255812590341,-0.000162649096650968,0.0206625787568904,0.0537047936934308
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,0.00399083706919857,0.00207009702788583,-6.65531054576517e-05,0.00804822724385479,0.0538946355848726
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,40357,-0.0522419974698807,0.0271408891937902,-0.105438140289709,0.000954145349948053,0.0542666010563322
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCRG1,Scrapie-responsive protein 1,37990,-0.00488884687757406,0.00254153294233048,-0.00987025144454179,9.25576893936794e-05,0.0544279510072868
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,0.00864145825874414,0.00449659288345293,-0.000171863792823594,0.0174547803103119,0.0546552097422529
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL7,Interleukin-7,40341,-0.0114438086748884,0.00596652171150953,-0.0231381912294471,0.000250573879670257,0.0551284890986366
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,0.00745428284109709,0.0038866319150614,-0.000163515712423257,0.0150720813946174,0.0551382998161679
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPM1F,Protein phosphatase 1F,37990,-0.00926734438421365,0.0048425920232463,-0.0187588247497764,0.000224135981349105,0.0556775564656132
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DKKL1,Dickkopf-like protein 1,40305,-0.015571414236736,0.00816384222279582,-0.0315725449934158,0.000429716519943843,0.0564915926661625
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PROCR,Endothelial protein C receptor,37562,0.00652705477956349,0.0034254777869385,-0.000186881682835956,0.0132409912419629,0.0567442842116448
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD55,Complement decay-accelerating factor,39802,0.00464578484378809,0.00243995804792531,-0.000136532930145513,0.00942810261772169,0.0569232741409499
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,-0.008609893418464,0.00452209894284631,-0.0174732073464428,0.000253420509514773,0.0569372660524327
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37562,0.0171623561595811,0.00901477400257365,-0.000506600885463213,0.0348313132046255,0.0569576853852482
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD82,CD82 antigen,37714,0.00739816250895801,0.00389143538724549,-0.000229050850043139,0.0150253758679592,0.0573053650251272
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUSD4,Sushi domain-containing protein 4,37900,-0.0078388047081345,0.00413122128222405,-0.0159359984212936,0.000258389005024642,0.0577893678270245
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,0.0106253976651503,0.00560916038453241,-0.000368556688533212,0.0216193520188338,0.0582080487397145
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRD2,Bromodomain-containing protein 2,37541,0.00607051830167519,0.00321131907270477,-0.000223667080826158,0.0123647036841765,0.0587331821963831
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,-0.0051695813721142,0.00273572005343079,-0.0105315926768386,0.000192429932610147,0.0588247629744886
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA6,Corticosteroid-binding globulin,38013,-0.00313325232077258,0.00165886786355203,-0.00638463333333456,0.000118128691789401,0.0589413504907477
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL28,C-C motif chemokine 28,40278,-0.0104403805566806,0.00552857562687073,-0.0212763887853472,0.000395627671986018,0.0589852454635071
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TK1,"Thymidine kinase, cytosolic",37714,-0.00783601611573143,0.00415250407028598,-0.0159749240934919,0.00030289186202909,0.0591743425258961
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMBS,Porphobilinogen deaminase,40489,-0.00793596150874214,0.00421133450147522,-0.0161901771316336,0.000318254114149289,0.0595250192152403
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GOLM2,Protein GOLM2,40471,-0.00390816146734182,0.00207699545748186,-0.00797907256400626,0.000162749629322619,0.0599027834497528
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37562,0.0124969789285433,0.00664473401755288,-0.000526699745860355,0.0255206576029469,0.0600302233440304
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP12,Macrophage metalloelastase,40346,-0.0090064637735825,0.00479304075728365,-0.0184008236578585,0.000387896110693455,0.0602530858557043
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DGCR6,Protein DGCR6,37541,-0.00791654366482353,0.00421787106136681,-0.0161835709451025,0.000350483615455414,0.0605533294275922
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA7,Carbonic anhydrase 7,37714,0.00612632875342965,0.00326516762602814,-0.000273399793585511,0.0125260573004448,0.0606404650405551
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FST,Follistatin,40396,0.00902420731385226,0.00481604241321163,-0.000415235816042527,0.0184636504437471,0.0609789334065805
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,37482,-0.0134555246618381,0.00718269682717867,-0.0275336104431083,0.000622561119432121,0.0610459042980555
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBCA,Tubulin-specific chaperone A,37671,-0.0151258328253378,0.00808143254822711,-0.0309654406198629,0.00071377496918734,0.0612733459595298
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,37541,0.0140133967246199,0.00752190448340118,-0.000729536062846418,0.0287563295120862,0.0624829899858467
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,-0.0100906577055675,0.00541709158616582,-0.0207081572144526,0.000526841803317465,0.0625166688505348
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,37541,0.0110089560685359,0.00591776091018768,-0.000589855315432002,0.0226077674525037,0.0628620300835816
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL3,C-X-C motif chemokine 3,40350,-0.0160290723086167,0.00861716220038841,-0.032918710221378,0.000860565604144561,0.0628850905136113
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37714,-0.0118398578386026,0.00636824046659073,-0.0243216091531205,0.000641893475915188,0.0630203665185244
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,-0.0058037671290036,0.00312743016305493,-0.0119335302485913,0.00032599599058407,0.0635058357012881
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,37541,0.00865119296536804,0.00466242252674343,-0.000487155187049074,0.0177895411177852,0.0635452436471319
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOH,Beta-2-glycoprotein 1,40332,-0.00610236450896718,0.00328944766778272,-0.0125496819378213,0.000344952919886949,0.0635956867524594
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK6,Kallikrein-6,40387,0.00519594417422593,0.00282068631082019,-0.000332600994981647,0.0107244893434335,0.0654812746125589
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,0.024214436614707,0.0131561861859125,-0.00157168830968143,0.0500005615390955,0.0657122833638225
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,40341,0.00586083797612618,0.00318713499590568,-0.000385946615848954,0.0121076225681013,0.0659478334690431
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,-0.00690986949417484,0.00376070264302963,-0.0142808466745129,0.000461107686163232,0.0661752102771195
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37572,-0.010506018832462,0.00572950261169622,-0.0217358439513866,0.000723806286462571,0.0667255878876881
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX9,Sorting nexin-9,40359,-0.0116667480247871,0.00636977510388062,-0.0241515072283931,0.000818011178818906,0.0670328182258678
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYBB1,Beta-crystallin B1,37990,-0.0109821048529912,0.00599806260869912,-0.0227383075660415,0.000774097860059083,0.0671311651898229
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,-0.0118122251568213,0.00645730359014589,-0.0244685401935072,0.000844089879864653,0.0673762412136704
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCNA,Proliferating cell nuclear antigen,37482,0.0106211727271517,0.00581264878472044,-0.000771618890900366,0.0220139643452038,0.0676847853729687
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWF,von Willebrand factor,40536,-0.0121242612618563,0.00663580593393531,-0.0251304408923695,0.000881918368656883,0.0677037041510379
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,-0.0129232814328485,0.00712722470829032,-0.0268926418610975,0.00104607899540055,0.0698160038351449
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40536,-0.0102496168123116,0.00565722070769897,-0.0213377693994016,0.000838535774778397,0.0700394543568106
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LCN15,Lipocalin-15,37959,-0.0107190310630967,0.00591698640878706,-0.0223163244243194,0.000878262298125928,0.0700749696532995
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYH7B,Myosin-7B,37482,0.00768041140770624,0.00424738084460913,-0.000644455047727649,0.0160052778631401,0.0705875318889454
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACRV1,Acrosomal protein SP-10,37598,0.00590751714237457,0.00326930755326359,-0.00050032566202207,0.0123153599467712,0.0707909328691625
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,-0.00791809129663468,0.00438997222342171,-0.0165224368545412,0.000686254261271876,0.071304811898567
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAT1,Diamine acetyltransferase 1,37562,0.0087345169257997,0.0048451176917699,-0.000761913750069305,0.0182309476016687,0.0714510573102157
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37562,-0.00627408754537525,0.00348248516691057,-0.01309975847252,0.000551583381769462,0.0716294162328695
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH3GLB2,Endophilin-B2,37942,-0.0111447882630183,0.00619341999970487,-0.0232838914624399,0.000994314936403212,0.0719688782597709
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,0.00819563337035439,0.00455732030686885,-0.000736714431108561,0.0171279811718173,0.0721453592314639
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX1,Peroxiredoxin-1,39953,0.0148508889440837,0.00826197865225026,-0.00134258921432684,0.0310443671024942,0.072276072629064
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37562,-0.019461499564053,0.010834996135897,-0.0406980919904113,0.00177509286230516,0.0724904326872562
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,-0.0193211706855361,0.0107654847597146,-0.0404215208145767,0.00177917944350448,0.0727186987822243
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAS6,Growth arrest-specific protein 6,40429,0.00427448375657532,0.00238194738449676,-0.000394133117038327,0.00894310063018896,0.0727469952629875
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,37482,0.0042535850624933,0.00237423975985531,-0.000399924866823104,0.0089070949918097,0.073227207984407
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,0.00574799130880409,0.00320940296156566,-0.000542438495864606,0.0120384211134728,0.0733189676272014
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37714,-0.0125930349111364,0.00703460282463653,-0.026380856447424,0.00119478662515116,0.0734516756324545
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39925,-0.0109827061259647,0.00613560909709148,-0.023008499956264,0.00104308770433457,0.0734743530674067
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHA10,Ephrin type-A receptor 10,39961,0.0108775874641356,0.00607782198271609,-0.00103494362198797,0.0227901185502591,0.0735187589743252
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PER3,Period circadian protein homolog 3,37598,-0.0195265469860244,0.0109324559979434,-0.0409541607419936,0.00190106676994471,0.0741048154591039
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,0.00705688470176176,0.00395401265518144,-0.00069298010239386,0.0148067495059174,0.0743224915741062
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDK1,Cyclin-dependent kinase 1,37482,-0.00606625140131176,0.00340049969774149,-0.0127312308088851,0.000598728006261561,0.0744584015145221
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYGD,Gamma-crystallin D,37942,-0.01580107841237,0.00887990803266304,-0.0332056981563895,0.00160354133164959,0.0751935772759041
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOLR3,Folate receptor gamma,40355,0.0304132961104079,0.0170932383934926,-0.00308945114083767,0.0639160433616535,0.0752164241067205
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SATB1,DNA-binding protein SATB1,37959,-0.00494959955088249,0.00279271880901616,-0.0104233284165542,0.000524129314789188,0.0763635059409771
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRN1,Neuritin,37959,-0.00601478431711953,0.0033975447400905,-0.0126739720076969,0.000644403373457842,0.0766942980932103
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,-0.00656601524952548,0.00371468925477218,-0.013846806188879,0.000714775689828005,0.0771541849633442
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,40044,-0.00987553106388378,0.00559411392480589,-0.0208399943565033,0.00108893222873576,0.0775256712454944
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL36A,Interleukin-36 alpha,37598,0.00966151242082592,0.00548695438336155,-0.00109291817056271,0.0204159430122146,0.0782929418297418
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,-0.00904626401674926,0.00513869361478211,-0.0191181035017222,0.00102557546822368,0.0783561638149748
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRADD,Death domain-containing protein CRADD,40192,-0.0124896504975552,0.00709537398677513,-0.0263965835116344,0.0014172825165241,0.0783844072197177
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PARD3,Partitioning defective 3 homolog,37714,-0.0120719404707218,0.00688403505168912,-0.0255646491720325,0.00142076823058884,0.0795197635346321
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPR15L,Protein GPR15L,37901,-0.00978339833674591,0.00557947280984148,-0.0207191650440352,0.00115236837054338,0.0795453683121232
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSNL1,Visinin-like protein 1,37942,-0.00604854588295874,0.00346564772382443,-0.0128412154216546,0.00074412365573714,0.0809578944707561
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMIGO2,Amphoterin-induced protein 2,40305,0.00365083813730692,0.00209240530586171,-0.000450276262182032,0.00775195253679588,0.0810382872169089
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP7,Matrilysin,40015,-0.00780985160352066,0.00448088585360614,-0.0165923878765887,0.000972684669547371,0.0813663248155788
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSTN,Growth/differentiation factor 8,40042,0.00827702835815475,0.00474925788671089,-0.00103151709979859,0.0175855738161081,0.0813874737490225
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN3,CCN family member 3,40522,-0.00545005850433874,0.00313294559898926,-0.0115906318783577,0.000690514869680206,0.0819491913716214
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,0.00482018473323914,0.0027876945773358,-0.000643696638339022,0.0102840661048173,0.0838159307847746
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTF3,Neurotrophin-3,40341,0.00560065086534507,0.00323947339065481,-0.00074871698033836,0.0119500187110285,0.0838505455909052
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,0.008386976582903,0.00485325995451994,-0.00112541292795609,0.0178993660937621,0.083991682819329
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNLR1,Interferon lambda receptor 1,40341,-0.00596512699195085,0.00346532017753297,-0.0127571545399155,0.000826900556013766,0.0852016627706253
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,0.0067165869300523,0.0039043994003471,-0.000936035894628012,0.0143692097547326,0.0854085006954216
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDSN,Corneodesmosin,40456,0.0068826841481537,0.00400161082354036,-0.000960473065985413,0.0147258413622928,0.0854557022358162
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,37482,0.00580718511393442,0.00338463350217042,-0.000826696550319615,0.0124410667781884,0.0862315712299203
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LMNB1,Lamin-B1,37874,0.00903193814836325,0.00527413956253493,-0.00130537539420522,0.0193692516909317,0.086828564455206
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37671,-0.00850763154042807,0.00496857240314668,-0.0182460334505956,0.00123077036973943,0.0868668883260952
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37901,0.00688935909076428,0.00402647992173164,-0.00100254155582973,0.0147812597373583,0.0871017910216893
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCD1,Programmed cell death protein 1,40455,0.0069281944251182,0.00405558793739196,-0.00102075793217005,0.0148771467824064,0.0875985497984264
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRTN,Neurturin,40044,-0.00785746428866909,0.00459972967393791,-0.0168729344495874,0.00115800587224922,0.0876108335655458
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SWAP70,Switch-associated protein 70,37901,-0.0055546991173268,0.00325317197147063,-0.0119309161814092,0.000821517946755636,0.0877574914828833
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",40042,-0.0147280903145407,0.00863516054795136,-0.0316530049885254,0.00219682435944399,0.0881033519110586
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMOTL2,Angiomotin-like protein 2,37855,-0.00758280684477738,0.00445051157362886,-0.01630580952909,0.00114019583953519,0.0884405791857893
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRCAM,Neuronal cell adhesion molecule,40359,0.00442139115057681,0.00259677801463796,-0.000668293758113592,0.00951107605926722,0.0886540569203681
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37959,-0.00618863083444516,0.00363842994994879,-0.0133199535363448,0.000942691867454464,0.088983477095386
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37598,-0.00606994858708918,0.00357122720731598,-0.0130695539134285,0.000929656739250136,0.0892145201684062
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,0.00778728910317207,0.0045949683792739,-0.00121884892020477,0.0167934271265489,0.0901479915698807
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,0.0159692213545631,0.00942990885099945,-0.00251339999339587,0.034451842702522,0.0903901336277968
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,0.00744497842934306,0.004399359050401,-0.0011777653094429,0.016067722168129,0.0906142687803338
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRSF1,G-rich sequence factor 1,37402,-0.0123822921623345,0.00732025915540856,-0.0267300001069353,0.0019654157822663,0.0907634843408844
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TYMP,Thymidine phosphorylase,40257,-0.0104457323111196,0.00618609347065935,-0.0225704755136119,0.0016790108913727,0.0913190965075293
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39961,0.00629713009918589,0.00373176617010477,-0.00101713159421945,0.0136113917925912,0.0915389588361177
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNL1,Interferon lambda-1,39961,-0.0071051999678034,0.00421468556695065,-0.0153659836790267,0.00115558374341988,0.0918506472811397
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37562,-0.00599125569252764,0.00355519592048008,-0.0129594396966686,0.000976928311613327,0.0919716463318137
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,0.00791775513010603,0.00469877271923416,-0.00129183939959293,0.017127349659805,0.0919988331883764
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLVRB,Flavin reductase,40332,-0.0103240538725077,0.00615034610617586,-0.0223787322406124,0.00173062449559697,0.0932470732003263
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RRP15,RRP15-like protein,37541,0.0142109613235631,0.00847525219376329,-0.00240053297621296,0.0308224556233391,0.0936133608154905
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,40182,0.0044552940669685,0.00266142365711925,-0.00076109630098524,0.00967168443492224,0.0941452475405904
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MANSC4,MANSC domain-containing protein 4,37562,0.0102006217991896,0.00609378355616489,-0.00174319397089361,0.0221444375692727,0.0941664480076771
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,-0.00634956664532344,0.00379369846035483,-0.0137852156276189,0.00108608233697203,0.0942066235252634
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,0.0122966215221376,0.00737795160572957,-0.00216416362509236,0.0267574066693676,0.0956036163321431
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37959,0.00543232772063816,0.00326243734024734,-0.000962049466246621,0.0118267049075229,0.0959133510943268
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,0.00431603773159901,0.00259244345587011,-0.000765151441906412,0.00939722690510443,0.095961655026946
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1R,Complement C1r subcomponent,38013,0.00307162060552439,0.00184755779732772,-0.000549592677237929,0.00669283388828672,0.0964296268931983
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,0.0111068978555686,0.00668912672899788,-0.00200379053326727,0.0242175862444044,0.0968454121080737
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TST,Thiosulfate sulfurtransferase,39923,-0.0116784488420923,0.0070409310975457,-0.0254786737932818,0.0021217761090973,0.0972063685132325
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,-0.00953896078573109,0.00575209878955256,-0.0208130744132541,0.00173515284179193,0.0972717762515087
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH23,Cadherin-23,37942,0.00406090752506903,0.00244903196148261,-0.000739195119436878,0.00886101016957494,0.0973067212635949
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HRAS,GTPase Hras,37697,0.0151700752046182,0.00915111301545468,-0.00276610630567295,0.0331062567149094,0.0973956435388166
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDHB15,Protocadherin beta-15,37900,-0.00617727091913978,0.00373092309193719,-0.0134898801793367,0.00113533834105712,0.0978069210734735
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,-0.00451634729686823,0.00273099332183395,-0.00986909420766278,0.000836399613926315,0.0982040060435703
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,-0.0125988825138168,0.00763239524492488,-0.0275583771938696,0.00236061216623598,0.098821600992902
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37598,0.00454019434194966,0.00275682279063544,-0.000863178327695802,0.00994356701159513,0.0996037796048954
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTN6,Dynactin subunit 6,39961,-0.0108200994407898,0.00657078281123862,-0.0236988337508175,0.00205863486923793,0.0996402543670674
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37942,-0.00334111121878827,0.00203157939867892,-0.00732300684019895,0.000640784402622408,0.100078091353616
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEFL,Neurofilament light polypeptide,39903,-0.00651062917930357,0.00396808977039751,-0.0142880851292827,0.00126682677067556,0.100870414115086
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDHR1,Cadherin-related family member 1,39961,-0.00670240084878895,0.00408726873239163,-0.0147134475642765,0.00130864586669865,0.101062073587998
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THBD,Thrombomodulin,40359,-0.00422243667319426,0.00257501980782601,-0.00926947549653325,0.000824602150144727,0.101073059066159
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,-0.0179934113607329,0.0109999993339142,-0.0395534100552048,0.00356658733373903,0.10190853480274
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CERT,Ceramide transfer protein,39961,-0.00928272054797438,0.00571042159477727,-0.0204751468737378,0.00190970577778907,0.104060342195736
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD84,SLAM family member 5,40341,-0.00463178323573524,0.00285314470283143,-0.0102239468532848,0.000960380381814356,0.104524651314633
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,-0.00550168255864115,0.00339563459883731,-0.0121571263723623,0.00115376125507997,0.10520858699013
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,40278,0.00384569518015033,0.00237403777032889,-0.000807418849694294,0.00849880920999495,0.105274462698937
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37900,-0.00793519696942201,0.00490222071976718,-0.0175435495801657,0.00167315564132167,0.105536494035163
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,40357,0.00595821164128579,0.00368790069714807,-0.00127007372512443,0.013186497007696,0.106198354064948
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAS2,Growth arrest-specific protein 2,37714,-0.00801527230108074,0.00496482493803148,-0.0177463291796224,0.00171578457746097,0.106461908986424
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APRT,Adenine phosphoribosyltransferase,40216,-0.00725471326036985,0.00449433429411861,-0.0160636084768423,0.00155418195610263,0.106506052124207
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,-0.00913501846931602,0.00566697947570009,-0.0202422982416882,0.00197226130305616,0.106991666453717
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,0.00497795507057357,0.00309313588356971,-0.00108459126122305,0.0110405014023702,0.10756195823996
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPB2,Carboxypeptidase B2,37981,0.00333431768627173,0.00207306517226422,-0.000728890051366134,0.00739752542390959,0.107770970774515
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37562,-0.00704067813603358,0.00437786707941767,-0.0156212976116922,0.00153994133962505,0.107805846026408
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,0.00787105210003881,0.00489622043022751,-0.00172553994320712,0.0174676441432847,0.107951900365383
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,0.00539052062487737,0.00335670560750553,-0.00118862236583347,0.0119696636155882,0.108320813309217
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD2,T-cell surface antigen CD2,37562,-0.00567281474851052,0.00354184788092425,-0.0126148365951221,0.001269207098101,0.109256240340531
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37901,-0.0144814353848707,0.00904518873234983,-0.0322100053002763,0.00324713453053499,0.109398245706025
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37562,-0.0150036932139078,0.00938234778834576,-0.0333930948790655,0.00338570845124988,0.10981346422997
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGLON5,IgLON family member 5,37482,0.0139788715549952,0.00875756542990149,-0.00318595668761168,0.0311436997976022,0.110467235787142
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37942,0.00489167257606249,0.00306597062041244,-0.00111762983994588,0.0109009749920709,0.110629983994936
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL9,Interleukin-9,37714,0.00850479918173531,0.00534292243666111,-0.00196732879412047,0.0189769271575911,0.11145620765043
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37942,-0.00553902032806425,0.00348097787286404,-0.0123617369588778,0.00128369630274927,0.111582295187173
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,0.0044613357542212,0.00280437777666501,-0.00103524468804223,0.00995791619648463,0.111668289408663
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNL1,Thioredoxin-like protein 1,37525,-0.0140584388648263,0.00886147420891458,-0.0314269283142989,0.00331005058464628,0.112657534840011
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,0.00464306825696716,0.00295024051499788,-0.00113940315242868,0.010425539666363,0.115559413171304
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP1,Caspase-1,39961,-0.00980228317980367,0.00625018640000146,-0.0220526485238065,0.0024480821641992,0.116827213501817
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,-0.00538278395825369,0.00343710415770469,-0.0121195081073549,0.0013539401908475,0.117349550967622
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFIC,Nuclear factor 1 C-type,37959,-0.00632708458527661,0.00404373360153584,-0.0142528024442869,0.00159863327373364,0.117685129356427
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HLA_A,,37959,0.00474341269875856,0.00303238942221881,-0.00120007056879031,0.0106868959663074,0.11778248619636
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,40341,-0.00476883274213493,0.00304983986146586,-0.010746518870608,0.00120885338633815,0.117923503700271
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM5,Intercellular adhesion molecule 5,40359,0.00638814368809565,0.00409500926446805,-0.00163807447026173,0.014414361846453,0.118783858463437
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37572,0.00522660804130309,0.00335250567993361,-0.00134430309136678,0.011797519173973,0.119016850783265
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VIT,Vitrin,37990,0.00532351959735633,0.00341493882019728,-0.00136976049023035,0.012016799684943,0.119045402886964
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAPPA,Pappalysin-1,40044,0.00679722138666591,0.00436899486619924,-0.00176600855108461,0.0153604513244164,0.119779265829503
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37572,0.0052097658300461,0.00334938618649887,-0.00135503109549169,0.0117745627555839,0.119865676932087
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB116,Beta-defensin 116,37541,0.0114145757102284,0.00735457281478105,-0.00300038700674248,0.0258295384271992,0.120677333739099
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37628,-0.0118975897960218,0.00767127678593133,-0.0269332922964472,0.00313811270440366,0.120943212048496
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP73,Tumor protein p73,37572,0.00503322260544007,0.00325159768657098,-0.00133990886023905,0.0114063540711192,0.121664973571738
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37628,-0.0376683351097335,0.0243979226178685,-0.0854882634407557,0.0101515932212888,0.12263277843519
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37714,0.00540348880919081,0.00350185524653144,-0.00146014747401082,0.0122671250923924,0.122845894311529
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB5,Integrin beta-5,40411,-0.0052963239967105,0.00343376463347223,-0.0120265026783161,0.00143385468489508,0.122990207111284
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,-0.00673641886718395,0.00437230100250616,-0.015306128832096,0.00183329109772812,0.123409446750817
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPMT,Thiopurine S-methyltransferase,39980,-0.0105525001672344,0.0068633918837345,-0.024004748259354,0.00289974792488524,0.124190037275291
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC1A4,Neutral amino acid transporter A,37572,-0.00750848979285822,0.00488511308059859,-0.0170833114308315,0.00206633184511502,0.124313865378663
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37942,0.00567341191352807,0.00369617825706768,-0.00157109747032458,0.0129179212973807,0.124822014565001
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,-0.00937520399619618,0.00611950219409142,-0.0213694282966154,0.00261902030422299,0.125541457299664
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,0.01357790387759,0.0088702053369397,-0.00380769858281182,0.0309635063379918,0.125860009009379
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37671,-0.0177456973129657,0.011610794054547,-0.0405028536598777,0.00501145903394637,0.126442317381913
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POMC,Pro-opiomelanocortin,37628,0.00965492038822763,0.00632681497384179,-0.00274563696050228,0.0220554777369575,0.127025965236204
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOLR2,Folate receptor beta,40471,0.00415900992415825,0.00272872704177813,-0.00118929507772689,0.00950731492604339,0.127489099854431
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,-0.0155388406044482,0.0102348927983656,-0.0355992304892448,0.00452154928034847,0.128978208788435
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,0.0058107807429026,0.00382749437524131,-0.00169110823257037,0.0133126697183756,0.128995805856276
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,0.0133360598712031,0.00878749878516458,-0.00388743774771953,0.0305595574901256,0.129134418158155
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,0.0127358479930148,0.008409160189839,-0.00374610597906968,0.0292178019650992,0.129917202214217
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOA1,Apolipoprotein A-I,38013,-0.00387177648296605,0.0025596448742924,-0.00888868043657916,0.00114512747064706,0.130398873070418
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39961,-0.00575378187894213,0.00380734853805892,-0.0132161850135376,0.00170862125565335,0.130750065028095
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NMI,N-myc-interactor,37857,0.0100112055896268,0.00662851420401049,-0.00298068225023378,0.0230030934294873,0.13098428304948
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,0.00808451976119487,0.00535617172862281,-0.00241357682690583,0.0185826163492956,0.131224824110974
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37628,-0.012129507510946,0.00803916624176117,-0.0278862733447979,0.00362725832290591,0.131373449149075
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP9,Fatty acid-binding protein 9,40341,0.00781205013622552,0.00518005407152746,-0.00234085584396831,0.0179649561164194,0.131548294180475
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,37482,0.00791333625048301,0.00524810741071817,-0.0023729542745246,0.0181996267754906,0.131618263967036
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,-0.00735697447781707,0.00489404687698004,-0.0169493063566979,0.0022353574010638,0.132798633419089
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39961,0.00779321734391994,0.00520248453385496,-0.00240365234243579,0.0179900870302757,0.134158820518485
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB118,Beta-defensin 118,37541,0.00811392088893017,0.0054175446336809,-0.00250446659308439,0.0187323083709447,0.13423224124327
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,0.00896487127832532,0.00599238537160705,-0.00278020405002449,0.0207099466066751,0.134666024419947
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37714,-0.0059557039275592,0.00399343808268596,-0.0137828425696237,0.00187143471450528,0.135887495950175
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,-0.00574169063873379,0.00385104781155742,-0.0132897443493863,0.00180636307191874,0.136000545107604
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOA2,Apolipoprotein A-II,37987,-0.00657334160285344,0.00441526863668759,-0.0152272681307611,0.00208058492505423,0.136569923698781
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTB,Lymphotoxin-beta,37900,0.00485735638885797,0.00328074202784289,-0.00157289798571409,0.01128761076343,0.138745583325475
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APPL2,DCC-interacting protein 13-beta,37671,-0.0153123200004711,0.0103510018240787,-0.0356002835756653,0.00497564357472304,0.139081839650232
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39980,0.00453802766494841,0.00307294430853219,-0.00148494317977467,0.0105609985096715,0.139757955324841
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37598,-0.0107670089344793,0.00730547398918666,-0.0250857379532851,0.0035517200843266,0.140551969043629
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37572,0.0114469814356824,0.00777497961578869,-0.00379197861126344,0.0266859414826282,0.140968072641061
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDIA2,Protein disulfide-isomerase A2,37482,0.00568900712354163,0.00386617264697524,-0.00188869126452984,0.0132667055116131,0.141184705487907
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37987,-0.00477636577007671,0.00324775838531914,-0.0111419722053022,0.00158924066514879,0.141404883404062
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHB6,Ephrin type-B receptor 6,40192,-0.00425757633902575,0.00289536382059881,-0.00993248942739942,0.00141733674934793,0.141451624199706
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,0.0155044840275581,0.0105622603500785,-0.00519754625859572,0.036206514313712,0.142151019512395
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNLY,Granulysin,40332,0.00688905631674243,0.00470680447166707,-0.00233628044772503,0.0161143930812099,0.143312768177467
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXK,Tyrosine-protein kinase TXK,37714,0.0103212761430204,0.00705187926798539,-0.00350040722223097,0.0241429595082718,0.143321326509438
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RSPO3,R-spondin-3,40489,-0.0038722626702707,0.00264764067233956,-0.00906163838805623,0.00131711304751483,0.143614719990853
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RYR1,Ryanodine receptor 1,37562,0.00468637579493659,0.00320545767142888,-0.00159632124106401,0.0109690728309372,0.143765462947048
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TEK,Angiopoietin-1 receptor,40411,0.00290387124366226,0.0019946059562784,-0.0010055564306434,0.00681329891796792,0.145450411827025
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,-0.0073557346605334,0.00506241816060338,-0.017278074255316,0.00256660493424923,0.146244834179995
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,-0.00422211352099242,0.00291204993690354,-0.00992973139732337,0.00148550435533852,0.147116745748221
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,0.00878031450655172,0.00606201820425228,-0.00310124117378274,0.0206618701868862,0.14752514150218
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,0.00933003784643736,0.00645432998849816,-0.00332044893101903,0.0219805246238938,0.148327908895028
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37959,-0.0167975985689065,0.0116244738202645,-0.0395815672566249,0.00598637011881188,0.148475432191301
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PMS1,PMS1 protein homolog 1,37572,-0.00697809849889337,0.00483214804707573,-0.0164491086711618,0.00249291167337506,0.148735104665905
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ST13,Hsc70-interacting protein,37671,-0.00762791949120186,0.00528491868932531,-0.0179863601222795,0.00273052113987575,0.148949215147069
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYOM1,Myomesin-1,37541,0.00627721879883081,0.00435049664927754,-0.00224975463375316,0.0148041922314148,0.149079878934698
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,-0.00904936003290683,0.00629211822639701,-0.021381911756645,0.0032831916908313,0.150395863443005
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MN1,Transcriptional activator MN1,37572,0.00797326285146717,0.00554815975940211,-0.00290113027696097,0.0188476559798953,0.150713301879154
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARG1,Arginase-1,40227,0.00702636440882938,0.00489349713588671,-0.00256488997750858,0.0166176187951673,0.151062731447739
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,-0.00718783246103463,0.00501265177305756,-0.0170126299362275,0.0026369650141582,0.151613018084825
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERVV_1,,37562,0.00640901154786684,0.00448417935101568,-0.00237997998012389,0.0151980030758576,0.15295633284397
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANK2,Ankyrin-2,37562,0.00983099016660821,0.00688731605577274,-0.00366814930270637,0.0233301296359228,0.153486974871147
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNU13,NHP2-like protein 1,37562,-0.00825094254523524,0.00578065498479934,-0.0195810263154419,0.00307914122497147,0.153506607622503
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTF,Ciliary neurotrophic factor,37541,0.00448641869213056,0.00314892430538231,-0.00168547294641876,0.0106583103306799,0.154254351916003
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37978,-0.00635702466134785,0.00447464477414885,-0.0151273284186796,0.0024132790959839,0.155433749415028
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MIA,Melanoma-derived growth regulatory protein,40411,0.00486606214408672,0.00342651925221351,-0.00184991559025175,0.0115820398784252,0.155592824753382
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,-0.00554705055824876,0.00392704436731212,-0.0132440575181805,0.00214995640168299,0.157818887798179
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TEF,Thyrotroph embryonic factor,37562,0.00562494512183554,0.00399403523880156,-0.00220336394621552,0.0134532541898866,0.159055202154278
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,-0.00481381382095725,0.00341852664329176,-0.0115141260418091,0.0018864983998946,0.159108429910475
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL3,Interleukin-3,37482,0.00787167222357093,0.00559716106273855,-0.00309876345939663,0.0188421079065385,0.159638512071485
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIF22,Kinesin-like protein KIF22,37562,-0.0159130511416203,0.0113174902915393,-0.0380953321130373,0.00626922982979677,0.159730514250683
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA11,Annexin A11,40312,-0.00875705904162372,0.00623549887574955,-0.0209786368380928,0.0034645187548454,0.160222960837493
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,-0.0073407183626635,0.00523121204627205,-0.0175938939733567,0.00291245724802972,0.16056417566093
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOP56,Nucleolar protein 56,37562,0.0143971251949639,0.0102627671383493,-0.00571789839620083,0.0345121487861286,0.160685187130887
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYH4,Myosin-4,37562,0.00618237538678176,0.00441362262815613,-0.00246832496440426,0.0148330757379678,0.161312954543935
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37628,-0.00690231919788406,0.00492803457426683,-0.016561266963447,0.00275662856767893,0.161350350108169
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LBP,Lipopolysaccharide-binding protein,40403,0.00756960350288944,0.00540656609689326,-0.00302726604702135,0.0181664730528002,0.161510006686923
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,-0.00841523105228766,0.0060137916729037,-0.0202022627311789,0.00337180062660359,0.161739983136053
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,0.00548233051422408,0.00395321314324353,-0.00226596724653323,0.0132306282749814,0.165524522143806
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLNK,B-cell linker protein,37598,-0.00491760588183793,0.00354930616851192,-0.0118742459721213,0.00203903420844544,0.165919506449256
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,0.00905836709746359,0.00654654409409968,-0.00377285932697179,0.021889593521899,0.166477914021409
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,37541,0.0101055684619681,0.0073053585683483,-0.0042129343319946,0.0244240712559308,0.166593724062096
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENO1,Alpha-enolase,40299,0.0101586417216128,0.00734863595725056,-0.00424468475459828,0.0245619681978239,0.166873101227764
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37990,0.00319478937871325,0.00231344218402742,-0.00133955730198051,0.007729136059407,0.16731162794491
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA2,Carbonic anhydrase 2,40291,-0.00903247598117536,0.00654846917192823,-0.0218674755581547,0.00380252359580396,0.167813634668925
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL4,Interleukin-4,40044,-0.0115116555131392,0.00834882866884855,-0.0278753597040823,0.00485204867780399,0.167965474036124
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,-0.00577472895585459,0.00419244019187597,-0.0139919117319315,0.00244245382022232,0.168406978873861
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,0.00433847973422412,0.00314987955644239,-0.00183528419640296,0.0105122436648512,0.168428289563412
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,37541,0.00904685424928331,0.00659761128924483,-0.00388446387763655,0.0219781723762032,0.170326223254928
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,40283,0.00409620649334475,0.00298996908102671,-0.00176413290546761,0.0099565458921571,0.170711670357899
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37562,0.00662954841451307,0.00484220050475049,-0.0028611645747979,0.016120261403824,0.170985554080819
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPL,Periplakin,37598,-0.00417980245042073,0.00305679731735443,-0.0101711251924354,0.00181152029159395,0.171529714766721
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX2,Peroxiredoxin-2,37763,0.00796416509809392,0.00582811736030627,-0.00345894492810638,0.0193872751242942,0.171802863021739
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FXN,"Frataxin, mitochondrial",40489,0.00933613900636166,0.00684723719174923,-0.00408444588946682,0.0227567239021902,0.172747293405773
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLGAP5,Disks large-associated protein 5,37959,0.0067937316670471,0.00498555584490927,-0.00297795778897507,0.0165654211230693,0.173005189847974
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WNT9A,Protein Wnt-9a,40044,0.00362446491595592,0.00266380941908839,-0.00159660154545731,0.00884553137736916,0.173649612529606
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COPB2,Coatomer subunit beta',37562,-0.00543680254823848,0.00400073623710133,-0.0132782455729571,0.00240464047648012,0.174185649654267
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,37482,0.0080044772276429,0.00590307911220104,-0.00356555783227115,0.0195745122875569,0.175127950995493
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",40293,0.00725375883293048,0.00536746440306804,-0.00326647139708287,0.0177739890629438,0.176576645029692
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBC1D17,TBC1 domain family member 17,39961,-0.00576690388279536,0.00427454612011055,-0.014145014278212,0.00261120651262132,0.17731600078903
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STXBP1,Syntaxin-binding protein 1,37959,0.00963271138014318,0.00716058450719143,-0.00440203425395202,0.0236674570142384,0.178570025716973
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD14,Monocyte differentiation antigen CD14,40048,0.00518970681178613,0.00385906491526661,-0.00237406042213641,0.0127534740457087,0.178706346816711
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCC,Netrin receptor DCC,37572,0.00290834164946928,0.00217124912475946,-0.00134730663505926,0.00716398993399781,0.180438131802866
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL22,C-C motif chemokine 22,40204,-0.00638199995986853,0.00476603482613846,-0.0157234282190999,0.00295942829936285,0.180570916332441
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNPY4,Protein canopy homolog 4,40305,-0.0092752077786049,0.00693181913610493,-0.0228615732853706,0.00431115772816077,0.180895230713817
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOST,Sclerostin,40330,-0.00478820899211668,0.00358448107550223,-0.011813791900101,0.00223737391586769,0.181628401983959
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39961,-0.00652940289595079,0.00489402553557825,-0.0161216929456842,0.00306288715378258,0.182171698654014
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37901,0.0101513124087126,0.00762924897459319,-0.00480201558149003,0.0251046403989153,0.183350397036536
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPM1A,Protein phosphatase 1A,39980,0.00381842691256367,0.0028809494208843,-0.00182823395236954,0.00946508777749689,0.185056112609106
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,37541,0.00697447331752016,0.00527157807324627,-0.00335781970604253,0.0173067663410829,0.185847417050068
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,0.0060304648195732,0.00456396659346746,-0.00291490970362302,0.0149758393427694,0.186417420115647
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,0.00538320985766,0.00407802643198937,-0.00260972194903917,0.0133761416643592,0.18683988721198
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,-0.00756479884184324,0.00573979669387552,-0.0188148003618393,0.00368520267815277,0.187540702467747
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,-0.00393815897900404,0.00298998932757253,-0.0097985380610462,0.00192222010303812,0.187819375467495
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDAC9,Histone deacetylase 9,37541,0.00775607473452271,0.00589632513904947,-0.00380072253801425,0.0193128720070597,0.18839577548318
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GKN1,Gastrokine-1,39602,-0.00341717345881412,0.00259817348366343,-0.00850959348679444,0.00167524656916619,0.188455398374837
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VCAM1,Vascular cell adhesion protein 1,40372,-0.00330144295259634,0.00251070754202492,-0.00822242973496518,0.0016195438297725,0.188547244470971
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37572,0.0123564530432476,0.00944126032044702,-0.00614841718482851,0.0308613232713238,0.190634665413633
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,37541,0.00917899804634315,0.00702583554939602,-0.00459163963047306,0.0229496357231593,0.191417922669703
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDAN1,Codanin-1,37942,0.00280967303745531,0.00215165694640983,-0.00140757457750797,0.00702692065241858,0.19163661902316
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MLLT1,Protein ENL,37482,0.00868122056550181,0.00666065547187607,-0.00437366415937528,0.0217361052903789,0.192475496318471
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37562,0.00462496081420158,0.00354913650093319,-0.00233134672762748,0.0115812683560306,0.192555715459274
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NID1,Nidogen-1,40355,-0.00477699313712457,0.00367293610688446,-0.0119759479066181,0.00242196163236897,0.19341682327443
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JCHAIN,Immunoglobulin J chain,40044,0.00745571755225477,0.00573807284578305,-0.00379090522548001,0.0187023403299896,0.193845887673087
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,-0.00455554907090851,0.00350722724171139,-0.0114297144646628,0.00231861632284582,0.19399928667968
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,0.00826016819905906,0.00636307892920509,-0.00421146650218292,0.020731802900301,0.194261904000431
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,-0.00604611673722015,0.00466261693041387,-0.0151848459208313,0.00309261244639104,0.194749195265601
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,0.00459089936595795,0.00354258007132491,-0.00235255757383889,0.0115343563057548,0.195025959573932
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,-0.0142629329417046,0.0110467525488455,-0.0359145679374419,0.00738870205403267,0.196673024917853
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37562,0.00466111259481286,0.00361199575066016,-0.00241839907648105,0.0117406242661068,0.19691600190764
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37562,-0.00481957191344369,0.00373900531086364,-0.0121480223227364,0.00250887849584904,0.19742138161495
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,0.00460737266415582,0.00357709003900911,-0.00240372381230203,0.0116184691406137,0.197756910564312
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TLR1,Toll-like receptor 1,37598,-0.00312804453325668,0.00242877862298298,-0.00788845063430331,0.00163236156778996,0.197800500490038
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,-0.0103783755229803,0.00809063072078142,-0.0262360117357119,0.00547926068975128,0.199596941600939
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37628,0.00447490218612933,0.00349156121803453,-0.00236855780121835,0.011318362173477,0.199993759085236
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39980,-0.00911204281048335,0.007120309379205,-0.0230678491937251,0.00484376357275844,0.200660746934259
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP1B4,Protein ATP1B4,37482,0.00502937084867953,0.00393065165021855,-0.00267470638574884,0.0127334480831079,0.20073468466316
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOP1,DNA topoisomerase 1,37901,-0.0126339799745192,0.00988856528922951,-0.0320155679414091,0.00674760799237061,0.201400104829368
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,40411,-0.00321392206009279,0.00251907734644079,-0.00815131365911674,0.00172346953893117,0.202033120938325
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HRG,Histidine-rich glycoprotein,37934,-0.00373033098458745,0.00292703650081308,-0.00946732252618109,0.0020066605570062,0.202529660565417
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,40042,-0.00589286051777768,0.00462931206191288,-0.0149663121591269,0.00318059112357156,0.203056474158168
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALMS1,Alstrom syndrome protein 1,37714,0.00532992304191962,0.00418828881513089,-0.00287912303573692,0.0135389691195762,0.20319023780399
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37959,-0.00867993133118671,0.00683733305507666,-0.022081104119137,0.00472124145676354,0.204287946134882
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,40411,-0.00296791508765863,0.00233876189689794,-0.00755188840557858,0.00161605823026133,0.204455569857935
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YY1,Transcriptional repressor protein YY1,37598,0.00330538367378855,0.00260612558230926,-0.0018026224675376,0.00841338981511469,0.204708557942441
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM171B,Protein FAM171B,37900,0.00324565069643012,0.00256457453732376,-0.00178091539672444,0.00827221678958468,0.205688704833136
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,0.00823002983036712,0.0065129982032854,-0.00453544664807227,0.0209955063088065,0.206380628816213
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40453,-0.0077365881587594,0.00612747037145201,-0.0197464300868053,0.00427325376928655,0.206748782202561
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,-0.00667103806058252,0.00528501425937287,-0.0170296660089534,0.00368758988778831,0.206875838431051
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39978,-0.00573837912649704,0.00455423508008914,-0.0146646798834718,0.00318792163047768,0.207684900363558
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,40305,-0.00247245104121288,0.00196244985052132,-0.00631885274823468,0.00137395066580891,0.207731251818529
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,0.00608223949824062,0.00482777080279049,-0.00338019127522874,0.01554467027171,0.207747963894331
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSG3,Desmoglein-3,40419,0.00390567456123559,0.00310339646515722,-0.00217698251047255,0.00998833163294374,0.2082235526318
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C7,Complement component C7,37678,0.00368546257555059,0.00292963371923325,-0.00205661951414659,0.00942754466524777,0.208416019535521
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37901,-0.00628956267695941,0.0050037652871789,-0.01609694263983,0.00351781728591123,0.208787788130577
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLTA,Clathrin light chain A,40042,-0.0055317478824818,0.00440168269551881,-0.0141590459656987,0.00309555020073507,0.208868506363688
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,0.0147663658086751,0.0117521912307889,-0.00826792900367116,0.0378006606210214,0.208961740084201
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLL4,Delta-like protein 4,37628,-0.00983428295371934,0.00783063711135199,-0.0251823316919692,0.00551376578453056,0.209184416053533
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAFB2,Scaffold attachment factor B2,37959,-0.00322241343523825,0.00256733217533565,-0.00825438449889612,0.00180955762841962,0.209442287493965
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,40203,-0.00461748770657826,0.00367929433172965,-0.0118289045967684,0.00259392918361186,0.209500012168201
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLKB1,Plasma kallikrein,37721,-0.00293372464059159,0.0023397423105896,-0.0075196195693472,0.00165217028816403,0.20991260140261
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,0.00850960164134224,0.00678976642756732,-0.0047983405566897,0.0218175438393742,0.210119611681059
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCUN1D1,DCN1-like protein 1,37541,0.00870809049894263,0.0069523377871577,-0.00491849156388647,0.0223346725617717,0.210395051996469
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,0.00587210049753275,0.00469466051568042,-0.00332943411320087,0.0150736351082664,0.211028326098521
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACYP1,Acylphosphatase-1,37622,-0.00766918352308685,0.00613438179383043,-0.0196925718389945,0.00435420479282079,0.211249936206558
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,0.00277587227266247,0.00222074735131921,-0.00157679253592317,0.00712853708124811,0.211328184055198
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,40192,0.00275138668578536,0.00220400456796113,-0.00156846226741846,0.00707123563898918,0.211918559082369
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,0.00310781549046533,0.00249255120936232,-0.00177758487988481,0.00799321586081547,0.212477358451312
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LMOD1,Leiomodin-1,37959,0.00418358701298161,0.00335978133128543,-0.00240158439633784,0.0107687584223011,0.213081233542994
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH4,Cadherin-4,37541,0.00572463307262328,0.004604703094261,-0.00330058499212829,0.0147498511373748,0.213811115331146
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAM,Signal transducing adapter molecule 1,37900,-0.00430000763270147,0.00347304587266,-0.0111071775431151,0.00250716227771213,0.215697444257381
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OMP,Olfactory marker protein,37541,0.00582398552345927,0.00470927035698135,-0.00340618437622416,0.0150541554231427,0.216218233185739
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSCA,Prostate stem cell antigen,37901,-0.0297687801051742,0.0240810256960609,-0.0769675904694536,0.0174300302591053,0.216408657220395
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PMVK,Phosphomevalonate kinase,39951,-0.0126793586538637,0.0102821951553054,-0.0328324611582623,0.00747374385053493,0.217543235070676
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37671,-0.00291949418010071,0.00237136211014105,-0.00756736391597717,0.00172837555577574,0.218289977208222
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37746,-0.00633796884225056,0.0051544137822112,-0.0164406198553845,0.00376468217088339,0.218861302264716
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDGF,Hepatoma-derived growth factor,40471,-0.0108686932263157,0.00884250871535298,-0.0282000103084076,0.00646262385577611,0.219036863199769
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GZMH,Granzyme H,40042,-0.00851916680217317,0.00693139617047305,-0.0221047032963003,0.005066369691954,0.219064344494785
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,-0.00334743990507998,0.00272502474034192,-0.00868848839615015,0.00199360858599019,0.219312135119444
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,0.00393995104137084,0.00321107421238083,-0.00235375441489558,0.0102336564976373,0.219844978871818
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,H2AP,Huntingtin-interacting protein M,37482,0.00594272367818141,0.0048446766135451,-0.00355284248436698,0.0154382898407298,0.219976246482071
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OTOA,Otoancorin,37541,0.00624384287968179,0.00509553658139101,-0.00374340881984459,0.0162310945792082,0.220463420522121
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A3,Protein S100-A3,37900,0.00521284818016396,0.00425445392276253,-0.00312588150845061,0.0135515778687785,0.220495549031216
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,40228,-0.00408423471018578,0.00334674294818743,-0.0106438508886331,0.00247538146826159,0.222346279947577
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCIN,Adseverin,37541,-0.00826801050889926,0.00682683125371721,-0.021648599766185,0.00511257874838648,0.225876972828763
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,-0.00693102243071461,0.00573528698024454,-0.0181721849119939,0.00431014005056468,0.226881551145444
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FADD,FAS-associated death domain protein,40359,-0.00855453814288244,0.00708090678322883,-0.022433115438011,0.00532403915224606,0.227021618581408
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,-0.00844156310009631,0.00699471500786586,-0.0221512045155134,0.00526807831532078,0.227508802831458
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MKI67,Proliferation marker protein Ki-67,37598,-0.00422124298879637,0.00350176643485006,-0.0110847052011025,0.00264221922350976,0.228047069161429
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37959,0.00505515820464504,0.00419382473332809,-0.00316473827267801,0.0132750546819681,0.228077226419194
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRD1,Bromodomain-containing protein 1,37714,0.00346783642499231,0.00287978029867966,-0.00217653296041983,0.00911220581040444,0.228533107680636
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOS,Proto-oncogene c-Fos,37457,-0.003931128408432,0.00326510471105785,-0.0103307336421054,0.00246847682524138,0.228618317529988
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,0.00717059631773488,0.00596565398451369,-0.00452208549191195,0.0188632781273817,0.229393150896139
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NXPH1,Neurexophilin-1,39961,0.00420302592527567,0.00350469714942538,-0.00266618048759807,0.0110722323381494,0.230447090500965
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,-0.0094356218384335,0.00789703756631462,-0.0249138154684101,0.00604257179154315,0.232174308329998
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL3,Fc receptor-like protein 3,40044,0.00603760602690661,0.00508265246747125,-0.00392439280933704,0.0159996048631503,0.234896861020641
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYBB2,Beta-crystallin B2,37942,-0.00755991571595845,0.00637028136115764,-0.0200456671838274,0.00492583575191052,0.235348116738779
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHA4,Ephrin type-A receptor 4,37671,-0.00309639255529873,0.00261768309216694,-0.00822705141594593,0.00203426630534847,0.236879863692179
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGA2,Integrin alpha-2,37671,-0.00370871783622233,0.00314130782302811,-0.00986568116935742,0.00244824549691277,0.237771542337256
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,-0.00879083749874201,0.00744807059840405,-0.0233890558716139,0.00580738087412992,0.237905344203005
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNL2,Interferon lambda-2,37541,-0.00710582661110843,0.0060207236630124,-0.0189064449906127,0.00469479176839587,0.23793099604759
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37901,0.0053520340740581,0.00453777521436026,-0.00354200534608802,0.0142460734942042,0.238243836780595
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RTKN2,Rhotekin-2,37562,0.00575909192726866,0.00488707125132591,-0.00381956772533011,0.0153377515798674,0.238644936504719
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37900,0.00464867287319776,0.003954402220308,-0.00310195547860592,0.0123993012250014,0.239787939868062
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HIP1,Huntingtin-interacting protein 1,37562,0.003697557498047,0.00315742817484171,-0.00249100172464274,0.00988611672073675,0.241593442327179
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM26,Tripartite motif-containing protein 26,37482,-0.00597420084230376,0.00511120130780422,-0.0159921554056,0.0040437537209925,0.242487567788669
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASQ2,Calsequestrin-2,37562,0.00543318150655359,0.00465181628361185,-0.00368437840932563,0.0145507414224328,0.242840137193722
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,0.00316791693005453,0.00271569763184759,-0.00215485042836673,0.0084906842884758,0.243421910909767
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYOM2,Myomesin-2,37562,-0.00507726312806499,0.00435522905614578,-0.0136135120781107,0.00345898582198074,0.243722366903668
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,-0.00720103876947067,0.00617973921098924,-0.0193133276230096,0.00491125008406823,0.243932375245337
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAND5,DAN domain family member 5,37598,0.00588764548336957,0.00505331876040172,-0.0040168592870178,0.0157921502537569,0.243997751651277
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAPK2,Death-associated protein kinase 2,37598,-0.00564727369870186,0.00484990694254244,-0.015153091306085,0.00385854390868132,0.244279565775572
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESPL1,Separin,37482,0.00618728883238305,0.00532928668909451,-0.00425811307824219,0.0166326907430083,0.245664161368248
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,-0.00291519019692225,0.00251815099829636,-0.00785076615358312,0.00202038575973862,0.247016088720449
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALCAM,CD166 antigen,40536,0.00206765839394756,0.00179999109344471,-0.00146032414920406,0.00559564093709918,0.250694812014048
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40522,0.00588491080535518,0.0051276632136094,-0.00416530909331925,0.0159351307040296,0.251118235558114
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OBP2B,Odorant-binding protein 2b,40184,0.00703822473468707,0.0061475549681803,-0.00501098300294632,0.0190874324723205,0.252275478119814
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYOM3,Myomesin-3,37671,-0.00954689731197873,0.00836745272887843,-0.0259471046605805,0.00685331003662298,0.253908807723403
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CGN,Cingulin,37572,-0.00445262687659555,0.00390318794235394,-0.0121028752436093,0.00319762149041817,0.253987838888482
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FSTL1,Follistatin-related protein 1,37628,-0.00237983285291218,0.00208782606344492,-0.00647197193726423,0.00171230623143986,0.254364666490168
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPS10,40S ribosomal protein S10,37562,0.00446553277075879,0.00392036262853173,-0.0032183779811634,0.012149443522681,0.254698461757011
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMMR,Hyaluronan mediated motility receptor,37460,0.00514918936819118,0.00452763546020045,-0.0037249761338017,0.0140233548701841,0.255442190817732
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGR,Progesterone receptor,37598,0.0109276644493514,0.00961059541831194,-0.00790910257054003,0.0297644314692428,0.255540852354659
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYB5A,Cytochrome b5,37482,-0.0077526180268849,0.00682088250629959,-0.0211215477392321,0.00561631168546229,0.255726260479459
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,0.00343804704324737,0.00302496838060921,-0.00249089098274668,0.00936698506924141,0.255744600947547
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARB1,Scavenger receptor class B member 1,39961,-0.00625726184528602,0.00551370237008775,-0.017064118490658,0.00454959480008598,0.256452921286299
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PROS1,Vitamin K-dependent protein S,38013,0.00263385102134063,0.0023275147393557,-0.00192807786779655,0.0071957799104778,0.2578162635358
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYO6,Unconventional myosin-VI,37959,0.0039220745922532,0.00347360044050382,-0.00288618227113427,0.0107303314556407,0.258871777498162
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGB2A2,Mammaglobin-A,37562,0.00335612960131467,0.00297254500124484,-0.00247005860112521,0.00918231780375455,0.258900569793282
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP13,Collagenase 3,39961,0.00345806621007773,0.00306548422932446,-0.00255028287939821,0.00946641529955366,0.259309817202436
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,0.00433329265157244,0.00384236355507777,-0.00319773991637999,0.0118643252195249,0.259438755326818
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BMP6,Bone morphogenetic protein 6,40024,-0.00442518606685721,0.00392927924576032,-0.0121265733885474,0.00327620125483302,0.260094806378075
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHD,SH2 domain-containing adapter protein D,37531,0.00916916967525981,0.00814427349899216,-0.00679360638276483,0.0251319457332844,0.26025282645048
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,0.00956419517267378,0.00850940616614467,-0.00711424091296977,0.0262426312583173,0.261048819644187
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,0.00535805766075428,0.00477795531694713,-0.00400673476046208,0.0147228500819707,0.262133126448479
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,-0.00592733986621459,0.00528897943565916,-0.0162937395601065,0.00443905982767737,0.262434046138524
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAG,S-arrestin,37541,0.00556127734862079,0.00496369062100375,-0.00416755626854655,0.0152901109657881,0.262567473514402
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NT5E,5'-nucleotidase,40411,-0.00600250444420594,0.00535812042647146,-0.01650442048009,0.00449941159167813,0.26261853225359
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,0.00698109028627195,0.00623318247143838,-0.00523594735774729,0.0191981279302912,0.262739344282842
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39980,-0.00431269175343063,0.00385453523143463,-0.0118675808070425,0.00324219730018125,0.263216461930344
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBP1,Guanylate-binding protein 1,37931,-0.00665894694758919,0.00595616408932765,-0.0183330285626714,0.00501513466749299,0.263590109841158
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,0.00368994345789656,0.00331058465973262,-0.00279880247517937,0.0101786893909725,0.265043550316427
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MUC16,Mucin-16,40305,-0.0193682515973,0.0173933642990033,-0.0534592456233464,0.0147227424287464,0.265492358701042
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LHB,Lutropin subunit beta,39980,0.00877173646731379,0.00787888313707931,-0.00667087448136166,0.0242143474159892,0.265587256543586
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39530,-0.00296286163814474,0.00266336015435676,-0.00818304754068399,0.00225732426439451,0.26596138216666
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MDM1,Nuclear protein MDM1,37572,-0.00322540091659258,0.00290442893071015,-0.00891808162078447,0.00246727978759931,0.266799147470846
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNF75D,Zinc finger protein 75D,37714,-0.00613486548957926,0.00552886341275624,-0.0169714377785815,0.00470170679942297,0.267188537374956
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MILR1,Allergin-1,40044,-0.00514401596406143,0.00463728668222948,-0.0142330978612312,0.00394506593310836,0.267329625525972
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDC1,Syndecan-1,40359,0.00410832761649241,0.00371407793762697,-0.00317126514125646,0.0113879203742413,0.268678292981329
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37950,-0.00202853495890265,0.00184054281383393,-0.00563599887401715,0.00157892895621184,0.270420674932159
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTR,Methionine synthase,37562,0.00668790490539539,0.00607056257447048,-0.00521039774056675,0.0185862075513575,0.270614769678074
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37562,-0.00987376482721371,0.0089647202597306,-0.0274446165362857,0.00769708688185826,0.270741761718969
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37628,-0.00629857845229719,0.00572861094179327,-0.017526655898212,0.00492949899361762,0.271572350564163
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA6C,Semaphorin-6C,37598,0.00271255869880935,0.00246983651674834,-0.0021283208740174,0.00755343827163611,0.272104716638409
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,0.00494851846385042,0.0045115681113549,-0.00389415503440518,0.013791191962106,0.272726632752061
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATXN2,Ataxin-2,37541,0.0117199925815337,0.0106920773407581,-0.00923647900635213,0.0326764641694196,0.273038541739032
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,-0.00814907459901863,0.0074417874489205,-0.0227349779989028,0.00643682880086556,0.273514939258326
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF12,Fibroblast growth factor 12,37598,0.00489888159325104,0.00447426434803765,-0.00387067652890276,0.0136684397154048,0.273579572635263
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,-0.00238953417429985,0.00219177166299887,-0.00668540663377764,0.00190633828517794,0.275631500489045
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,-0.00197871357186711,0.00181719753288594,-0.00554042073632355,0.00158299359258933,0.276225302064996
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEFTY2,Left-right determination factor 2,40453,-0.0052275478891267,0.00480603209954344,-0.0146473708042318,0.00419227502597844,0.276741490954056
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLIT2,Slit homolog 2 protein,39961,-0.00529759039053566,0.00487234031971127,-0.0148473774171697,0.00425219663609842,0.276930688389709
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,-0.00671741019573123,0.00618049164513656,-0.0188311738201989,0.00539635342873643,0.277112995245366
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37562,-0.00456563288137907,0.00421131002122866,-0.0128198005229872,0.0036885347602291,0.278324431533412
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,0.0035019298021307,0.00323364130793634,-0.00283600716142452,0.00983986676568592,0.278838917235343
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RASA1,Ras GTPase-activating protein 1,39961,-0.00327310632783439,0.00302969001429735,-0.00921129875585719,0.00266508610018842,0.280005984295684
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRR1B,Cornifin-B,37714,0.00854256794421197,0.00792069708599479,-0.00698199834433781,0.0240671342327618,0.280824883625962
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37598,-0.00203878939854264,0.00189801453772282,-0.00575889789247937,0.00168131909539409,0.282766418347001
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCUN1D2,DCN1-like protein 2,37482,0.0080639460707955,0.00752015636466418,-0.00667556040394628,0.0228034525455373,0.283600246364545
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,-0.00206053638784886,0.00192179081151437,-0.00582724637841702,0.00170617360271931,0.283648540240694
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FH,"Fumarate hydratase, mitochondrial",37541,0.00851751538097217,0.00795597382616185,-0.00707619331830505,0.0241112240802494,0.28437755637278
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DENND2B,DENN domain-containing protein 2B,37562,0.00520355702637837,0.00486855746966456,-0.00433881561416417,0.0147459296669209,0.285175515883739
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,0.00188494705988501,0.0017646292494819,-0.00157372626909952,0.00534362038886953,0.285456961690358
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RILPL2,RILP-like protein 2,37990,-0.00959568447761339,0.00900197298642416,-0.0272395515310047,0.00804818257577796,0.286463678986726
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRTG,Protogenin,40489,-0.00248053437340923,0.00233244686934707,-0.00705213023732948,0.00209106149051102,0.287575722846391
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACTN2,Alpha-actinin-2,37562,-0.00538215166043784,0.00506749301917948,-0.0153144379780296,0.00455013465715394,0.288212781176241
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCP2,Non-specific lipid-transfer protein,39980,-0.00765795671838074,0.00724415899930096,-0.0218565083570106,0.00654059492024915,0.290472554517239
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNNI3,"Troponin I, cardiac muscle",40042,-0.00830400121220247,0.00787293259508727,-0.0237349490985735,0.00712694667416858,0.291554538030787
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37572,-0.00288435453939534,0.00274192001216934,-0.00825851776324725,0.00248980868445657,0.292843239219049
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA13,Carbonic anhydrase 13,40173,-0.010115986217631,0.00961946468894027,-0.028970137007954,0.0087381645726919,0.292991773270156
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPO,Myeloperoxidase,40332,-0.00455670852027424,0.0043343549626953,-0.013052044247157,0.00393862720660854,0.293136702953298
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPHS2,Podocin,37598,0.0102313818020618,0.00973660395114333,-0.00885236194217917,0.0293151255463027,0.293362299895323
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37921,-0.00375111227620156,0.00357598037674524,-0.0107600338146222,0.0032578092622191,0.294208670169162
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGM2,Phosphoglucomutase-2,37572,0.00585060679718035,0.0055784570665934,-0.00508316905334272,0.0167843826477034,0.294296013519846
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNPEP,Aspartyl aminopeptidase,37942,-0.00577034021309264,0.00550412934048512,-0.0165584337204435,0.0050177532942582,0.294488948537659
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB6,Integrin beta-6,40044,0.00292679648256785,0.00280168742918673,-0.00256451087863814,0.00841810384377385,0.296198694434217
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITM2A,Integral membrane protein 2A,40341,0.0057121842246741,0.00548183948317083,-0.00503222116234074,0.0164565896116889,0.297418442905267
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37572,-0.00662362794243171,0.00639163432915482,-0.0191512312275752,0.00590397534271174,0.300082962663944
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,37482,0.00252244768414485,0.00245233344385484,-0.00228412586581063,0.00732902123410034,0.303691083405904
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBP7,Retinoid-binding protein 7,37901,-0.00555728613343956,0.00540860792063114,-0.0161581576578766,0.00504358539099747,0.304208655257969
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39980,-0.00452637485993781,0.00441838618529533,-0.0131864117831166,0.00413366206324103,0.305643101238482
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37562,0.00545218927794252,0.00533717726269997,-0.00500867815694943,0.0159130567128345,0.307013151315647
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37562,-0.00447739037110963,0.00439568223514378,-0.0130929275519914,0.00413814680977218,0.308417270961437
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGS8,Regulator of G-protein signaling 8,40044,-0.00628780770925225,0.00617778838563861,-0.0183962729451039,0.00582065752659943,0.308784596603604
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENO2,Gamma-enolase,40471,-0.0061935821699941,0.00608954847045149,-0.018129097172079,0.00574193283209083,0.309128843278273
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGS10,Regulator of G-protein signaling 10,37959,-0.00563590404809833,0.00554873175816158,-0.016511418294095,0.00523961019789838,0.309785550787443
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBQLN3,Ubiquilin-3,37562,0.00425001052391775,0.00418619124944712,-0.00395492432499861,0.0124549453728341,0.310007700705004
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,40042,-0.00319972562146542,0.00317221311991933,-0.00941726333650729,0.00301781209357646,0.313147154926001
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELAVL4,ELAV-like protein 4,37541,-0.00814657202573945,0.00809446539917145,-0.0240117242081155,0.00771858015663659,0.314223855926539
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TEX101,Testis-expressed protein 101,37572,0.00367004653613363,0.00365305492015712,-0.00348994110737432,0.0108300341796416,0.315083292727903
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37900,-0.003799116356729,0.00379306632980692,-0.0112335263631506,0.00363529364969256,0.316557247265088
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37562,-0.00515219467254514,0.00514855747991662,-0.0152433673331817,0.00493897798809143,0.316987218372332
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,0.00652178001969651,0.00651870218080291,-0.00625487625467718,0.0192984362940702,0.317100517596329
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,0.00820662974045071,0.00822661419902793,-0.00791753408964403,0.0243307935705455,0.31850276728459
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EVI2B,Protein EVI2B,37482,0.00390302397722913,0.00391755643614428,-0.00377538663761366,0.0115814345920719,0.319127554309395
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37562,0.00452265377040994,0.00454620408723494,-0.00438790624057054,0.0134332137813904,0.319842282771498
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOL1,Apolipoprotein L1,37987,0.00599934873495702,0.00603990618924586,-0.00583886739596486,0.0178375648658789,0.320588800401599
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,0.00526217090724081,0.00529937246251147,-0.00512459911928167,0.0156489409337633,0.320734853169779
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HK2,Hexokinase-2,40042,-0.00255178989563101,0.00257224240396368,-0.00759338500739982,0.0024898052161378,0.321189135401117
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,-0.00338290967806355,0.00342353278199928,-0.0100930339307821,0.00332721457465504,0.323104649904574
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSAP,Gamma-secretase-activating protein,39980,0.00818914096314423,0.00829836094719325,-0.00807564649335454,0.024453928419643,0.323737259001711
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHPK,Sedoheptulokinase,37714,0.00392832095805174,0.0039832368970294,-0.00387882336012589,0.0117354652762294,0.324046476340701
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,-0.00814518984188997,0.00826765355668318,-0.024349790812989,0.00805941112920905,0.324550218657737
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,0.00330203967379992,0.00336792329806362,-0.00329908999040477,0.00990316933800461,0.32688804774821
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",40314,-0.00990477728218145,0.0101446825070308,-0.0297883549959618,0.00997880043159892,0.328905133229654
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN2B,Sodium channel subunit beta-2,37572,0.00269118662289529,0.00275765118061219,-0.00271380969110461,0.00809618293689519,0.329132943110123
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,-0.00547545916395838,0.00562926255785188,-0.0165088137773481,0.00555789544943131,0.33072833602014
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37714,-0.00701119157318723,0.00722135469275859,-0.0211650467709941,0.00714266362461962,0.331617281245957
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FRMD7,FERM domain-containing protein 7,37572,0.00300402299536247,0.00309481488557817,-0.00306181418037073,0.00906986017109568,0.331733904686113
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37901,-0.00854386005640293,0.00880849710634256,-0.0258085143848344,0.00872079427202849,0.33208556002245
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL20,Interleukin-20,40044,0.00459041203507288,0.00474089744146472,-0.00470174695019797,0.0138825710203437,0.33293053655936
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,-0.00582687974190572,0.00601893894179624,-0.0176240000678263,0.00597024058401492,0.333016406891691
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK10,Kallikrein-10,40354,0.0035173864599442,0.00363834842950444,-0.0036137764618845,0.0106485493817729,0.333681924887763
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TREML1,Trem-like transcript 1 protein,37987,-0.00472394884573063,0.00489561225259252,-0.014319348860812,0.00487145116935071,0.334594482724879
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,0.00519249516846001,0.00538501928998572,-0.005362142639912,0.015747132976832,0.334939397948806
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37598,0.00523421566721274,0.00543616363400504,-0.00542066505543715,0.0158890963898626,0.335640005865789
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,37482,-0.00261039266953416,0.00271209365648076,-0.00792609623623645,0.00270531089716812,0.335815896894407
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MORN4,MORN repeat-containing protein 4,37482,-0.00705316875877027,0.00733515926672665,-0.0214300809215545,0.00732374340401396,0.33629036434682
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PALM3,Paralemmin-3,37562,0.00646616220373829,0.00672493130130468,-0.00671470314681888,0.0196470275542955,0.33630804003734
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37714,0.00600469846818476,0.00624646521401042,-0.00623837335127565,0.0182477702876452,0.336421170703329
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,0.00563405075569621,0.00586398955532504,-0.00585936877274086,0.0171274702841333,0.336676293360566
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAP1A,Ras-related protein Rap-1A,37598,0.00621636426540536,0.00647013783596611,-0.00646510589308821,0.0188978344238989,0.336681615101494
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEP1B,Meprin A subunit beta,40359,0.010544906418029,0.0109847293790402,-0.0109851631648898,0.0320749760009478,0.337089680890465
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,40042,-0.00519736915020231,0.00545675217648249,-0.015892603416108,0.00549786511570337,0.34087563194382
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOX2,Transcription factor SOX-2,37937,0.00205553882281514,0.0021629604976756,-0.00218386375262903,0.00629494139825932,0.341958678796093
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,0.00528679199621909,0.00556363250440636,-0.00561792771241737,0.0161915117048556,0.342007301369697
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,-0.00634773251476732,0.00668150023493369,-0.0194434729752374,0.00674800794570272,0.342103609438384
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX5,Syntaxin-5,37598,-0.00368896932765301,0.00388450788163964,-0.0113026047756667,0.00392466612036069,0.342301507594552
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,0.0106482198069519,0.0112502598135977,-0.0114022894276997,0.0326987290416034,0.343915197760544
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,-0.00740599057456641,0.00783050380733203,-0.0227537780369372,0.00794179688780437,0.34427454656115
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MANSC1,MANSC domain-containing protein 1,40411,0.00240127154808813,0.0025409636680681,-0.00257901724132535,0.00738156033750161,0.344660950821543
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MST1,Hepatocyte growth factor-like protein,37787,-0.00540197292742335,0.00571946932447028,-0.0166121328033851,0.0058081869485384,0.344937194580735
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TREML2,Trem-like transcript 2 protein,40332,-0.0029324839049397,0.00310633653641728,-0.00902090351631757,0.00315593570643817,0.345167195912504
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,0.00217864370111874,0.00231241930872227,-0.00235369814397691,0.0067109855462144,0.346133126334803
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37761,0.00389836258143895,0.00416654003519497,-0.0042680558875432,0.0120647810504211,0.349477889379853
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,0.00230932769869158,0.00247134369702235,-0.00253450594747223,0.00715316134485539,0.350090034341012
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,0.00472653702634925,0.00506295096251496,-0.00519684686018006,0.0146499209128786,0.350551294885227
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39980,-0.00311518229883347,0.00333849550588607,-0.00965863349037016,0.00342826889270323,0.350777877212455
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBM19,Probable RNA-binding protein 19,37562,-0.00412533147485261,0.00443960172080223,-0.012826950847625,0.00457628789791975,0.352796305237992
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NENF,Neudesin,37900,0.00930381332028071,0.0100279164376367,-0.0103509028974872,0.0289585295380486,0.353532504870205
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTPN,Myotrophin,40042,0.00285090632869795,0.00307882272234793,-0.003183586207104,0.00888539886449989,0.354474410186663
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,-0.00278149062609006,0.0030118189612825,-0.00868465579020376,0.00312167453802365,0.355747938450763
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSH,Pro-cathepsin H,40013,-0.00620603621690556,0.00672550680846587,-0.0193880295614987,0.00697595712768755,0.356146011766265
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,0.0043127793037361,0.00470232414095266,-0.0049037760125311,0.0135293346200033,0.359075995695868
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,37541,0.00516804857685761,0.0056390906750687,-0.00588456914627704,0.0162206662999923,0.359438143284132
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,0.00516079939696274,0.00564016134507722,-0.00589391683938861,0.0162155156333141,0.36020364078203
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37901,-0.00650117272670859,0.00711676811705327,-0.020450038236133,0.00744769278271582,0.360995636114972
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFNB2,Ephrin-B2,37572,-0.00490439077766607,0.00538480964420242,-0.0154586176803028,0.00564983612497068,0.362426679533173
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",37482,0.00766949771607432,0.00842296120528286,-0.00883950624628008,0.0241785016784287,0.36255122192785
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39961,0.00433963913789321,0.00477430354089511,-0.00501799580226121,0.0136972740780476,0.363386670617537
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH3GL3,Endophilin-A3,37643,-0.00697615011734513,0.00770690426686207,-0.0220816824803948,0.00812938224570452,0.365385570155011
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,-0.0040967540279612,0.00452798067393889,-0.0129715961488814,0.00477808809295903,0.36560703901592
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCLN,Nicalin,40044,-0.00447820692138465,0.00496363745102361,-0.0142069363253909,0.00525052248262163,0.366963157552964
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37598,0.0047050399096504,0.00523094310427384,-0.00554760857472632,0.0149576883940271,0.368422556994529
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,-0.00599113009576482,0.00666213410624883,-0.0190489129440125,0.0070666527524829,0.368519374533229
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,0.00531295577289766,0.00592138513719494,-0.00629295909600443,0.0169188706417997,0.369602742035264
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37779,-0.000676740794337849,0.000754318005690651,-0.00215520408549152,0.000801722496815826,0.369651978509591
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA3,Carbonic anhydrase 3,40500,0.00508145888932829,0.00566550261326527,-0.00602292623267163,0.0161858440113282,0.369779179065724
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC123,Cell division cycle protein 123 homolog,37482,-0.00533534071136219,0.00596033067026398,-0.0170175888250796,0.00634690740235521,0.370727863726843
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,0.00329245332697592,0.00368292244525189,-0.00392607466571778,0.0105109813196696,0.371347289797226
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,-0.00395617441713113,0.00442903097747616,-0.0126370751329844,0.00472472629872214,0.371744150903628
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37572,-0.00446442082444385,0.00500335510020639,-0.0142709968208484,0.00534215517196068,0.372256329764116
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,-0.00323555512141076,0.00362781370668558,-0.0103460699865145,0.00387495974369297,0.372476441446781
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PMM2,Phosphomannomutase 2,37562,-0.00498263063804407,0.00559710688161245,-0.0159529601260045,0.00598769884991634,0.373366582590512
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GZMB,Granzyme B,40341,-0.00518750920867041,0.00583340647323447,-0.01662098589621,0.00624596747886916,0.3738681527781
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,0.00753231410631326,0.00847144348849515,-0.00907171513113724,0.0241363433437638,0.373943134734232
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,0.00214762711400653,0.00241592124212438,-0.00258757852055727,0.00688283274857032,0.374047154056983
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,0.00393932890801294,0.00444054635517375,-0.00476414194812762,0.0126427997641535,0.375024227234123
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCS,Copper chaperone for superoxide dismutase,40228,0.00396049248777863,0.0044779896418728,-0.00481636721029206,0.0127373521858493,0.376474707802311
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSLNL,Mesothelin-like protein,37572,0.00308386427720792,0.00349641036573678,-0.00376910003963616,0.00993682859405201,0.37778827406809
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACTN4,Alpha-actinin-4,40044,-0.0026614107327611,0.00301898986383078,-0.00857863086586942,0.00325580940034723,0.378030170042488
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,0.00476216059073834,0.00540284010927167,-0.00582740602343412,0.0153517272049108,0.378104929608875
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39961,-0.00312966974420069,0.00355775497576609,-0.0101028694967022,0.00384353000830085,0.379048776942161
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOSB,Protein fosB,39961,-0.00319713580970224,0.00363503984721698,-0.0103218139102475,0.00392754229084303,0.37912622814341
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,0.00295101260995885,0.00335560774586707,-0.0036259785719406,0.0095280037918583,0.379183261017867
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,0.00519482475510233,0.00592978743579253,-0.00642755861905104,0.0168172081292557,0.381015559443894
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39980,0.00404929550809616,0.00462560397055268,-0.0050168882741871,0.0131154792903794,0.381364926016486
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MUC2,Mucin-2,37998,0.00734710764762176,0.00839329641645068,-0.00910375332862156,0.0237979686238651,0.381396707938116
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MUCL3,Mucin-like protein 3,37482,0.00365179029568996,0.00419050959034122,-0.00456160850137883,0.0118651890927588,0.38352836550032
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37951,-0.00547759361962726,0.00628803171937127,-0.0178021357895949,0.00684694855034042,0.383707301720711
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUGT1,Protein SGT1 homolog,39980,-0.0065586669840721,0.00754617329751814,-0.0213491666472077,0.00823183267906345,0.384785014083102
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37901,0.00442364745084899,0.00508969507932287,-0.00555215490462384,0.0143994498063218,0.384787159067464
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZPR1,Zinc finger protein ZPR1,37541,0.00783964241955486,0.00903787739772603,-0.00987459727998816,0.0255538821190979,0.385727416803178
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GHRL,Appetite-regulating hormone,40359,-0.00633937607317457,0.00731432467758547,-0.0206754524412421,0.00799670029489294,0.386115666330483
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,0.00711707673911255,0.00822200832600936,-0.0089980595798658,0.0232322130580909,0.386715485418846
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FZD10,Frizzled-10,37572,-0.004902369917707,0.00566471434878505,-0.0160052100413257,0.00620047020591169,0.386822889178201
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,0.00310151444307564,0.00358540956748053,-0.0039258883091862,0.0101289171953375,0.38703341603065
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37900,-0.00309287668985255,0.00357763856955141,-0.0101050482861733,0.00391929490646821,0.387327449724993
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37628,0.00462643472168942,0.00538443711098136,-0.00592706201583405,0.0151799314592129,0.390232870260693
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,-0.00355543107804988,0.00414183873810895,-0.0116734350047434,0.00456257284864367,0.390677055749367
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA3G,Semaphorin-3G,37671,0.00344126931996447,0.00401519327010144,-0.00442850948943435,0.0113110481293633,0.39142619278642
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37959,0.00292666868350305,0.00342131094467937,-0.00377910076806851,0.00963243813507461,0.392332089702914
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PROC,Vitamin K-dependent protein C,40372,-0.00200180662100869,0.00234176862234582,-0.00659167312080649,0.00258805987878911,0.392659892608047
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE3,Eosinophil cationic protein,40288,0.00859464249891761,0.010074902428463,-0.0111521662608699,0.0283414512587051,0.39363088563346
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,-0.0062552263701296,0.00734102105175819,-0.0206436276315757,0.00813317489131646,0.394178124396963
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,-0.0020927157060381,0.00246257424081365,-0.00691936121803286,0.00273392980595666,0.395447361089951
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39961,-0.0112308363480664,0.0132329681052137,-0.0371674538342853,0.0147057811381525,0.396060658899367
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DGKZ,Diacylglycerol kinase zeta,40044,-0.00274733907156899,0.00325396530423869,-0.00912511106787682,0.00363043292473885,0.398511964578662
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37714,-0.00352623161609382,0.00417863779171503,-0.0117163616878553,0.00466389845566764,0.398756667194804
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,40451,-0.00233030634159581,0.00276837278651302,-0.00775631700316134,0.00309570431996972,0.399934712675787
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37863,0.00336576509800069,0.00401113693816736,-0.00449606330080734,0.0112275934968087,0.401425341801062
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,-0.00519351109048554,0.00619483176988592,-0.0173353813594619,0.00694835917849086,0.40184277559937
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPN1,Epsin-1,37714,-0.00344329226695464,0.00410993685808667,-0.0114987685088045,0.00461218397489524,0.402159890732242
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK4,Kallikrein-4,40489,0.0047188600274337,0.00563673072022374,-0.00632913218420483,0.0157668522390722,0.402513663527688
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,40272,0.00179911909116447,0.00214949446709017,-0.00241389006433226,0.0060121282466612,0.402607245205009
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PROK1,Prokineticin-1,40341,-0.00532590989752026,0.00638499577993091,-0.0178405016261848,0.00718868183114432,0.404220856612911
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37628,-0.00330496343498657,0.00396581750794914,-0.0110779657505669,0.00446803888059373,0.404655445947024
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF16,Fibroblast growth factor 16,37598,0.00379232486691825,0.00455737601701438,-0.00514013212642993,0.0127247818602664,0.405351235060068
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGMA,Repulsive guidance molecule A,40471,0.00237287263855071,0.00286659768219786,-0.0032456588185571,0.00799140409565851,0.407815257567959
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37598,0.00480018631657056,0.00580038431900043,-0.00656856694867028,0.0161689395818114,0.407932771519118
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUSP29,Dual specificity phosphatase 29,37572,-0.00509885573015875,0.00619833147452531,-0.0172475854202284,0.00704987395991085,0.410740513427142
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LCP1,Plastin-2,37998,0.00357987966697337,0.00435648357036533,-0.00495882813094268,0.0121185874648894,0.411241590972422
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PFDN4,Prefoldin subunit 4,37482,0.00412022254708495,0.00505287269733141,-0.00578340793968462,0.0140238530338545,0.414845814900749
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C2orf69,UPF0565 protein C2orf69,37572,-0.00452502099876855,0.0055975076462335,-0.0154961359853862,0.00644609398784912,0.418875439604825
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,-0.0022725740154435,0.0028161936242305,-0.00779231351893528,0.00324716548804827,0.419698137600773
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENSA,Alpha-endosulfine,37900,-0.00393057471617328,0.00488471032678801,-0.0135046069566778,0.00564345752433123,0.421024968632536
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,0.0036797809826961,0.00460390094559721,-0.00534386487067443,0.0127034268360666,0.424145786013652
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,0.0057744338666495,0.00722923252858288,-0.00839486188937293,0.0199437296226719,0.424443015739505
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,0.00350899084451527,0.00439463221002855,-0.0051044882871407,0.0121224699761712,0.424608462951661
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAPN3,Calpain-3,37900,-0.00274565377524358,0.00343944696539672,-0.00948696982742115,0.00399566227693398,0.424720085110958
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,-0.00370415410147854,0.00468820898294212,-0.0128930437080451,0.00548473550508803,0.429483725330774
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS1,Galectin-1,40359,-0.002447650450876,0.00312059106065905,-0.00856400892976774,0.00366870802801574,0.432843656233338
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COPE,Coatomer subunit epsilon,39961,-0.00352458301371937,0.00449516824456407,-0.0123351127730649,0.00528594674562621,0.433003644244193
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF3,Fibroblast growth factor 3,37598,0.00221230659145013,0.00282824331668785,-0.00333105030925806,0.00775566349215831,0.434099775204238
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37562,-0.00284023475058737,0.00364434365425965,-0.00998314831293628,0.00430267881176154,0.435785128193915
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,0.00680281829072668,0.00874114003614448,-0.0103298161801165,0.0239354527615699,0.436431569895696
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB6B,Ras-related protein Rab-6B,39961,-0.00352938570904474,0.00453674610603885,-0.0124214080768809,0.00536263665879141,0.436607228979778
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,0.00294401038828551,0.0037874966379623,-0.00447948302212059,0.0103675037986916,0.436997494365711
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37572,0.00279202654890208,0.00360779086632531,-0.00427924354909552,0.00986329664689968,0.439010890104516
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXN,Thioredoxin,37819,-0.00319501169626301,0.00413354373175028,-0.0112967574104936,0.00490673401796753,0.439567204524694
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37692,-0.00399845166620521,0.00517836806682778,-0.0141480530771877,0.00615114974477724,0.440042259313321
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FBN2,Fibrillin-2,37572,-0.00436694448583392,0.00566594344715083,-0.0154721936422496,0.00673830467058171,0.440877527690501
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDNRB,Endothelin receptor type B,37598,-0.00338771290688929,0.00439847508663294,-0.0120087240766899,0.00523329826291127,0.441194106972289
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX1B,Syntaxin-1B,37572,0.00307086106698344,0.00399449874156203,-0.00475835646647813,0.010900078600445,0.4420421727774
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PKD1,Polycystin-1,37990,0.00184078398109298,0.00239690896006138,-0.00285715758062732,0.00653872554281328,0.442511014902539
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IST1,IST1 homolog,37812,-0.00710073438423856,0.00926080616697754,-0.0252519144715145,0.0110504457030374,0.443242994955858
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,0.00351711605744084,0.00459875505308889,-0.00549644384661339,0.0125306759614951,0.444405965040377
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37901,0.00391129277744731,0.00511785143034181,-0.00611969602602264,0.0139422815809173,0.444734614540926
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37942,-0.00744240285572584,0.0097609116274656,-0.0265737896455584,0.0116889839341067,0.445792838294949
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,-0.00171871602315239,0.00225779908899484,-0.00614400223758228,0.0027065701912775,0.446527937806139
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP15,Matrix metalloproteinase-15,37990,0.00351850410709609,0.0046244513817158,-0.00554542060106688,0.0125824288152591,0.446761173837354
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEBP1,Heme-binding protein 1,40042,0.00384901590157802,0.00506582917241213,-0.00608000927634976,0.0137780410795058,0.447385762170682
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,0.00611874143475503,0.00805734784497279,-0.00967366034139163,0.0219111432109017,0.447627589386471
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,-0.00323915779198132,0.00426811907258818,-0.0116046711742542,0.00512635559029152,0.447914519452179
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,-0.00617823559763524,0.00814148566638043,-0.0221355475037409,0.00977907630847039,0.447950812129044
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,-0.00284807087135071,0.00377579560692999,-0.0102486302609335,0.00455248851823208,0.45068451936818
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MATN3,Matrilin-3,40203,0.0021756907963473,0.00290174434989993,-0.00351172812945656,0.00786310972215116,0.453394072354516
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA1,Carbonic anhydrase 1,40003,0.00434476986685358,0.00580645493158424,-0.00703588179905152,0.0157254215327587,0.454311349337744
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,40305,0.00269360220835002,0.00360438482247549,-0.00437099204370193,0.00975819646040197,0.454885969888524
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,40359,0.00197052879327335,0.00264303648127264,-0.00320982271002103,0.00715088029656773,0.455947353129814
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37714,-0.00320856911196507,0.00430834715356367,-0.0116529295329499,0.00523579130901972,0.456446228022294
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,37482,0.00225238820168536,0.00302545282371424,-0.00367749933279455,0.00818227573616528,0.456599745683069
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTTG1,Securin,37714,0.00285226242983818,0.00384106575527439,-0.00467622645049963,0.010380751310176,0.457754857126405
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ROBO4,Roundabout homolog 4,37628,-0.00123173959171407,0.00165985809743482,-0.00448506146268631,0.00202158227925817,0.45805497962926
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRDT,Bromodomain testis-specific protein,37562,0.00255004663994557,0.00344688758512217,-0.00420585302689389,0.00930594630678503,0.459427703773145
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,-0.00213959029093333,0.00290540201080855,-0.00783417823211809,0.00355499765025144,0.461489242523462
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB5,Serpin B5,40042,-0.00334044305701191,0.00453740411925345,-0.0122337551307487,0.00555286901672486,0.461619245095322
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA4D,Semaphorin-4D,40471,0.00202846611741167,0.00276232290238868,-0.00338568677127015,0.00744261900609349,0.462756282069365
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37572,0.00493867981519802,0.00673880471456964,-0.00826937742535847,0.0181467370557545,0.463649728575717
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40516,-0.00497239240517994,0.00679348213796829,-0.0182876173955978,0.00834283258523791,0.464218465582214
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SF3B4,Splicing factor 3B subunit 4,40305,0.00497521393476997,0.00680535156710909,-0.00836327513676385,0.0183137030063038,0.464744908013296
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,37482,0.00403486483667594,0.00552300953118045,-0.00679023384443775,0.0148599635177896,0.465063853375583
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRK1,Protein BRICK1,39961,0.00299602042807268,0.00410478176386007,-0.00504935182909306,0.0110413926852384,0.465471239005638
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIF20B,Kinesin-like protein KIF20B,37541,-0.00529936521736741,0.00726393074567155,-0.0195366694788836,0.00893793904414882,0.465681334043383
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFBR1,TGF-beta receptor type-1,37598,-0.00145766978379685,0.00199863384951538,-0.005374992128847,0.00245965256125331,0.465810934948923
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,37541,0.00366573725719201,0.00504465759863725,-0.00622179163613699,0.013553266150521,0.467448913562484
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERC2,ERC protein 2,37572,-0.00515568894123259,0.00714964049884152,-0.019168984318962,0.00885760643649679,0.470853682798228
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPSD1,Tryptase delta,37959,-0.00254611149924095,0.00354381253471306,-0.00949198406727855,0.00439976106879666,0.47248196560138
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,0.00300927034889401,0.00419676751369585,-0.00521639397794986,0.0112349346757379,0.473359160632481
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPI,Mannose-6-phosphate isomerase,40305,-0.00567025623333151,0.00796005712282759,-0.0212719681940736,0.00993145572741056,0.476265587897791
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37714,0.00270439986494267,0.003798613536321,-0.00474088266624649,0.0101496823961318,0.476512018314808
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,0.00260016924056418,0.00365871312862898,-0.00457090849154861,0.00977124697267697,0.477295649349127
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37572,0.00327758470232646,0.00461525229000042,-0.00576830978607436,0.0123234791907273,0.477615242320612
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,40311,0.00266591036630474,0.00376013300753613,-0.00470395032846607,0.0100357710610756,0.478338849195314
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPA4,Carboxypeptidase A4,37410,-0.00288922144885684,0.00407832405921254,-0.0108827366049134,0.00510429370719975,0.478688829192986
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESR1,Estrogen receptor,37598,0.00382731350846464,0.00540334705371381,-0.00676324671681443,0.0144178737337437,0.478757427015683
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,40225,-0.00381555374803051,0.00540904731922603,-0.0144172864937135,0.00678617899765251,0.480570407289802
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRR4,Proline-rich protein 4,37577,0.00450773787519128,0.00639786910086521,-0.00803208556250453,0.0170475613128871,0.481091226873983
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THPO,Thrombopoietin,40042,-0.00249514796474901,0.00354307935204152,-0.0094395834947504,0.00444928756525238,0.481299157416969
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHC1,SHC-transforming protein 1,37482,0.00764074846696954,0.0108585049203894,-0.0136419211769937,0.0289234181109328,0.481654075476191
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37990,-0.00176062976988028,0.00250910407068711,-0.00667847374842702,0.00315721420866646,0.482880462452852
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PMCH,Pro-MCH,37562,0.00549970992724718,0.00788225584990756,-0.00994951153857163,0.020948931393066,0.485356567867985
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,-0.00438861061045206,0.0063342191163664,-0.0168036800785302,0.00802645885762607,0.488420916459183
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1S,Complement C1s subcomponent,38013,0.00132767522399024,0.00192429251229347,-0.00244393810010495,0.00509928854808544,0.490234298721868
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,-0.00255740506796069,0.00372239148319976,-0.00985329237503222,0.00473848223911085,0.492073816450009
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEO1,Neogenin,37959,0.00135280284973781,0.00197788356852509,-0.00252384894457137,0.005229454644047,0.494009091947919
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A11,Protein S100-A11,40207,-0.00283725050987695,0.00417184261509782,-0.0110140620354687,0.00533956101571478,0.496454120037754
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENAH,Protein enabled homolog,40044,-0.00298560543393818,0.00439074623082725,-0.0115914680463596,0.00562025717848323,0.49652926615617
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37572,0.00232228697446917,0.00342612384683106,-0.0043929157653197,0.00903748971425804,0.497899316005894
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPC1,Glypican-1,40489,0.00183927190259622,0.00272000041436352,-0.00349192890955628,0.00717047271474871,0.498921645107177
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL33,Interleukin-33,40044,-0.00242887969513588,0.00359426883002465,-0.00947364660198418,0.00461588721171243,0.499200125833841
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LUZP2,Leucine zipper protein 2,37900,-0.00279098137926571,0.00413568013250754,-0.0108969144389805,0.00531495168044906,0.499779961181007
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,0.00150786289618202,0.00224517671517878,-0.00289268346556839,0.00590840925793243,0.501847471433914
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,37482,0.00347841128909006,0.00518935211820248,-0.00669271886258681,0.0136495414407669,0.502679850957513
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,-0.00165890074087531,0.00247685232221536,-0.00651353129241742,0.0031957298106668,0.503021469995957
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APCS,Serum amyloid P-component,37882,-0.00222905727146282,0.00332877133797858,-0.00875344909390083,0.0042953345509752,0.503102875355344
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,-0.00177433733055398,0.00265163681129975,-0.00697154548070149,0.00342287081959354,0.503412830654588
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNF830,Zinc finger protein 830,37900,-0.0050067518235482,0.00748395839515942,-0.0196753102780607,0.00966180663096426,0.503508354902743
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,-0.00303010121368704,0.00452982070095538,-0.0119085497875596,0.00584834736018549,0.503554310559101
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TLR2,Toll-like receptor 2,37714,-0.00142798999216939,0.00213604013245532,-0.00561462865178181,0.00275864866744303,0.503812027793757
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,0.00161088407641464,0.00242027103216232,-0.0031328471466235,0.00635461529945278,0.505691222544605
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ROBO1,Roundabout homolog 1,40379,0.00148248499977286,0.00223285464092908,-0.00289391009644814,0.00585888009599386,0.506737324174108
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,-0.00576451383592199,0.00870514867589529,-0.0228266052406768,0.0112975775688328,0.507857284057854
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37714,-0.00429188868823357,0.00648301633995105,-0.0169986007145376,0.00841482333807049,0.507969688539047
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,0.00344355919816066,0.00522072069508385,-0.00678905336420369,0.013676171760525,0.509525471671112
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,-0.00173458917413133,0.00263263278043723,-0.00689454942378831,0.00342537107552565,0.509984089234529
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPGN,Epigen,37900,-0.003016751907505,0.00458377088209972,-0.0120009428364205,0.00596743902141046,0.510460991292664
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLNS1A,Methylosome subunit pICln,37572,0.00205249602867379,0.00312444122999884,-0.00407140878212393,0.00817640083947151,0.511246329971925
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,-0.00295154694687866,0.00450151882768487,-0.011774523849141,0.0058714299553837,0.512042482458388
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37598,0.00563276997428031,0.00859682614200566,-0.0112170092640508,0.0224825492126114,0.512340762897027
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,0.00233072032305934,0.00356898129738068,-0.0046644830198068,0.00932592366592547,0.513735928443767
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAD2,Glutamate decarboxylase 2,37598,0.00286618363856694,0.00439723465633691,-0.0057523962878534,0.0114847635649873,0.514531899805153
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SULT1A1,Sulfotransferase 1A1,40471,-0.00776418363702064,0.0119143970931297,-0.0311164019395549,0.0155880346655136,0.514627301726214
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKCQ,Protein kinase C theta type,40044,-0.00267265341566925,0.00412278872716544,-0.0107533193209135,0.005408012489575,0.516824088972988
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37598,-0.00176684833669221,0.00273074007571912,-0.00711909888510168,0.00358540221171726,0.51762913691942
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37714,-0.00319905220199138,0.00495232823035587,-0.0129056155334889,0.00650751112950614,0.518310388103297
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37900,0.0034341630844771,0.0053281358572301,-0.00700898319569389,0.0138773093646481,0.519240409611153
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRC1,Macrophage mannose receptor 1,37987,-0.00169152197468023,0.00262460117451513,-0.00683574027672989,0.00345269632736943,0.51927044945858
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSP90B1,Endoplasmin,39878,0.00420021179321437,0.00652692073450827,-0.00859255284642185,0.0169929764328506,0.519895536449889
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,-0.00413823945948668,0.00644520857230111,-0.0167708482611969,0.00849436934222349,0.520840810578427
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,0.00302968518126075,0.00473315330491113,-0.00624729529636507,0.0123066656588866,0.522119633514837
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CORO6,Coronin-6,37541,0.00216818188677691,0.00338764394044917,-0.00447160023650346,0.00880796401005728,0.522166575363844
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,37541,0.00643177631779725,0.0100575696996329,-0.0132810602934833,0.0261446129290778,0.522511459878392
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK15,Kallikrein-15,37880,-0.00302265814000165,0.00474510317160598,-0.0123230603563494,0.00627774407634607,0.524131939131412
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39980,-0.00270338309539723,0.00425443210094113,-0.0110420700132418,0.00563530382244738,0.525159009876793
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37900,0.00274185071042266,0.00432228707694223,-0.0057298319603841,0.0112135333812294,0.525862029953642
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,-0.00433815727961765,0.00687925977838229,-0.0178215064452469,0.00914519188601163,0.528303832341085
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IMPA1,Inositol monophosphatase 1,40228,-0.00355468077563353,0.00565009462137875,-0.0146288662335359,0.00751950468226881,0.529268803722244
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBP1,Retinol-binding protein 1,37572,0.00398091981530283,0.00640725983678837,-0.00857730946480238,0.016539149095408,0.534403881862991
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37990,0.00158435991323505,0.00255777697253751,-0.00342888295293848,0.00659760277940857,0.535644545166407
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,-0.00597140266036025,0.00964460008403764,-0.024874818825074,0.0129320135043535,0.53583181352433
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F3,Tissue factor,40393,-0.00160398569624944,0.00260198041379464,-0.00670386730728694,0.00349589591478806,0.537607665744935
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IKZF2,Zinc finger protein Helios,39980,0.0053154838773881,0.00870062956727125,-0.0117377500744636,0.0223687178292398,0.541254237166809
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37572,0.00219689053280421,0.00360672566965247,-0.00487229177971463,0.00926607284532305,0.542462469526181
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37879,-0.00234612086931683,0.00385379270711008,-0.0098995545752526,0.00520731283661893,0.542679032263453
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD99,CD99 antigen,40332,0.00109252808286264,0.0018008306590352,-0.00243710000884636,0.00462215617457164,0.544071919320827
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39897,-0.0032201065454902,0.00531405127790891,-0.0136356470501917,0.00719543395921127,0.544549716082726
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,0.00283359102645974,0.00470296212448727,-0.00638421473753531,0.0120513967904548,0.546843875460308
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNGR1,Interferon gamma receptor 1,40422,0.00113190437683781,0.00189885185558525,-0.00258984526010927,0.00485365401378489,0.551117299784527
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PVALB,Parvalbumin alpha,40417,0.00617597970267714,0.0104576379269284,-0.0143209906341024,0.0266729500394567,0.554816130970488
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAA4,Serum amyloid A-4 protein,38013,-0.00178899441480292,0.00303198922152448,-0.0077316932889909,0.00415370445938506,0.555173775637879
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,37541,0.00272588217182573,0.00463229777090654,-0.0063534214591511,0.0118051858028026,0.556239490276465
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL34,Interleukin-34,39934,0.00196106809047751,0.00333770050653067,-0.00458082490232261,0.00850296108327763,0.55684251505294
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,40044,0.00211689851498982,0.00360821955213051,-0.00495521180718599,0.00918900883716563,0.557421873628788
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RP2,Protein XRP2,40305,-0.00224722040115905,0.00383166084126907,-0.00975727565004643,0.00526283484772833,0.557556447695809
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PALM,Paralemmin-1,37824,-0.00158182380450543,0.00270990920246065,-0.00689324584132831,0.00372959823231745,0.559419645928379
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C2,Complement C2,40372,-0.00129838473852807,0.00222563523376331,-0.00566062979670415,0.00306386031964801,0.559647700964343
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNPY2,Protein canopy homolog 2,40042,0.00329915194842474,0.00567988687076118,-0.00783342631826718,0.0144317302151167,0.561351176591907
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,-0.00278963975166267,0.00482941106910736,-0.0122552854471131,0.00667600594378775,0.563518322689691
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37714,-0.00290151763351368,0.00504790393055548,-0.0127954093374024,0.00699237407037507,0.565438668026068
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEDD9,Enhancer of filamentation 1,37598,-0.0017561973674127,0.0030638088427236,-0.00776126269915095,0.00424886796432555,0.566514196968768
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,37482,0.00178966842487348,0.0031230226859915,-0.00433145603966986,0.00791079288941681,0.56661633343368
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP8,Caspase-8,40434,-0.00327747894677198,0.00572680903316924,-0.0145020246517837,0.00794706675823973,0.567123708255504
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP4,Caspase-4,37714,-0.00908632346358643,0.0158767316981377,-0.0402047175919364,0.0220320706647635,0.567125467984475
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40471,0.00121997380160199,0.00213424200598712,-0.00296314053013276,0.00540308813333674,0.567587975502626
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX6,Peroxiredoxin-6,40489,0.00313990450481194,0.00553875415946305,-0.00771605364773564,0.0139958626573595,0.570791926324411
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37598,-0.00256133228257584,0.00454131959338691,-0.0114623186856142,0.00633965412046251,0.572759552718466
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,-0.00621182058225323,0.0110493096911522,-0.0278684675769115,0.0154448264124051,0.573993939363865
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,0.00714590866784482,0.0127515480596405,-0.0178471255290506,0.0321389428647403,0.575219047407181
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOE,Apolipoprotein E,38013,0.00389686278980717,0.00695938024783056,-0.00974352249594072,0.0175372480755551,0.575526925771401
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,0.00178658928558241,0.00320029999621025,-0.00448599870698968,0.00805917727815449,0.57667691976078
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,0.00178310548836567,0.00320164617658044,-0.004492121017732,0.00805833199446335,0.577582102223741
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAPS,Calcyphosin,37942,0.00489630269191591,0.00879245131441448,-0.0123369018843365,0.0221295072681683,0.577621580097093
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YAP1,Transcriptional coactivator YAP1,37942,-0.00137154711727236,0.0024660063245341,-0.00620491951335919,0.00346182527881447,0.578096003898792
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,0.00302449007088655,0.00561843562468306,-0.00798764375349226,0.0140366238952654,0.590368478243618
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GJA8,Gap junction alpha-8 protein,37482,-0.00311517354905837,0.00579076198460892,-0.0144650670388918,0.00823471994077512,0.590616805048427
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,0.00598851945916763,0.0111613446126271,-0.0158877159815815,0.0278647548999168,0.591592334294506
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CABP2,Calcium-binding protein 2,37572,0.0032532368942035,0.00607286887307068,-0.00864958609701504,0.015156059885422,0.5921748660254
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL13,Interleukin-13,40044,0.00238288794222158,0.00445797401910989,-0.00635474113523381,0.011120517019677,0.592987626969888
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP10,Stromelysin-2,40341,-0.00297009012974524,0.00555862069196561,-0.0138649866859978,0.00792480642650734,0.593126647280613
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX7,Syntaxin-7,37598,-0.00247096273458009,0.00466098865776159,-0.0116065005037928,0.00666457503463262,0.596025872707731
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37688,0.00257907201106647,0.00487910367381817,-0.00698397118961715,0.0121421152117501,0.597094978992191
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,-0.00397883127328008,0.00753715191246625,-0.0187516490217139,0.0107939864751538,0.597579172357976
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37987,-0.00126396612263511,0.0023998922351809,-0.00596775490358968,0.00343982265831946,0.598427096725425
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37987,-0.0035244527843045,0.00669369210507078,-0.0166440893102432,0.00959518374163423,0.598526246632748
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDHB,Succinate dehydrogenase,37901,-0.00345409494409109,0.00658126154211699,-0.0163533675666404,0.00944517767845821,0.599704590482006
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,-0.00104169868754063,0.00198837761636715,-0.00493891881562025,0.00285552144053898,0.600361046440632
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,0.00157283441330965,0.00301338363123638,-0.00433339750391365,0.00747906633053296,0.601714233182709
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37942,-0.0031157122728081,0.00599527750713234,-0.0148664561867875,0.00863503164117128,0.603285102981649
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,0.00180944414208647,0.00348709805387682,-0.0050252680435121,0.00864415632768505,0.603840049652659
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,40359,-0.00167922279299923,0.00326057574749968,-0.0080699512580986,0.00471150567210014,0.606554543280328
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LIFR,Leukemia inhibitory factor receptor,40341,-0.00116614542219087,0.00227001419786025,-0.00561537324999696,0.00328308240561523,0.607456842254629
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNF174,Zinc finger protein 174,37598,0.00184253217682966,0.00360331668657358,-0.00521996852885455,0.00890503288251388,0.609119213854901
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,0.00168615964463839,0.00329977646479227,-0.00478140222635447,0.00815372151563124,0.609364989961895
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39961,0.00402048393996229,0.00788359759482585,-0.0114313673458964,0.019472335225821,0.610072123007711
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,-0.00212597226485512,0.00417472807658262,-0.010308439294957,0.0060564947652468,0.610585432426075
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFD,Complement factor D,38013,-0.00089956432111184,0.00176796043728644,-0.00436476677819326,0.00256563813596958,0.610890367923212
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,40042,0.00159581151965498,0.00313652933628983,-0.00455178597947309,0.00774340901878305,0.610911823945123
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,-0.00347323602551599,0.00686431238593351,-0.0169272883019457,0.0099808162509137,0.612876015878415
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37901,-0.00121866588420785,0.00240920372023414,-0.00594070517586676,0.00350337340745106,0.612978934605155
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUOX2,Dual oxidase 2,40042,0.00340072446079088,0.00674106116689596,-0.0098117554263252,0.016613204347907,0.613931876208892
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,40305,-0.00102812637373455,0.00203826011534077,-0.00502311619980246,0.00296686345233337,0.613977686956197
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCL2,Phosducin-like protein 2,37482,0.00249544907582207,0.00501408871421948,-0.0073321648040481,0.0123230629556922,0.618712746781043
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLASP1,CLIP-associating protein 1,37482,-0.00329247237702089,0.00663249031495697,-0.0162921533943366,0.00970720864029478,0.619609518601393
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX3,Syntaxin-3,37942,0.00177923816140477,0.00358512955364021,-0.00524761576373004,0.00880609208653957,0.619702980144528
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,0.00474255408246303,0.00956010575104166,-0.0139952531895786,0.0234803613545047,0.619846546394588
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACE,Angiotensin-converting enzyme,37987,-0.00117465717363992,0.00237325617962427,-0.00582623928570349,0.00347692493842365,0.620639277138266
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGMB,RGM domain family member B,40471,0.00118240313468294,0.0024047725734361,-0.00353095110925182,0.00589575737861769,0.622945096323624
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,0.0024959242546368,0.00511963622418988,-0.00753856274477536,0.012530411254049,0.625898148468933
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,0.00225499480134325,0.00462628032202774,-0.00681251462983112,0.0113225042325176,0.625959457921427
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF5,Fibroblast growth factor 5,40044,0.00145641283819746,0.00299646245819002,-0.00441665357985497,0.0073294792562499,0.626942743875776
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37562,-0.00159695892511698,0.00329547161194631,-0.00805608328453174,0.00486216543429779,0.627973940226366
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,40044,-0.00207523017334136,0.00429797920493761,-0.0104992694150191,0.00634880906833635,0.629217134538229
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,-0.00395448853130689,0.0082510605377564,-0.0201265671853094,0.0122175901226957,0.631754252835633
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,40403,0.00120791702990614,0.00252396658013522,-0.00373905746715889,0.00615489152697117,0.632244825214758
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBP6,Guanylate-binding protein 6,37562,0.00210524688021467,0.00440380108397533,-0.00652620324437697,0.0107366970048063,0.63262100974619
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37671,-0.00167076589229488,0.00352995628221403,-0.00858948020543438,0.00524794842084463,0.6359993828039
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPLX2,Complexin-2,37482,0.00136363255186555,0.00288119507626146,-0.0042835097976069,0.007010774901338,0.636016270624698
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYL6B,Myosin light chain 6B,37572,0.00406293415689948,0.00860425461066672,-0.0128014048800073,0.0209272731938063,0.636791467795321
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM171A2,Protein FAM171A2,37959,-0.00701101297815121,0.0149198922286431,-0.0362540017462918,0.0222319757899894,0.638426598331433
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP53BP1,TP53-binding protein 1,37598,0.00386208852696345,0.0082506742572427,-0.0123092330172322,0.0200334100711591,0.639725354468732
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHGB,Secretogranin-1,40406,-0.00174761745962776,0.00373577112783133,-0.00906972887017716,0.00557449395092165,0.639929468417031
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX2,Sorting nexin-2,37900,-0.0033573673433614,0.0072156351891858,-0.0175000123141656,0.0107852776274428,0.641730888094613
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMY2A,Pancreatic alpha-amylase,39695,0.00203043062237969,0.00438099436420753,-0.00655631833146707,0.0106171795762265,0.64303884782086
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,-0.00232338910821795,0.00502072998095207,-0.012164019870884,0.0075172416544481,0.643544426472997
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VEGFB,Vascular endothelial growth factor B,37598,0.00122278431832616,0.00264369706976106,-0.00395886193840552,0.00640443057505784,0.643710274524213
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,0.00193531379682873,0.00419076182993852,-0.00627857938985076,0.0101492069835082,0.64422880099429
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRUNE2,Protein prune homolog 2,37714,-0.00125774318119812,0.00274421120745418,-0.0066363971478083,0.00412091078541207,0.646725800379326
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37572,-0.00224012692194322,0.00490699755394462,-0.0118578421276747,0.00737758828378824,0.648025935134143
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMBN,Ameloblastin,40044,0.00125152240822697,0.00275830300839932,-0.00415475148823569,0.00665779630468963,0.650030116950549
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB2B,Ras-related protein Rab-2B,37900,-0.0025723974986363,0.0056769414410302,-0.0136992027230555,0.0085544077257829,0.650461807713508
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBP2,Guanylate-binding protein 2,40044,-0.00250094085567731,0.00552655499007035,-0.0133329886362152,0.00833110692486057,0.650892346894945
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,-0.0022480667075484,0.00499273281779804,-0.0120338230304326,0.00753768961533576,0.652524810251219
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37572,0.00280993605760727,0.00624469740036545,-0.00942967084710902,0.0150495429623236,0.652738401719287
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INSR,Insulin receptor,37598,-0.000703488852739309,0.00156497810316903,-0.00377084593495062,0.002363868229472,0.653064042919654
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,37541,0.00160200077640416,0.00356935243508859,-0.00539392999636948,0.0085979315491778,0.653568128363035
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37942,0.00190330830310793,0.00424520238767304,-0.00641728837673122,0.0102239049829471,0.653912612699612
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRX,Cone-rod homeobox protein,40042,0.00444567115429732,0.00999203974958741,-0.015138726754894,0.0240300690634886,0.656382817669733
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRTAP,Cartilage-associated protein,37572,0.00197992557669404,0.00450032574405135,-0.00684071288164661,0.0108005640350347,0.659979398892201
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37598,-0.00262920398336718,0.00599524623282772,-0.0143798865997095,0.00912147863297516,0.66099619999254
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSB,Lupus La protein,39961,0.00246215397097113,0.00561817403542625,-0.00854946713846432,0.0134737750804066,0.661212564098793
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,-0.00218857345788544,0.00509733935081651,-0.0121793585854858,0.00780221166971492,0.667669972093426
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,0.00344662108826583,0.00807317476281964,-0.0123768014468607,0.0192700436233923,0.669442508230531
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37883,-0.00165356173671161,0.00389925300077042,-0.00929609761822164,0.00598897414479842,0.671520523417839
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,0.00190873413126378,0.00450427350510642,-0.00691964193874481,0.0107371102012724,0.671747269100453
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,METAP1,Methionine aminopeptidase 1,39961,-0.00119778887421352,0.00285697338000216,-0.00679745669901776,0.00440187895059073,0.675038528287516
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRING1,SREBP regulating gene protein,37482,0.0022357659653644,0.00535485908819047,-0.00825975784748892,0.0127312897782177,0.67630426785712
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37714,-0.0027429503739536,0.00658439363162643,-0.0156483618919414,0.0101624611440342,0.676989752179165
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,0.00341051507406423,0.00822683792638628,-0.0127140872616529,0.0195351174097813,0.678471072523817
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,37482,0.00189723742820086,0.00458570389980389,-0.00709074221541476,0.0108852170718165,0.679079596843139
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRR5,Proline-rich protein 5,37598,0.00185201320303565,0.0044775684445568,-0.00692402094829569,0.010628047354367,0.679158951233731
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,-0.00161894241377543,0.00393018905620435,-0.00932211296393595,0.00608422813638509,0.680401258611973
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN9,Septin-9,40305,0.00107383143480673,0.00261167056460859,-0.0040450428718261,0.00619270574143957,0.680956011496872
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37572,-0.00297019965923306,0.00726089711869374,-0.0172015580118728,0.0112611586934067,0.682496537737009
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMA4,Laminin subunit alpha-4,40422,0.00124314374062754,0.00303947051411039,-0.00471421846702883,0.00720050594828391,0.682545073235499
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37714,0.00257419235789446,0.00631701144934401,-0.0098071500828198,0.0149555347986087,0.683646186792249
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL25,Interleukin-25,37429,-0.00132009964166103,0.0032451078403271,-0.00768051100870214,0.00504031172538009,0.68416391066672
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MELTF,Melanotransferrin,37990,0.00110048384400056,0.00270609226525263,-0.0042034569958946,0.00640442468389571,0.684257538062202
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37572,0.00188562435009251,0.00464509536928207,-0.00721876257370034,0.0109900112738854,0.684794202723967
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA7A,Semaphorin-7A,40490,-0.00101269083083508,0.00249541529779354,-0.00590370481451042,0.00387832315284026,0.684879865502048
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRL,Prolactin,40471,-0.00288175267345272,0.00710709115498278,-0.016811651337219,0.0110481459903135,0.685133301048601
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHP1,Calcineurin B homologous protein 1,37541,0.00271834549612564,0.00678796127007494,-0.0105860585932212,0.0160227495854725,0.688820095806788
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC44A4,Choline transporter-like protein 4,37572,-0.00258085752401478,0.00651596543980648,-0.0153521497860355,0.0101904347380059,0.692050875644457
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37572,0.00143354998285979,0.00364607385306376,-0.00571275476914518,0.00857985473486476,0.694195629718868
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAP1,Antigen peptide transporter 1,37714,0.0022406656001767,0.0057306708103659,-0.00899144918814046,0.0134727803884939,0.695806958957652
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37942,0.00144449218923121,0.00369587545510671,-0.00579942370277794,0.00868840808124035,0.695922433022642
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,40419,0.00115295375536039,0.00295188487772164,-0.00463274060497403,0.00693864811569481,0.696111279208869
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,0.00175912812518435,0.00450507212973409,-0.00707081324909447,0.0105890694994632,0.696188920819986
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NGF,Beta-nerve growth factor,40228,-0.000440266441842545,0.00113190938898381,-0.00265880884425082,0.00177827596056573,0.697311661654979
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STXBP3,Syntaxin-binding protein 3,39980,-0.00157742891699277,0.00409891206045458,-0.00961129655548374,0.0064564387214982,0.700360581436147
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CILP,Cartilage intermediate layer protein 1,37998,-0.00191425149795458,0.00498023979339478,-0.0116755214930084,0.0078470184970992,0.700710752844752
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RELB,Transcription factor RelB,37598,-0.00182973283461518,0.00478522070663726,-0.0112087654196242,0.00754929975039385,0.702191881908091
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,0.00202943779774595,0.0053290074965632,-0.00841541689551792,0.0124742924910098,0.703335716988988
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD276,CD276 antigen,40357,0.00127059084839944,0.00333736569835185,-0.00527064592037017,0.00781182761716906,0.703418561791449
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,-0.0022296301624739,0.00593124755787714,-0.0138548753759131,0.00939561505096528,0.706986939229846
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,0.00199692301160375,0.00531967348997209,-0.00842963702874154,0.012423483051949,0.707380608077474
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37562,-0.00416002256891571,0.0110846882010884,-0.0258860114430491,0.0175659663052176,0.707447523939991
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37562,-0.00147671075241053,0.00393557150736025,-0.00919043090683661,0.00623700940201556,0.707501866929609
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,0.00253453364885357,0.00676274377790898,-0.010720444155848,0.0157895114535552,0.707830968103821
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,0.00204384798348214,0.00549259138661448,-0.00872163113428224,0.0128093271012465,0.709815997979325
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,-0.00238879722452338,0.00642369303375588,-0.0149792355706849,0.0102016411216382,0.709992403520943
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RUVBL1,RuvB-like 1,39980,0.00370145446149835,0.00997756134187565,-0.0158545657685779,0.0232574746915746,0.710659074971258
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPT,Microtubule-associated protein tau,39961,0.00183117677199577,0.00494157093229709,-0.00785430225530653,0.0115166557992981,0.710966082072583
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37900,-0.00212006284219937,0.00575134043376449,-0.0133926900923778,0.00915256440797904,0.71241630493783
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SKIV2L,Helicase SKI2W,37562,0.00137729732733728,0.00376504356085971,-0.00600218805194775,0.00875678270662231,0.714511423270318
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRP2BP,LRP2-binding protein,37572,0.00294846992730841,0.00807888865428091,-0.0128861518350822,0.018783091689699,0.715147265630783
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,-0.00116552131814839,0.00322392147140318,-0.00748440740209863,0.00515336476580185,0.717713458907439
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTX3,Pentraxin-related protein PTX3,40341,0.0016437114305578,0.00455377497719078,-0.00728168752473613,0.0105691103858517,0.718137297646233
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCN2,Transcobalamin-2,40497,-0.000996068584188024,0.00277156057488068,-0.00642832731095415,0.0044361901425781,0.719308777821156
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,-0.00100141986656264,0.0028039623306421,-0.00649718603462116,0.00449434630149589,0.720988447551791
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,0.000972913451554954,0.00272468256192572,-0.00436746436981945,0.00631329127292936,0.721041070702902
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP5,Platelet glycoprotein V,37671,-0.00117514198809821,0.00333072431498522,-0.00770336164546923,0.00535307766927282,0.724229951795749
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD33,Myeloid cell surface antigen CD33,40411,-0.00258551185499954,0.00735804191278259,-0.0170072740040534,0.0118362502940543,0.725303530910124
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOX9,Transcription factor SOX-9,37572,0.000881317460560862,0.00252354721815754,-0.00406483508702791,0.00582747000814964,0.726916578922327
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LMOD2,Leiomodin-2,37541,0.0021072934067593,0.0060449829243413,-0.00974087312494964,0.0139554599384682,0.727393699429073
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,0.00123366740793221,0.00354451750393483,-0.00571358689978005,0.00818092171564447,0.727808625418238
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRN,Progranulin,40262,-0.00077923299506787,0.00225057431579822,-0.00519035865403238,0.00363189266389664,0.729168918714364
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FN1,Fibronectin,38013,0.000834911717773304,0.00243082805713083,-0.00392951127420312,0.00559933470974973,0.731251714466057
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37901,0.000835273467318512,0.00244458740669052,-0.00395611784979491,0.00562666478443193,0.732594956749972
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPB41L5,Band 4.1-like protein 5,37572,-0.00200448100294558,0.00592335949313987,-0.0136142656094997,0.00960530360360856,0.735065134661811
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,0.000933782468984671,0.0027654233037198,-0.00448644720630613,0.00635401214427547,0.735621300947028
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39980,-0.00142785743208338,0.00432418955541542,-0.00990326896069761,0.00704755409653084,0.741251547030813
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,37541,-0.00133361492921728,0.0040392307124137,-0.00925050712554814,0.00658327726711357,0.741280141151113
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,40042,-0.00194508689366788,0.00590460118149232,-0.0135181052093928,0.00962793142205706,0.741843552140367
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,-0.00138299342106623,0.00423726316833788,-0.00968802923100848,0.00692204238887602,0.744135745169755
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABHD14B,Protein ABHD14B,40171,-0.00175273247887197,0.00542618616892406,-0.0123880573699631,0.00888259241221919,0.746689162135293
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,37482,0.00130090960574401,0.00405340026109134,-0.00664375490599502,0.00924557411748303,0.748258890080516
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PFDN2,Prefoldin subunit 2,39961,-0.00166362403235426,0.00521981156468154,-0.0118944546991301,0.00856720663442155,0.749948123832132
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSC1,Hamartin,37598,0.00224676720882172,0.00707542343990818,-0.0116210627333983,0.0161145971510418,0.750834942275501
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EXTL1,Exostosin-like 1,37562,0.00140182629837391,0.00442556466496066,-0.00727228044494899,0.0100759330416968,0.751433430183986
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,0.00202166250594982,0.0064063823642232,-0.0105348469279277,0.0145781719398273,0.752333736760891
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRXN3,Neurexin-3,37572,0.00102194533425908,0.00324002683057419,-0.00532850725366634,0.00737239792218449,0.752453406745773
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,0.00102525623385801,0.00328808132026448,-0.00541938315386038,0.00746989562157639,0.755189971523622
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH1,Protocadherin-1,40475,-0.000627880495386462,0.00201681872995642,-0.00458084520610105,0.00332508421532813,0.755559722905552
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VGF,Neurosecretory protein VGF,37959,-0.000878274790340625,0.00282518013635941,-0.00641562785760507,0.00465907827692382,0.755901277717711
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,0.00129000556607289,0.00415029606744077,-0.00684457472611101,0.0094245858582568,0.755940505121494
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NECTIN1,Nectin-1,37598,0.000917332885072838,0.00296132699395308,-0.0048868680230752,0.00672153379322088,0.756740103287081
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,0.00310173449874148,0.0100376131376732,-0.0165719872510981,0.022775456248581,0.757318076070151
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAT,Catalase,37786,-0.00154740332851309,0.00505706502489403,-0.0114592507773054,0.00836444412027921,0.759618240980361
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CENPJ,Centromere protein J,37714,0.00207528182804665,0.00681082529008726,-0.0112739357405244,0.0154244993966177,0.760596818141905
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST6,Cystatin-M,39992,0.00135107955808269,0.00443840744981765,-0.00734819904355991,0.0100503581597253,0.760822381558267
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,-0.00206468450723305,0.00679657615248891,-0.0153859737661113,0.0112566047516452,0.761297863652334
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BPIFA2,BPI fold-containing family A member 2,37150,0.00312828674103942,0.0103101020744928,-0.0170795133249665,0.0233360868070453,0.761575104245776
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,-0.00177656911713119,0.00586268010851995,-0.0132674221298303,0.00971428389556792,0.761871616281087
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37598,0.00189198598230443,0.00633612063240243,-0.0105268104572043,0.0143107824218132,0.765247532827549
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTF4,Neurotrophin-4,39980,0.00112474441444047,0.00379026372489741,-0.00630417248635846,0.00855366131523941,0.766664642667743
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC25A,M-phase inducer phosphatase 1,37482,0.00111988001303763,0.00380843590404448,-0.00634465435888955,0.00858441438496481,0.768722487497658
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,0.00202656593965852,0.00689387752701698,-0.0114854340132948,0.0155385658926118,0.768787688333514
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,-0.0012497529423215,0.00428209001568607,-0.00964264937306619,0.00714314348842318,0.770401449969295
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCARE,Photoreceptor cilium actin regulator,37541,-0.00231780300877429,0.00800977416179018,-0.018016960365883,0.0133813543483345,0.772301432709229
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,0.0009609688745027,0.00335409547112398,-0.00561305824890031,0.00753499599790571,0.77449498337801
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,-0.00230040264601619,0.00804601170682026,-0.0180705855913839,0.0134697802993515,0.774954006795881
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1A,Interleukin-1 alpha,40044,0.00142269005722186,0.00500607365815698,-0.00838921431276582,0.0112345944272096,0.776266411684479
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDI2,Protein DDI1 homolog 2,37671,0.00205825548574053,0.00726171982988256,-0.0121747153808293,0.0162912263523103,0.776844681794831
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC4A1,Band 3 anion transport protein,37998,-0.00120347825592968,0.0042760923836578,-0.00958461932789897,0.0071776628160396,0.778374583683946
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40489,-0.000983950507799402,0.00351042724112647,-0.00786438790040729,0.00589648688480849,0.779255828079559
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37959,-0.00203650208141271,0.00727517103064968,-0.0162958373014861,0.0122228331386607,0.779539350829122
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHH,Sonic hedgehog protein,37598,-0.00112051987334581,0.0040331490032437,-0.00902549191970346,0.00678445217301185,0.781149116923379
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,0.00136918073992045,0.00492916386989115,-0.00829198044506621,0.0110303419249071,0.781192178334904
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,0.000740006365468014,0.00269323822005009,-0.00453874054583016,0.00601875327676619,0.783501459236063
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA4,Annexin A4,40279,-0.00182007794279761,0.00666001727061168,-0.0148737117931965,0.0112335559076013,0.784638273545727
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARG2,"Arginase-2, mitochondrial",37900,-0.00110559998800853,0.00411840812414955,-0.00917767991134165,0.00696647993532458,0.788354584119895
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,-0.00105983866857767,0.00398862894923935,-0.00887755140908681,0.00675787407193146,0.790462860629735
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LY6D,Lymphocyte antigen 6D,40268,-0.000915520246461748,0.00346392855594572,-0.00770482021611535,0.00587377972319186,0.791551330080703
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK3,Prostate-specific antigen,37998,0.00139386429181225,0.00529608506071036,-0.00898646242718005,0.0117741910108045,0.792409936054177
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,-0.00210613878492609,0.00814498230775961,-0.0180703041081349,0.0138580265382827,0.795961773660129
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMY2B,Alpha-amylase 2B,39311,0.00113135861790391,0.00447567066362472,-0.00764095588280054,0.00990367311860837,0.800441964122867
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300LF,CMRF35-like molecule 1,40489,0.00141455415623377,0.0056260020536272,-0.00961240986887554,0.0124415181813431,0.8014837349607
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,-0.000616823692573642,0.00250670198603854,-0.00552995958520918,0.00429631220006189,0.805631381495112
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,0.00115174508768996,0.00473035399976911,-0.00811974875185749,0.0104232389272374,0.807637629655272
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INSL3,Insulin-like 3,37942,0.00132914817618732,0.00553043228076979,-0.00951049909412147,0.0121687954464961,0.810075374453989
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDAC8,Histone deacetylase 8,37598,0.00138847907236556,0.00580586223601136,-0.00999101091021672,0.0127679690549478,0.81099204939284
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HLA_DRA,,40288,-0.00079145617378466,0.00334250730361635,-0.00734277048887271,0.00575985814130339,0.812826516569413
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37901,0.00247238850274082,0.0104792909496051,-0.0180670217584851,0.0230117987639668,0.813489885987428
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPM1B,Protein phosphatase 1B,37598,-0.0013804099403793,0.00588625501601898,-0.0129174697717765,0.0101566498910179,0.814589521541805
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,-0.00103234381654176,0.00440230765556224,-0.00966086682144376,0.00759617918836024,0.814600024216348
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37901,0.00276558344938164,0.0119267675995524,-0.020610881045741,0.0261420479445043,0.816634448651179
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUMF1,Formylglycine-generating enzyme,37598,0.00144295099150861,0.00622717766016263,-0.0107623172224101,0.0136482192054274,0.816760427146455
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,-0.00166960623380024,0.007206312021884,-0.0157939777966929,0.0124547653290924,0.816784932327724
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGAX,Integrin alpha-X,37714,0.00118162944800114,0.00513393188992201,-0.008880877056246,0.0112441359522483,0.817970435115185
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,-0.0012704070558871,0.00574894397424833,-0.0125383372454138,0.00999752313363963,0.825110719003873
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37598,-0.00219764973696194,0.00998874258421647,-0.0217755852020262,0.0173802857281023,0.825864718194029
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARTN,Artemin,40044,0.000904713198791386,0.00413749470799427,-0.00720477642887738,0.00901420282646015,0.826916151787515
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARA5,Scavenger receptor class A member 5,40471,-0.000584176180889076,0.00271421673043705,-0.0059040409725457,0.00473568861076755,0.829592088321913
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AFAP1,Actin filament-associated protein 1,37671,-0.00168908336397351,0.00786336368736775,-0.0171012761912143,0.0137231094632673,0.829923309802207
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,-0.00133879923211956,0.00625411168289953,-0.0135968581306026,0.0109192596663635,0.830498072933868
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAGE2A,G antigen 2A,37482,0.00123913825204167,0.0057904916665333,-0.0101102254143636,0.0125885019184469,0.830554036985169
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,-0.00241409636999936,0.0113499202481447,-0.024659940056363,0.0198317473163642,0.831565871670108
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRND,Prion-like protein doppel,37942,-0.00105148700597947,0.00497486335935297,-0.0108022191903113,0.00869924517835236,0.832609577603971
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,0.000650734727673909,0.00310960037669365,-0.00544408201064565,0.00674555146599346,0.834243568725313
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMOD4,Tropomodulin-4,37482,0.000778295077191041,0.00389236908245773,-0.00685074832442611,0.00840733847880819,0.841519615356792
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37697,-0.00186728426639741,0.00936390298052702,-0.0202205341082304,0.0164859655754355,0.84194272976915
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37671,0.000462550598396814,0.00232269827317692,-0.00408993801702996,0.00501503921382358,0.842153444617006
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,-0.00152593909274677,0.00766331434853166,-0.0165460352158688,0.0134941570303753,0.84216989399072
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYTH3,Cytohesin-3,37482,-0.00136464010243429,0.00685888598141601,-0.0148080566260097,0.0120787764211411,0.842297578014139
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37714,-0.00156826362279458,0.00789011723574603,-0.0170328934048568,0.0138963661592676,0.842451162178716
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NME1,Nucleoside diphosphate kinase A,37598,-0.000403025406814591,0.00203736049936105,-0.00439625198556225,0.00359020117193307,0.843190971344733
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA11,Serpin A11,40536,-0.000729839469332736,0.00372878533930441,-0.00803825873436938,0.0065785797957039,0.844823068753209
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C5,Complement C5,38013,0.000277734202918159,0.00141950198631009,-0.00250448969024961,0.00305995809608593,0.844882289605361
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,0.000737896345531513,0.00377897326788005,-0.00666889125951338,0.00814468395057641,0.845189515162764
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37714,0.000824455770657958,0.00423212026088314,-0.00747049994067299,0.00911941148198891,0.845545339267453
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37562,-0.000868093405183728,0.00448459276462667,-0.009657895223852,0.00792170841348454,0.846513706249931
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37562,-0.000730116076211171,0.00377992014439516,-0.00813875955922569,0.00667852740680335,0.846839411623508
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37562,0.00101203203620754,0.00537992615182073,-0.00953262322136109,0.0115566872937762,0.850791275105757
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL11,Interleukin-11,40044,0.00111081005386263,0.00593413908502569,-0.0105201025527877,0.012741722660513,0.851514291147715
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37572,0.000742953350837524,0.00399153978408735,-0.00708046462597368,0.00856637132764873,0.852344112306533
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BMP4,Bone morphogenetic protein 4,40203,0.000781511452537217,0.00421545002219227,-0.00748077059095963,0.00904379349603406,0.852923831791305
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,-0.00157257669679567,0.00851549619219078,-0.0182629492334896,0.0151177958398983,0.853488858055375
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,0.000845262137110856,0.00460289886873208,-0.00817641964560402,0.00986694391982573,0.854300704167771
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTO1,Protein LTO1 homolog,40044,0.000691785311952393,0.00382501162433402,-0.00680523747174228,0.00818880809564707,0.856481107914184
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36973,-0.000842297940147968,0.00465923172030388,-0.00997439211194357,0.00828979623164763,0.856542846062592
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEB,Nebulin,37562,-0.000595840272445484,0.00337819165801775,-0.00721709592216027,0.0060254153772693,0.859999343160046
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37598,-0.000518696012135763,0.0030260086541991,-0.006449672974366,0.00541228095009447,0.863901986036015
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL24,Interleukin-24,40044,0.000777285322506167,0.00458427724412059,-0.00820789807597019,0.00976246872098252,0.865362624215255
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,-0.00115060997410137,0.00680986607433906,-0.0144979474798059,0.0121967275316032,0.865828509785845
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37714,-0.00132591813531883,0.00785784762612799,-0.0167272994825297,0.014075463211892,0.86600523662271
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KEL,Kell blood group glycoprotein,39961,-0.000530371627602843,0.0033115646861534,-0.0070210384124635,0.00596029515725781,0.872759162873212
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,-0.000620880357635818,0.00389632211872123,-0.00825767171032944,0.0070159109950578,0.873395233787788
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,0.00036767737416437,0.0023483792311388,-0.00423514591886769,0.00497050066719643,0.875588983636266
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRD3,Bromodomain-containing protein 3,37562,0.000679809978538175,0.00448916136589304,-0.00811894629861218,0.00947856625568853,0.87963599648195
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,-0.000496468981220084,0.00334211002685375,-0.00704700463385343,0.00605406667141326,0.881911333368921
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTLA,B- and T-lymphocyte attenuator,37482,-0.00121695348283627,0.00826028526803605,-0.0174071126081869,0.0149732056425144,0.882877115420769
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTN,Pleiotrophin,40042,-0.00068437549946872,0.0046629609774081,-0.0098237790151886,0.00845502801625116,0.883316695382339
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTNL10,Butyrophilin-like protein 10,37482,0.00055586796094198,0.00389150620648317,-0.00707148420376504,0.008183220125649,0.886417695921241
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37572,0.000548050006446686,0.00388365080701535,-0.0070639055753034,0.00816000558819677,0.887779506477316
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,-0.000721458341410162,0.00524874755545,-0.0110090035500922,0.00956608686727184,0.89067452654627
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,40422,0.000352376289138656,0.00258012200196471,-0.00470466283471218,0.00540941541298949,0.891369646605028
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,37541,-0.000508966659620631,0.00373605848390775,-0.00783164128807982,0.00681370796883856,0.89164083272986
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TTN,Titin,37562,-0.000828295520295208,0.00608896278173945,-0.0127626625725045,0.0111060715319141,0.891797847091893
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37959,-0.000420443757592674,0.00313799459156181,-0.00657091315705382,0.00573002564186847,0.893416544767356
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37562,-0.000780968492708444,0.00583853476470357,-0.0122244966315274,0.0106625596461106,0.893593587567323
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMEM132A,Transmembrane protein 132A,37628,0.000777199418905811,0.00583816449769523,-0.0106656029965768,0.0122200018343885,0.8940974008398
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARFIP1,Arfaptin-1,37959,-0.000845383977718051,0.00636178386419658,-0.0133144803515434,0.0116237123961073,0.89428651721621
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17F,Interleukin-17F,40044,0.000965035384021564,0.00739279246103497,-0.013524837839607,0.0154549086076501,0.896143006294992
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PFDN6,Prefoldin subunit 6,37572,0.000794049329273115,0.00615029932760229,-0.0112605373528274,0.0128486360113736,0.897274623330133
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICOSLG,ICOS ligand,40305,0.000227885733880717,0.0017745585088818,-0.00325024894352761,0.00370602041128904,0.897819602400502
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PKLR,Pyruvate kinase PKLR,40374,0.000775609391676816,0.00616936859885261,-0.0113163530620743,0.0128675718454279,0.899955622661186
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KHDC3L,KH domain-containing protein 3,37482,0.000796233314236692,0.00634256232248829,-0.0116351888378404,0.0132276554663137,0.900099489553265
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLSPN,Claspin,39925,-0.00039768112163341,0.00317296490675793,-0.00661669233887895,0.00582133009561213,0.900260580441499
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL18,C-C motif chemokine 18,40172,0.000814562704171833,0.00651753253084871,-0.0119598010562916,0.0135889264646353,0.900540801167715
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,0.000698009021336739,0.0056368508445692,-0.0103502186340189,0.0117462366766924,0.901452099719776
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,-0.000823629744712699,0.00673239002978179,-0.014019114203085,0.0123718547136596,0.902632851004344
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSLP,Thymic stromal lymphopoietin,40042,-0.000689043274139151,0.0056637870404531,-0.0117900658734272,0.0104119793251489,0.903171687057843
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM1,Intercellular adhesion molecule 1,40291,0.000315131679067119,0.00264706849245269,-0.00487312256614015,0.00550338592427439,0.905237799111223
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,-0.000450806121793906,0.00381826489477388,-0.00793460531555072,0.00703299307196291,0.906017408648809
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDRG1,Protein NDRG1,39961,-0.000754613548648442,0.00639510814425909,-0.0132890255113963,0.0117797984140994,0.906070327387521
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37900,0.000585086838847488,0.00508088902344682,-0.00937345564710827,0.0105436293248032,0.908324443485957
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,40305,-0.000380112390909061,0.00333007940081192,-0.00690706801650043,0.0061468432346823,0.909124182247724
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,-0.000573491664705348,0.00509670689281439,-0.0105630371746215,0.00941605384521086,0.910411243257635
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,-0.000507941265253331,0.00453700748446817,-0.00940047593481094,0.00838459340430428,0.910860748322337
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37598,0.000415807692590537,0.00380862801987019,-0.00704910322635504,0.00788071861153611,0.91306520350115
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNN,Tenascin-N,37998,0.000439087764795519,0.00405123149677152,-0.00750132596887665,0.00837950149846769,0.913692875918637
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,0.000659703621628066,0.00610178270316806,-0.0112997904765813,0.0126191977198375,0.913904648208562
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD244,Natural killer cell receptor 2B4,40516,0.000264907138082192,0.00246696526604063,-0.00457034478335743,0.00510015905952182,0.914487444033319
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,-0.00169851120209767,0.0160642511551068,-0.033184443466107,0.0297874210619117,0.915796280766959
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP152,Centrosomal protein of 152 kDa,37482,0.00038629522449441,0.00386088639691431,-0.00718104211345764,0.00795363256244646,0.920303385280867
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37598,0.000191262270421278,0.00207625686448757,-0.00387820118397437,0.00426072572481692,0.926605063184068
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ISM2,Isthmin-2,37998,0.000379813336016046,0.00412802012701642,-0.00771110611293614,0.00847073278496823,0.926692570524584
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40516,-0.000216167586433661,0.00242519816396186,-0.00496955598779891,0.00453722081493159,0.928976536747766
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK12,Kallikrein-12,39980,-0.00118469538079604,0.013297851005921,-0.0272484833524012,0.0248790925908091,0.929012141087411
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSTN,Osteocrin,37572,0.000339972375246293,0.00400215091364854,-0.00750424341550484,0.00818418816599743,0.932304492259116
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF7,Fibroblast growth factor 7,37482,0.000618266691035411,0.00753457204267498,-0.0141494945126076,0.0153860278946784,0.934602403059112
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMEM25,Transmembrane protein 25,37959,0.00033163429496434,0.00406327246710005,-0.00763237974055176,0.00829564833048044,0.934952063831172
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,-0.000209039431036811,0.00256579867417116,-0.00523800483241229,0.00481992597033867,0.935068051576941
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RALB,Ras-related protein Ral-B,37598,0.000217894222179256,0.00274744746370581,-0.00516710280668413,0.00560289125104264,0.936788949199644
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL2,Interleukin-2,40044,0.000225603860385024,0.0029115884123045,-0.0054811094277318,0.00593231714850185,0.938238873009466
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37598,0.000263802057651478,0.00342611927923153,-0.00645139172964233,0.00697899584494528,0.938626835922276
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCP11,T-complex protein 11 homolog,37714,0.000428808919161199,0.00564922800060733,-0.0106436779620292,0.0115012958003516,0.939495222824034
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,0.000293138249234286,0.00400850191023727,-0.00756352549483077,0.00814980199329934,0.941704305982316
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTA,Lymphotoxin-alpha,40341,-0.000261606473973022,0.00373100423001044,-0.00757437476479347,0.00705116181684743,0.944101492943994
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NLGN1,Neuroligin-1,37572,-0.000418387849995332,0.00648213572900288,-0.013123373878841,0.0122865981788503,0.94853745692093
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,0.000193052019774414,0.00304176086568834,-0.00576879927697473,0.00615490331652356,0.949395446584534
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AK1,Adenylate kinase isoenzyme 1,40359,-0.000358033566024769,0.00593166574001794,-0.0119840984164599,0.0112680312844104,0.951869912920599
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,40305,-0.000146708215274296,0.00244211794774961,-0.00493325939286354,0.00463984296231494,0.952097317265713
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDK2,Protein sidekick-2,37671,0.000212685480644789,0.0035440298875203,-0.006733613098895,0.00715898406018458,0.952146724017136
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37942,-0.000386867366987216,0.00660098416546,-0.0133247963312888,0.0125510615973144,0.95326558227354
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,0.000280585986310321,0.00522005924351059,-0.00995073013097043,0.0105119021035911,0.957133979339819
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39980,0.000220420434081348,0.00441017081214917,-0.00842351435773103,0.00886435522589373,0.960138951413984
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37598,0.000431097948756243,0.00869358069956502,-0.0166083202223912,0.0174705161199037,0.960451401496113
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EP300,Histone acetyltransferase p300,37598,-0.000130725151813344,0.00276644218341877,-0.00555295183131414,0.00529150152768745,0.962311596059791
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,-0.000119941475345989,0.00261495670892788,-0.00524525662484463,0.00500537367415265,0.963416570537715
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA8,Carbonic anhydrase-related protein,37598,-0.00011526553037023,0.00258180055303836,-0.00517559461432542,0.00494506355358496,0.96439062915205
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,-0.000338605798628624,0.00762987071585312,-0.0152931524017007,0.0146159408044435,0.964602882837816
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCRN1,Secernin-1,40341,0.000216081126048119,0.0052099124277617,-0.00999534723236481,0.0104275094844611,0.966917742691842
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHIT1,Chitotriosidase-1,40398,-0.00054321558676416,0.0138481658969794,-0.0276856207448439,0.0265991895713156,0.968710267810482
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DRAXIN,Draxin,40228,-0.000154421524866038,0.0040198552825421,-0.00803333787864855,0.00772449482891648,0.969357528750944
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN7,Septin-7,37714,-0.000181716141609339,0.0048776210661259,-0.0097418534312161,0.00937842114799742,0.970282185805467
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNCA,Alpha-synuclein,37671,-0.000360328220979282,0.0105583404050179,-0.0210546754148143,0.0203340189728558,0.972776111090685
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAGLN3,Transgelin-3,37482,-0.000188396202359576,0.0056718014412442,-0.0113051270271982,0.0109283346224791,0.973502616397911
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPT1,Translationally-controlled tumor protein,40044,0.000184357414786401,0.00618113576579435,-0.0119306686861705,0.0122993835157433,0.976206351882769
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,-0.000119522724944021,0.00405469470791376,-0.00806672435245498,0.00782767890256694,0.976484120198213
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,0.000452843286079501,0.0166957549283277,-0.0322708363734427,0.0331765229456017,0.978361765350329
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37714,-0.000136338458487086,0.00505547843831382,-0.0100450761975822,0.00977239928060801,0.97848529742986
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FZD8,Frizzled-8,37541,0.000112368278801904,0.00417413431972885,-0.00806893498786663,0.00829367154547044,0.97852384061728
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL2,Fc receptor-like protein 2,40442,-0.000114314099629209,0.00451268924604095,-0.00895918502186947,0.00873055682261105,0.97979070352945
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAG,Myelin-associated glycoprotein,37572,-0.000107903321695456,0.00433496279921598,-0.00860443040815877,0.00838862376476786,0.980141960192423
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37714,-0.000163204092056695,0.00694188386523904,-0.0137692964679252,0.0134428882838118,0.981243769312124
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,37541,0.000246686004317013,0.0111088714629823,-0.0215267020631284,0.0220200740717624,0.982283797291713
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1B,Interleukin-1 beta,39946,0.000114599092040887,0.00523645798889855,-0.0101488585662003,0.0103780567502821,0.982540092492909
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB39B,Ras-related protein Rab-39B,37562,0.00015825471683626,0.00825908847667144,-0.0160295586974398,0.0163460681311123,0.984712736639596
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17RA,Interleukin-17 receptor A,40332,-7.63018833882747e-05,0.0040683492635406,-0.00805026643992784,0.00789766267315129,0.985036789305765
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,0.000138880771688351,0.00800262657420735,-0.015546267313758,0.0158240288571347,0.986154153997921
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,8.83251453626534e-05,0.00530493729502171,-0.0103093519528799,0.0104860022436052,0.986716398889997
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,9.27395285412816e-05,0.00629601351737952,-0.0122474469655226,0.0124329260226051,0.988247869991184
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBR1,T-box brain protein 1,37572,-6.0442163935255e-05,0.00453687394090396,-0.00895271508810701,0.0088318307602365,0.989370759579582
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,3.25860880356939e-05,0.00245394315295032,-0.00477714249174694,0.00484231466781833,0.989405340440835
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,-6.41481783449289e-05,0.00509990642976936,-0.0100599647806929,0.00993166842400301,0.989964421005956
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPR101,Probable G-protein coupled receptor 101,37541,4.96543672744795e-05,0.0060038126046524,-0.0117178183378442,0.0118171270723932,0.993401318919885
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,1.94509013427551e-05,0.00342410862786571,-0.00669180200927403,0.00673070381195954,0.995467668340345
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSMB,Beta-microseminoprotein,40236,-2.96252335166251e-05,0.0064257904853743,-0.0126241745848502,0.012564924117817,0.996321532991469
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VIM,Vimentin,40042,-3.19176254215377e-05,0.0110055285838198,-0.0216027536497084,0.0215389183988653,0.997686059668129
